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This thesis describes structural studies on the interactions between the fucosylated 
chondroitin sulfate (fCS) oligosaccharides and human proteins known as selectins. fCS is a 
carbohydrate obtained from sea cucumbers, that can be classified as a branched 
glycosaminoglycan (GAG). It has attracted much attention due to its anti-coagulant, anti-
inflammatory, antimetastatic and anti-HIV properties and its structure was previously 
determined by NMR. Selectins constitute a family of proteins involved in cell adhesion 
processes, such as inflammation, attachment of viral particles and migration of tumour cells. 
fCS oligosaccharides have been shown to bind to selectins, which is likely a reason behind 
their biological activity. However, the mechanism of this interaction is currently unknown. 
The initial part of the thesis describes the experimental work on expression and purification 
of the recombinant L- and P-selectin constructs in Pichia pastoris, Escherichia coli and HEK 
293 cells. The aim of these experiments was to produce two constructs for each selectin, a 
single domain construct, consisting of the C-type lectin domain only, and a double domain 
construct, consisting of both the C-type lectin and the EGF-like domains. The intention was 
that the recombinant proteins would be labelled with 13C and 15N to allow for the in-depth 
structural NMR studies on the fCS-selectin interaction. Various experimental approaches 
have been explored, including the use of different cell lines, modifications to construct design, 
as well as alterations to expression and purification conditions. Although it was not possible 
to produce soluble selectin constructs in either bacterial or yeast cells, protein expression 
tests in HEK293 cells, performed in collaboration with the Oxford Protein Production facility 
(OPPF), led to production of a soluble L-selectin construct, consisting of the L-selectin C-type 
lectin domain.  
The produced L-selectin construct, as well as two commercially available constructs of the L- 
and P-selectin extracellular domains, were used in the Saturation Transfer Difference (STD) 
NMR experiments to provide new information about the nature of the fCS-selectin binding. 
The STD experiments allowed to identify the regions within the fCS oligosaccharides that are 
in direct contact with the protein and likely play an important role in this interaction. 
Experiments on different protein constructs allowed the comparison of fCS binding to P-
selectin and to two different recombinant constructs of L-selectin. Results of these studies 




the fCS oligosaccharides bind to one-domain L-selectin construct with similar affinity as to a 
larger construct, consisting of the entire extracellular region of the protein. 
Alongside the experimental work, theoretical in silico studies on the fCS-selectin binding 
were undertaken as part of this project. The existing X-ray structures of selectin complexes 
were subjected to Molecular Dynamics (MD) simulations, which allowed to explore the 
dynamic behaviour of E-selectin upon binding to sialyl Lewis x (sLex). It was found that sLex 
forms a more favourable interaction with the extended conformation of E-selectin and that 
the protein in this conformation is characterised by a high degree of interdomain flexibility, 
with a new type of interdomain movement observed in the MD studies on this complex. 
In further in silico studies, the fCS oligosaccharides were docked to the existing P-selectin 
structures. The docking tests were performed on the computationally produced fCS 
trisaccharides with fucose branches either 2,4 or 3,4-sulfated. Results were evaluated with 
MD simulations and analysed in the light of current knowledge of selectin-ligand binding and 
the STD NMR experimental results. The in silico studies allowed to identify a subset of P-
selectin residues that are likely involved in the interaction with fCS oligosaccharides in vivo. 
The conformational behaviour of P-selectin upon binding to fCS was also explored and it was 
found that the interdomain hinge is flexible during this interaction and allows transition from 
bent to extended conformational state. 
Finally, a new NMR method was developed to facilitate the studies of complex carbohydrates, 
incorporating the concepts of G-matrix Fourier Transform (GFT) NMR into 2D HSQC and 2D 
HSQC-TOCSY experiments. The method allows to separate peaks in the regions of high 
spectral overlap, providing information that can simplify the assignment process. The new 
experiments facilitated the structural evaluation of a sample containing a mixture of 

















Marine organisms have adapted to life in harsh environments, surviving at great ocean 
depths with high salt concentrations and extreme pressure and temperature conditions. 
Because of that, they are able to produce bioactive compounds that are not found anywhere 
else on Earth. Some of these compounds have medical properties that could serve as an 
inspiration in design of new drugs. One example of such compound is a new type of 
carbohydrate found in the body walls of the sea cucumbers, named fucosylated chondroitin 
sulfate (fCS). It has attracted much interest as it was shown to reduce inflammation, HIV 
infection and migration of cancer cells to new tissues. The main aim of the work described in 
this thesis was to study the molecular mechanisms that underlie these biological properties 
of fCS and to obtain new information that would help in design of new drugs for treatment of 
these conditions. 
We believe that the biological activity of the fCS is due to its interaction with a family of 
proteins called selectins. Selectins help cells to attach to each other, allowing certain cell 
types to migrate to new regions within the body. For example, the cells of our immune system 
need to travel to the site of injury during inflammation. Previous research has shown that fCS 
binds to two selectins more strongly than carbohydrates found on the surface of our cells. 
This means that it could outcompete the natural binders of selectins, interfering with their 
function and preventing migration of some of the cells, such as tumour cells. 
The studies described in this thesis allowed to describe the interaction between the fCS and 
selectins in more detail, providing information about the structural regions within both 
molecules that are involved in the binding. We were able to compare the binding between 
the two types of selectins and predict the region within selectins which is responsible for the 
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Chapter 1: Introduction 
 
 
Glycosylation is a language that cells use to communicate with each other. Glycans present 
on the cell surface allow cells to interact with the surrounding environment and to pass on 
important messages to their neighbours. Efficient communication is crucial for processes 
such as the inflammatory response, cell growth, differentiation, proliferation and 
homeostasis. Misregulation of these processes can in turn lead to development of disease 
states such as the chronic inflammatory disease or cancer. 
Even though carbohydrates perform a multitude of substantial functions in the human 
organism, their importance is often overlooked. The field of structural biology is dominated 
by the studies of the structure and function of proteins and nucleic acids, yet our 
understanding of structural properties of proteoglycans and protein-carbohydrate 
complexes is still very limited.  The main issue in glycobiology is the incredible complexity of 
sugar molecules, characterised by a huge number of possible combinations of 
monosaccharides and glycosidic linkages, as well as the limited knowledge about the 
processes involved in the regulation of carbohydrate synthesis. Studies of glycan structure 
and interactions are also hindered by the complexity of carbohydrate samples, 
heterogeneous and polydisperse in nature, which makes them difficult to study using 
spectroscopic techniques. 
The major aim of this work is to gain a more in-depth understanding of the protein-
carbohydrate interactions, focusing on the fucosylated chondroitin sulfate – a marine 
carbohydrate closely related to a group of mammalian glycans known as glycosaminoglycans 
– and its interactions with a group of cell adhesion proteins known as selectins. This chapter 











Glycosaminoglycans (GAGs) are complex carbohydrates found in the majority of animal 
species, both vertebrates and invertebrates. Interestingly, GAGs have never been found in 
plant species which indicates that they occurred on evolutionary timescale after the 
eukaryotes had divided into plant and animal kingdoms1. Carbohydrates structurally similar 
to GAGs are found in certain species of bacteria, however, it is believed that their evolutionary 
origin may be different to the animal GAGs. Structure of GAGs varies greatly amongst the 
different animal species, as well as among the different organ and tissues within a single 
organism, due to the extensive modifications present on the carbohydrate chains1. 
GAGs participate in a variety of physiological processes. Many of them are attached to the 
cell-surface proteins, forming proteoglycans which participate in recognition and signal 
transmission between different cell types. Each tissue produces its own set of GAGs on its 
surface that helps in regulation of tissue-specific contacts with proteins such as chemokines, 
cytokines, growth factors, morphogens, enzymes and adhesion molecules.  Some types of 
GAGs are also secreted by the cells to the surrounding extracellular matrix (ECM) where they 
become part of the complex extracellular environment that regulates cell proliferation and 
differentiation. Regulation of the surface presentation and secretion of GAGs and 
proteoglycans moderates cell-cell communication by allowing the cells to receive signals and 
respond to the extracellular environment2-4.  
GAGs have been implicated in a variety of biological functions, such as the structural 
organisation of the ECM, control of homeostasis, cell adhesion, regulation of cell growth and 
differentiation4. Acting as co-receptors for growth factors, they play important role in cell 
proliferation and contribute to development of malignant cancer tissue and tumour 
progression4. By interacting with bacterial receptors, they can also take part in microbial 
invasion. Sulfated GAGs are associated with inflammatory response and are also a common 
constituent of amyloid plaques in neurodegenerative diseases3. These varied biological roles 
and the importance of GAGs in disease progression have attracted much interest from the 







1. 1. 1. Classification of GAGs 
 
GAGs are linear polysaccharides, built of repeating disaccharide units consisting of a 
hexosamine – N-glucosamine (GlcN) or N-galactosamine (GalN) – and a hexuronic acid, which 
can be either glucuronic (GlcA) or iduronic acid (IdoA). The only exception to this rule is 
observed in keratan sulfate, where hexuronic acid is replaced by galactose (Gal). The 
individual subunits are connected to one another by glycosidic linkages which may involve 
atoms at different positions along the carbohydrate ring. The individual GAG chains also 
differ from each other in the pattern of substituents – hexuronic acid subunits can be 
decorated with sulfate groups and hexosamine subunits with either sulfate or acetyl groups. 
These features lead to a great structural diversity among the glycosaminoglycan family. 
Based on their monosaccharide composition, configuration of their glycosidic linkages and 
the amount and location of the sulfate substituents, GAGs are divided into six major groups: 
heparin, heparan sulfate (HS), chondroitin sulfate (CS), dermatan sulfate (DS), keratan 
sulfate (KS) and hyaluronan (HA). Table 1.1.1 summarises the main structural features of 
these GAG subclasses.  
 








Heparin 5 – 30 
L-IdoA, D-GlcA, D-
GlcN 
1.6 - 3.0 
Heparan sulfate (HS) 30 
L-IdoA, D-GlcA, D-
GlcN 
0.4 - 2.0 
Chondroitin sulfate 
(CS) 
5 – 50 D-GlcA, D-GalN 0.1 - 1.3 
Dermatan sulfate (DS) 15 – 40 L-IdoA, D-GalN 1.0 - 3.0 
Keratan sulfate 4 – 19 D-Gal, D-GlcN 0.9 - 1.8 
Hyaluronan (HA) 5 – 20000 D-GlcA, D-GlcN N/A 
 
 
Even among the individual subclasses, GAGs exhibit high degree of variability as different 
regions of the polysaccharide chains can have different chemical composition. The 




charged ‘patches’ along the chain. In some GAGs, even the distribution of individual 
monosaccharide subunits can vary, for example in some regions GlcA is more prevalent than 
IdoA. This multitude of structural variants of GAG chains, their heterogeneity, as well as their 
different patterns of attachment to proteins in formation of proteoglycans, are the source of 
diverse structural motifs that can be utilised in interactions with other macromolecules. For 
example, the arrangement of sulfate groups along the GAG chains is believed to play an 
important role in their recognition by the cell surface proteins5,6. A brief overview of some of 
the main types of GAGs will be given in the following sections. 
All GAGs, except for hyaluronan, are synthesised as O-linked proteoglycans, covalently 
attached to a specific serine residue of the core protein via a tetrasaccharide linkage 
GlcAβ1→3Galβ1→3 GlcAβ1→4Xylβ1→O-(Ser)4. Synthesis of the linkage region is catalysed 
by four glycosyltransferases: xylosyl transferase (XylT), β-4-galactosyltransferase (GalT-I), 
β-3-galactosyltransferase (GalT-II) and β-3-GlcA transferase (GlcAT-I). Once the synthesis of 
the linker is complete, the first hexosamine unit is added onto the chain by the action of 
another glycosyltransferase. Initially, all hexosamine units are N-acetylated. The first residue 
determines whether the chain matures into a HS-type (GlcNAc) or CS-type (GalNAc) GAG. The 
chain is then gradually extended by alternative addition of hexuronic acid and hexosamine 
residues. Glycosyltransferases involved in these processes vary, depending on the type of 
GAG chain being synthesised6.  
Once the synthesis of the sugar backbone is complete, modifications can be added by the 
action of deacetylases, sulfotransferases and epimerases. N-deacetylase-N-sulfotransferase 
is a large enzyme that cleaves off acetyl group from some of the hexosamine residues and 
attaches an N-sulfate groups instead6. The final chain is divided into sections with 
predominantly N-sulfated residues (NS domains), N-acetylated residues (NAc domains) or a 
mixture of both (NS/NAc mixed domains)6. Other sulfotransferases add O-sulfate groups 
onto specific positions along the carbohydrate chain. GlcA-C5 epimerase catalyses 
epimerisation of GlcA to IdoA in biosynthesis of heparin and dermatan sulfate6. Iduronic acid 
residues provide the carbohydrate chains with greater flexibility and are therefore important 
in facilitating interactions with proteins2,7.  
It is important to note here that GAG biosynthesis is a nontemplate-driven process, in 
contrast to synthesis of nucleic acids or proteins. For this reason, GAG biosynthesis is very 
challenging to study, control or recreate under laboratory conditions. Therefore, our 
knowledge of the processes involved in the regulation of GAG biosynthesis, including the 




carbohydrate backbone is still very limited. Several studies indicate that the type of GAG 
chain and the pattern of modifications can be influenced by the protein core to which the 
chain is attached8. However, it remains unclear how the regulatory information is transferred 
from the protein to the biosynthetic machinery.  
 
 
1. 1. 1. 1. Heparin and heparan sulfate 
 
Without a doubt, the most familiar GAG is heparin, which is a molecule well-recognised for 
its wide use in medicine as a potent anticoagulant agent. Heparin is built of repeating units 
of α-D-GlcN (1⟶4) linked to either one of the hexuronic acids, although in the majority of 
cases it is α-L-IdoA. Heparin is the most densely sulfated type of GAG, with sulfate 
substituents at various positions – most commonly the amine group or the O6 of GlcN or the 
O2 of IdoA. Occasionally, O3 of GlcN can also be sulfated. The amino group of GlcN can be 








Fig. 1. 1. 1. Chemical structure of a typical heparin disaccharide unit. In over 90% of 
heparin units the hexuronic acid is IdoA. Heparan sulfate has higher proportion of GlcA subunits. 
R designates potential sites of sulfation, whilst R’ – of sulfation or acetylation. 
 
Pharmaceutically available heparin is derived from animal sources – it is found in the mast 
cells of certain organs, such as the liver, intestine or lungs. Its natural function is unclear but 
it is known to interact with histamine, proteases and inflammatory mediators, also located 
in the mast cell granules9. Heparin acts as an anticoagulant agent in several ways but its main 
mechanism of action is activation of antithrombin, a small protein which inhibits activity of 




pentasaccharide sequence within heparin via a set of basic amino acid residues9. Binding to 
heparin causes local conformational changes in antithrombin which in turn lead to higher 
affinity binding between antithrombin and thrombin. Following the heparin-induced 
conformational changes, antithrombin is able to covalently bind to thrombin, blocking its 
activity and stopping the coagulation cascade9. Several other clotting factors are also affected 
by the altered antithrombin which enhances the anticoagulatory effect of heparin even 
further9. 
Aside for its importance in preventing blood clotting, heparin also acts as an anti-
inflammatory agent and has been shown to have beneficial effects for patients with 
conditions such as asthma, arthritis, inflammatory bowel disease, osteoporosis and cancer5. 
In treatment of such conditions, however, the anticoagulant activity of heparin becomes a 
problem as it may pose risks to patients. For this reason, efforts have been made to develop 
non-anticoagulant heparin derivatives and heparin-mimicking polyanions. Low molecular 
weight heparins (LMWHs), which are the heparin chains of size 2 to 10 kDa, display more 
predictable anticoagulant activity than the large heparin polysaccharides and can therefore 
be administered with less risk. Compared to heparin, they allow for more controlled 
treatment of thrombosis and have also been shown to inhibit angiogenesis better than the 
unfractionated heparin5,10. 
Both heparin and LMWHs have been reported to inhibit cell adhesion processes, blocking the 
recruitment of leukocytes, pathogens and migrating cancer cells to vascular endothelium. 
Studies show that heparin acts by binding to cell adhesion proteins, L- and P-selectins, 
competing with their natural ligands, and that the binding affinity can be regulated by 
introducing structural modifications onto heparin chains. For example, the elimination of 
sulfation at position O6 of GlcN dramatically reduced its inhibitory effect on tumour cell 
adhesion11. This inhibitory activity of heparins could have a potential use in treatment of 
inflammation and prevention of pathogenic invasion or cancer metastasis. Moreover, 
heparin binds to gp120 – an adhesion molecule present on the surface of HIV particles that 
plays an important role in the attachment and spread of the virus5. 
Heparan sulfate (HS) is closely related to heparin, the main differences being the density of 
the sulfate substituents along the carbohydrate chain, usually higher in the case of heparin, 
and a higher percentage of GlcA subunits in HS chains. HS is expressed in all types of cells, as 
well as in the ECM proteoglycans. Similarly to heparin, it interacts with a wide variety of 
proteins via its negatively charged sulfate groups. Acting like an antenna on the cell surface, 




morphogenetic proteins, chemokines, interleukins, enzymes and apolipoproteins. Heparan 
sulfate interacts with complement regulators, helping to distinguish between the self and 
non-self cells. It is also believed to be an important participant in the pathogenic invasion, 
where it acts as a receptors for viral adhesion proteins. In addition to these roles, HS chains 
found in the ECM enhance structural integrity of tissues5,12.  
 
 
1. 1. 1. 2. Chondroitin sulfate and dermatan sulfate 
 
Chondroitin sulfate (CS) is the most abundant GAG subclass in the human body. It is found in 
cartilage, tendons, ligaments and in the lining of blood vessels. It consists of β-D-
galactosamine (GalNAc) and β-D-GlcA subunits, linked through alternating β (1⟶3) and β 
(1⟶4) linkages4 (Fig. 1. 1. 2). There are four variants of CS, classified based on the position 
of sulfate groups on its subunits. CS-A and CS-C are monosulfated at positions C4 and C6 of 
GalNAc, respectively. CS-D is disulfated at position C6 of GalNAc, as well as at position C2 of 

























Fig. 1. 1. 2. Chemical structure of CS and DS disaccharides. A. Disaccharide subunit of 
chondroitin sulfate. B. Disaccharide subunit of dermatan sulfate. R designates potential sites of 





Less abundant dermatan sulfate (DS) is found in the skin and also in the blood vessels and 
heart valves3. The main difference between CS and DS polysaccharides is the presence of GlcA 
instead of IdoA in the DS subunits (Fig. 1. 1. 2). Because of this high level of similarity, DS 
used to be classified as a subtype of CS (CS-B). In fact, it is not uncommon that these two types 
of GAGs are found within the same polysaccharide chain – such a chain would be referred to 
as a CS/DS chain7. Both sugars are characterised by the sulfation density lower than in the 
case of heparin and HS. As they are closely related and often occur together on the cell 
surface, it can be difficult to distinguish between the individual contributions of CS and DS to 
some of the cell functions. 
Proteoglycans that contain CS have been shown to regulate many cellular processes, 
including proliferation, apoptosis, cell adhesion and migration. CS is a major component of 
the ECM of many connective tissues, including cartilage, bone, skin, ligaments and tendons. 
CS is responsible for many of the important biochemical properties of these tissues, 
providing them with high resistance and elasticity and is therefore considered as a potential 
therapeutic agent in treatment of osteoarthritis and joint-related pathologies13. CS-rich 
proteoglycans are also present in the ECM of the central nervous system, where they interact 
with the hyaluronan and the ECM proteins, contributing to the development and 
maintenance of the nervous tissue. There is evidence that chondroitin sulfates contribute to 
the plasticity of the nervous system and take part in the processes that underlie learning and 
memory14. CS proteoglycans have also been implicated in wound repair, by regulating cell 
adhesion, cell proliferation and cell migration. It is possible that different CS subtypes show 
different contributions to these processes and a specific combination of CS chains is required 
for correct wound healing15. It has also been shown that the CS sulfation pattern plays an 
important role in cancer progression – CS-E chains are overexpressed in many types of 
cancer and may be involved in the mediation of metastasis as they interact with the cell 
adhesion proteins such as selectins. Structural alterations in the CS chains have been 
identified in pancreatic, rectal and gastric carcinomas and certain subtypes of CS have been 
explored as pharmacological agents in the treatment of cancer12,13. 
Similarly to CS, DS is involved in the interactions with proteins of the ECM, the growth factors, 
chemokines and the pathogenic adhesion proteins. Dermatan sulfates are major constituents 
of the skin where they provide structural support to the tissue and assist in wound repair. In 
addition to that, DS-rich chains exhibit anticoagulant activity, although close to 50-fold less 




in the coagulation cascade suggests that DS may be even more effective than heparin in 
preventing postoperative thrombosis16. 
The above examples highlight only some of the biological functions that GAGs are involved 
in. Even these few instances clearly illustrate how crucial these sugars are for the correct 
functioning of the human organism. It is not surprising that these compounds have attracted 
much interest as potential therapeutic agents. The following sections will introduce the novel 
type of GAG-like molecule obtained from the sea cucumbers and its interesting biological 
properties that could be useful in design of new drugs. 
 
 
1. 1. 2. GAG-protein interactions 
 
As described above, GAGs are involved in a variety of physiological processes thanks to their 
interactions with multiple types of proteins.  Many of these interactions originate in the 
negative charge of the highly sulfated GAG chains which are able to form multiple 
electrostatic interactions with the positively charged residues on the protein surface. 
However, due to the fact that the nature of this interactions is electrostatic, as well as the 
flexibility of carbohydrate ligands and the fact that GAG-binding proteins often lack a clearly 
defined binding site, GAG-protein interactions tend to be fairly weak, with milimolar binding 
affinities. 
Initial studies of GAG-protein interactions focused on the protein sequence analysis and 
aimed to find common traits between the heparin-binding domains of different proteins. It 
was proposed that such domains are characterised by an array of basic residues, often 
following a very similar pattern. Modelling studies suggested that these residues would be 
located on the same face of any secondary structure, forming a positively charged cluster that 
could interact with the sulfated sugars17. Since then, many X-ray structures of GAG-protein 
complexes have been obtained, largely confirming the initial hypothesis. Patches of positively 
charged residues – lysine, arginine or histidine – are a common feature of the sugar-binding 
sites, typically accompanied by other polar residues that participate in hydrogen bonding 
interactions with the hydroxyl and sulfate groups. Tyrosine, glutamine and asparagine are 




Many previous studies have focused on the heparin binding proteins such as the fibroblast 
growth factor (FGF), heparinases or antithrombin. As these proteins vary greatly in structure 
and function, there are some major differences between the heparin-binding domains. 
However, all of them share the same feature – a positively charged cluster of basic residues 
that forms the basis for protein’s interaction with GAGs. Such cluster may not necessarily be 
formed by residues that are sequentially close to one another. Often, basic residues are 
brought together from different regions of the sequence and it is the protein’s tertiary 
structure that determines its affinity for GAGs. One such example would be the binding site 
of antithrombin III, where the residues located far apart from each other in sequence are 
brought together in the folded protein to form a heparin binding site (Fig 1. 1. 3.)2. 
 
Fig. 1. 1. 3. Synthetic heparin pentasaccharide bound to antithrombin III2. Ribbon 
representation of the antithrombin III heparin binding site, highlighting the basic residues that 
support electrostatic interactions with the negatively charged oligosaccharide. The protein is 
shown in blue, the heparin pentasaccharide is shown in light grey and the interacting residues are 
shown in orange. 
 
The protein-binding behaviour of GAGs is similar to that of nucleic acids and is driven by the 
so-called polyelectrolyte effect18. In physiological conditions, these long negatively charged 
chains are surrounded by the positively charged cations. Upon binding to protein, positively 
charged side chains of the protein residues displace these cations and the GAG-protein 
interaction is therefore entropically favoured18. 
Some studies have also proposed that there are specific sequences within GAGs that may 
contribute to protein recognition. Disulfated disaccharide sequences found in DS chain have 




and heparin – to growth factor proteins such as fibroblast growth factor (FGF). All of the 
specific protein-binding sequences within GAGs have been shown to contain at least one 
iduronic acid residue and it is believed that the conformational flexibility of this residue plays 








1. 2. 1. Marine organisms as a source of novel polysaccharides 
 
In the recent years there has been much interest in the analysis of the bioactive compounds 
from marine organisms. Because of the necessity to adjust to the aquatic environment, the 
underwater creatures had developed specific features different or even completely absent 
from those found in the land organisms. The necessity to adapt to very harsh living conditions 
such as the low sunlight and high pressure levels, low temperatures, high salt concentration 
and low nutrient content, has led these organisms to development of new structural and 
chemical mechanisms that provide their bodies with ability to adjust to the difficult 
environment that they live in.  
The main sources for heparin at the moment are meat by-products, such as bovine lungs or 
porcine intestines. Production of heparin from such sources is expensive and not very 
efficient, and there have been incidents of heparin contamination with other polysaccharides. 
For these reasons, finding an alternative source of heparin and other GAG polysaccharides is 
highly desirable. GAG-like polysaccharides are often found in the extracts from tissues of 
marine organisms. For example, heparin-like polysaccharides have been prepared from 
certain species of marine bacteria and algae. As these organisms are easy and cheap to 
culture, they attract an interest as a means for production of GAG-like polysaccharide on an 
industrial scale. Indeed, such approach has been already used in production of food 
stabilisers such as xanthan and gellan19. Moreover, marine polysaccharides are often suitable 
as starting materials for production of heparin-like drugs. Structural derivatives of marine 




organisms have therefore attracted much commercial interest as a potential cheap 
alternative source of heparin and heparin mimetics19. Similarly, many marine organisms are 
rich in chondroitin sulfate and dermatan sulfate as they use these polysaccharides to built 
their cartilaginous skeletons and body walls20. Since many marine tissues are currently 
discarded as waste-products of the fishing industry, some marine GAG-like carbohydrates 
could be obtained more cheaply than similar mammalian products. 
Although structurally similar to mammalian GAGs, polysaccharides from sea organisms can 
have distinct structural features and these differences are a source of the unique properties 
of these sugars20,21. The CS and DS chains found in marine organisms often differ from their 
mammalian equivalents in sulfation patterns22–24. Unlike the mammalian GAGs which are 
always linear, marine polysaccharides can have branches, as in the case of the fucosylated 
chondroitin sulfate (fCS), a sea cucumber polysaccharide which has been the main interest 
of this work25,26. The following sections will introduce the fCS, its structure, biological 




1. 2. 2. Biological properties of the sea cucumber extracts 
 
Sea cucumbers (Holothuroidea) are animals belonging to a phylum of echinoderms, alongside 
the organisms such as star fish and sea urchins. When translated from Latin, Echinodermata 
means ‘spiny skin’ – this name refers to the endoskeleton of these animals, composed of hard, 
calcium-rich plates. Sea cucumbers are extraordinary members of this family, unique in both 
their body structure and behaviour. Although their body has a five-fold radial symmetry, it is 
not as obvious as in other echinoderms because of their elongated shape. As their 
endoskeletal plates are microscopic in size, the sea cucumber body is soft and gelatinous, 
protected only by a thick skin, sometimes decorated with spikes that give it the familiar look 
of a well-known vegetable. (Fig. 1. 2. 1). They are characterised by an unusual defence 
mechanism – they are able to eject their internal organs in the direction of approaching 
predators and entangle them, blocking the attack, as well as to regrow the organs lost or 




















Fig. 1. 2. 1. Sea cucumbers are a culinary delicacy in some regions of Asia. Although at 
first glance they may look like ordinary cucumbers, these are the sea organisms that keep 




There are over 1500 species of sea cucumbers world-wide and many of them are able to 
survive in the extreme conditions of the deepest ocean trenches. Their curious properties 
have caused them to be a sought-for delicacy in some regions of the world – they are a 
popular food source and a traditional remedy in some Asian countries, such as China or 
Malaysia. In these countries sea cucumber products are a home remedy for many medical 
problems, ranging from cuts and burns to more serious conditions like rheumatism, 
hypertension or impotence27. In recent years, pharmacological properties of sea cucumber 
extracts have been studied and it has been confirmed that the body wall of these organisms 
contains compounds that can stimulate wound healing28, inhibit inflammatory processes29 
and act as anticoagulants or antithrombotics30–39. They have also been shown to have 
anticancer properties, by reducing angiogenesis and metastasis40–44, as well as anti-HIV 
properties by interfering with viral adhesion processes45–48. 
The body wall of the sea cucumbers consists of collagen fibres, surrounded by a matrix of 
polysaccharides. A large proportion of these polysaccharides consists of GAG-like 
compounds closely related to chondroitin sulfate. As mammalian CS is involved in a range of 
biological functions, it is likely that its derivatives, present in large quantities in the sea 
cucumber extracts, are the source of unique biological properties of these extracts. As an 
example, sulfated glycosaminoglycans extracted from the body wall of the sea cucumber 




stimulate growth of mesenchymal stem cells which are self-renewing cells that differentiate 
into cells of connective tissues49. Therefore, it is likely that the regenerative and wound-
healing properties of the sea cucumber extracts are brought about by the presence of the 
sulfated GAG-like carbohydrates such as fCS.  
Low molecular weight fCS chains from the sea cucumber species Thelenota ananas was 
shown to inhibit replication of HIV, reducing infection by clinical isolates of the virus49. fCS 
was found to bind to viral envelope glycoprotein gp120 with milimolar affinity and further 
studies suggested that the anti-HIV activity of fCS is dependent on the presence of sulfated 
fucose branches, similarly to other fCS activities50. Development of fCS derivatives allows to 
fine-tune some of the carbohydrate properties to upregulate the anti-HIV activity and 
downregulate the anticoagulant properties. Therefore, it is speculated that fCS could be 
developed into a novel HIV inhibitor49. 
Of special interest for this project are the anti-metastatic properties of the sea cucumber 
extracts, also attributed to fCS polysaccharides. fCS samples from the sea cucumber species 
Ludwigothurea grisea demonstrated inhibitory activity towards adenocarcinoma MC-38 cells 
in experimental model for lung colonisation in mice50. The same samples were also able to 
inhibit neutrophil recruitment in two models of inflammation. These biological activities 
were associated with high binding affinity for L- and P-selectins50, a topic which will be 




1. 2. 3. Structure of the fucosylated chondroitin sulfate (fCS) 
 
Fucosylated chondroitin sulfate (fCS) was first described in 1988 by Vieira and Mourão in 
their study of chemical composition of polysaccharide fractions extracted from the sea 
cucumber Ludwigothurea grisea51. The study reported that the largest polysaccharide 
fraction was composed of equimolar quantities of α-L-fucose, β-D-glucuronic acid and N-
acetyl β-D-galactosamine. Further examination revealed that this new type of polysaccharide 
is a chondroitin sulfate with fucose branches attached to glucuronic acid and that the 
presence of such branches blocks the access of chondroitinases normally used to 
depolymerise CS chains51. NMR analysis of this compound allowed to establish that the 




These findings were soon followed by the reports of similar compounds found in other sea 
cucumber species. Analysis of fucose chemical shifts from Stichopus japonicus helped to 
determine that there are three types of fucose present in the fCS sample, differing from each 
other in the sulfation pattern. In this species, the most dominant form of fucose residues 
(>55%) was 2,4-sulfated, slightly less (>33%) was 3,4-sulfated and the smallest fraction 
(>11%) was 4-sulfated26. Recent studies, comparing structures and properties of fCS from 
different sea cucumber species, have found that the distribution of these different fucose 
forms can vary between the different species and that it is correlated to the anticoagulant 
potential of different fCS samples36,50,52–54. It was generally observed that the fCS samples 
characterised by a higher proportion of 2,4-sulfated fucose showed higher anticoagulant 
activity50.  
Based on the above findings, a single trisaccharide building block of the fCS can be described 
as: ⟶3)GalNAcβ(1⟶4)[Fucα(1⟶3)]GlcAβ(1⟶, where [Fuc(1→3)] denotes fucose branch 
from position O3 of glucuronic acid, with potential sulfation sites at positions O4 and O6 of 
galactosamine and O2, O3 and O4 of fucose (Fig. 1. 2. 2.).  
 
Fig. 1. 2. 2. Chemical structure of a repeating trisaccharide unit of the fCS. Fucosylated 
chondroitin sulfate (fCS) is built of a CS disaccharide with a sulfated fucose branch attached at 
position O3 of glucuronic acid. R designates potential sites of sulfation. 
 
 
Previous studies in the Uhrín group have allowed to elucidate the structure of the fCS from a 
sea cucumber species Holothuria forskali. The structure of this GAG resembles that of the fCS 




NMR chemical shifts indicated that galactosamine units are always disulfated at positions O4 
and O6. The sulfation pattern on fucose residues is more variable – approximately 46% of 
fucose residues are disulfated at positions O3 and O4, 39% at positions O2 and O4 and 15% 
are monosulfated at position O455. In addition to these results, some interesting information 
about the fCS conformation was obtained: fucose H-5 was found to have an unusually high 
chemical shift (4.79-4.89 ppm), compared to that of free fucose (~4.2 ppm). The 2D 1H, 13C 
NOESY-HSQC spectrum showed strong NOEs between the protons of fucose and 
galactosamine residues, which indicates that these monosaccharides are in close proximity 
to one another. These observations indicate that fucose residue may be stack on top of 
galactosamine and that this stacking interaction is independent of the fucose sulfation 
pattern55. 
As a result of the presence of sulfated fucose branches, fCS has more charged groups per unit 
than a standard CS chain. This property could have implications for the protein-binding 
behaviour of fCS and its resulting biological activity. Previous studies have shown that fCS 
has approximately five-fold higher affinity for Ca2+ ions than mammalian CS chains56. As 
some of the carbohydrate binding proteins rely on Ca2+ ions in their interactions with sugars, 
this could suggest that fCS binds such proteins with higher affinity than human GAGs.  
fCS also shares structural similarities with some of the carbohydrate determinants 
recognised by the proteins involved in cell adhesion processes.  As cell adhesion is a crucial 
step in the processes such as inflammation, blood coagulation, pathogenic adhesion and 
cancer metastasis, there is a strong indication that the fCS could act as a competitive inhibitor 
to some of the natural ligands of these proteins and, by doing so, disrupt their function. This 
topic will be discussed in more detail in further sections, focusing on a family of cell adhesion 















1.3. Selectins and their ligands 
 
 
This section will describe a family of cell adhesion glycoproteins known as selectins. These 
proteins are known for their ability to mediate cell rolling – the earliest response to 
inflammatory stimuli or tissue damage at cellular level. Cell rolling is likely also an important 
step in attachment of viral particles and tumour cells as they spread to new tissues. 
Importance of selectins in the above processes makes them an exciting target in development 




1. 3. 1. Members of selectin family 
 
Selectin family consists of three members, L-, P- and E-selectin. All selectins mediate cell 
rolling, however, the three proteins are expressed in different cell types, have different ligand 
preferences and perform different functions during the leukocyte recruitment process. 
L-selectin is constitutively expressed on the surface of leukocytes, playing central role in 
formation of initial tethers between leukocytes and vascular endothelium at sites of 
inflammation. It also mediates the attachment of naïve lymphocytes to high endothelial 
venules (HEV) in secondary lymphoid tissues, where they are able to encounter antigens and 
undergo activation57,58. L-selectin is rapidly lost from the surface of leukocytes following 
their activation, forming a soluble protein, in the process known as shedding. It is believed 
that soluble form of L-selectin can compete with the cell-surface protein for ligand binding 
which is likely to cause dampening of inflammatory response58,59. 
E-selectin is expressed on the surface of vascular endothelium. However, its expression is 
inducible at the transcription level, meaning that the protein will be expressed only in 
presence of inflammatory stimuli, such as interleukin-1 (IL-1), tumour necrosis factor-α 
(TNF-α) or bacterial lipopolysaccharide (LPS), and that it will be transported to cell 
membrane after several hours. Therefore, this protein does not participate in immediate 
inflammatory response60,61. E-selectin was long thought to merely enhance P-selectin’s 




independent role. This selectin is capable of mediating slow rolling of neutrophils which 
facilitates cell arrest and transmigration to the sites of injury – processes crucial for correct 
immune response62. Recent studies have shown that it is also involved in trafficking of 
hematopoietic stem cells to the bone marrow63. 
P-selectin is expressed in platelets, as well as in endothelium. Similarly to E-selectin, its 
expression on the cell surface is also inducible by a variety of chemical stimuli, such as 
thrombin, histamine, complement fragments or adenine diphosphate (ADP). However, in 
contrast to E-selectin, P-selectin is stored in the granules inside the cells, ready to be released 
to the membrane within minutes from activation, which allows for a much quicker response 
than in the case of E-selectin61. P-selectin is mostly involved in the initial stages of leukocyte 
rolling. However, P-selectin and E-selectin are often coexpressed in endothelial cells and 
complement each other’s function. A single gene knockout of either E- or P-selectin does not 
impair leukocyte recruitment – only a double knockout of those two genes will cause serious 
defects in cell rolling57,61. 
The summary of selectin expression sites and their individual roles in leukocyte recruitment 
cascade is presented in Table 1. 3. 1.. As P- and E-selectins are located on the endothelium, it 
is likely that they are also involved in adhesion of other cell types, including platelets, 
pathogens and tumour cells. 
  Expression site Function 
L-selectin 
Lymphocytes Lymphocyte entry into secondary lymphoid organs. 
Neutrophils 
Initial attachment and cell rolling on endothelium at 
sites of inflammation or tissue injury. 
E-selectin Endothelium 




Leukocyte-platelet interactions in wound healing 
and homeostasis 
Endothelium Early leukocyte rolling in inflammatory response. 
 





1. 3. 2. Selectin structure 
 
Despite the differences in their individual roles, the three proteins are highly similar in both 
their sequence and structure. Selectins are type I transmembrane glycoproteins composed 
of five domain types. Starting at the N-terminus, selectins are built of a Ca2+-dependent (C-
type) lectin domain, an epidermal growth factor (EGF)-like domain, from two to nine short 
consensus repeat (SCR) domains, a membrane spanning region and a C-terminal cytoplasmic 
tail61 (Fig. 1. 3. 1.). As the number of SCR domains is different for each selectin – there are 
two SCR domains in human L-selectin, six in E-selectin and nine in P-selectin64 – the three 
proteins extend to different heights above the cell surface which is likely to contribute to 




Fig. 1. 3. 1. Schematic representation of selectin structure and domain homologies. 
Individual domains are represented with different colours – orange for the C-type lectin domain, 
purple for the EGF-like domain, yellow for the SCR domains and red for the transmembrane 
domain. The cytoplasmic domain is a short peptide tail, consisting of less than 20 residues. The 
right hand side of the figure includes information on average percentage homology between the 
individual domains of different selectins from the same species, as well as between the domains 




The extracellular domains display high degree of sequence similarity among selectins of the 
same species, as well as when comparing human selectins to selectins from different species, 
such as a mouse or a cow61 (Fig. 1. 3. 1.).  High sequence conservation observed for the C-
type lectin and the EGF-like domains suggests their importance for correct protein function. 
Interestingly, although the C-type lectin, EGF and SCR domains occur in many proteins, no 
known proteins other than selectins combine these three domains types together. This could 
indicate that this particular structural arrangement is key to selectin function61. 
Because of the large size and transmembrane nature of these proteins, their full-size 
structure has not been solved as yet. However, the individual domains and their 
combinations have been studied by X-ray crystallography, NMR and molecular dynamics. 
Summary of all selectin domain structures published to date is presented in Table 1. 3. 2.. 
 




Lectin + EGF N/A X-ray 
Graves et al.65 
(1994) 
1ESL 
Lectin + EGF sLex X-ray 
Somers et al.66 
(2000)  
1G1Q 
Lectin + EGF + 
2xSCR 
sLex X-ray 
Preston et al.67 
(2016) 
4CSY 
Lectin + EGF + 
2xSCR 
glycomimetic X-ray 4C16 
P 
EGF N/A NMR 
Freedman et al.68 
(1996) 
1FSB 
Lectin + EGF N/A X-ray 
Somers et al.66 
(2000) 
1G1T 
Lectin + EGF sLex X-ray 1G1R 
Lectin + EGF PSGL-1 X-ray 1G1S 
L Lectin + EGF glycomimetic X-ray 









1. 3. 2. 1. C-type lectin domain 
 
Many proteins of the immune system belong to the family of lectins. There are at least twelve 
structural subtypes of lectins, one of them being the C-type lectin, where the term ‘C-type’ 
refers to the calcium-dependent activity manifested by this domain. The C-type lectin domain 
occurs frequently in virtually all species of the animal kingdom, has been identified in over a 
thousand of proteins and thoroughly reviewed in the literature70–72.  
A distinguishing feature of the C-type lectin domain is the presence of a Ca2+-coordination 
site which participates in binding of carbohydrate ligands. The overall domain fold is well 
conserved among the different proteins, despite its high sequence variability. The C-type 
lectin domain is usually between 110 – 130 amino acids long, with the N- and C-terminal 
regions aligned in a two-stranded antiparallel β-sheet. These regions are connected by a 
series of loops, two α-helices and antiparallel β-sheets72.  
This general description fits well with the published structures of selectin domains. The 
domains are 121 amino acids long with highly conserved N- and C-termini that fold over each 
other into an antiparallel β-sheet. The sequence if the N-terminus is well conserved between 
P- and L-selectins, however, several changes in that region are observed in E-selectin. 
Tyrosine at position 2 is replaced by serine, histidine 4 – by asparagine and tyrosine 5 – by 
threonine. Nevertheless, the N-terminus maintains the same fold in E-selectin as in the other 
two selectins. There are two α-helices flanking two opposite sides of the domain, between 
the residues 17-27 and 32-41, and multiple antiparallel β-strands in the centre of the domain 
(Fig. 1. 3. 2. A). The Ca2+-coordination sphere is well conserved among selectins, in all three 
proteins consisting of four amino acids, Glu80, Asn82, Asn105 and Asp106 (Fig. 1. 3. 2. B)66. 
There are two disulfide bridges within the C-type lectin domain, conserved among all 
selectins. One of them is the disulfide bridge between the residues 19 and 117 that pins the 
two domain termini together. The second disulfide bridge is located close to the Ca2+-
















Fig. 1. 3. 2. X-ray structure of the C-type lectin domain from P-selectin66. Top of the figure 
shows a multiple sequence alignment of the C-type lectin domain amino acid sequences from 
human selectins. A. Ribbon representation of the overall structure of the C-type lectin domain. 
Calcium ion is shown in green. B. Ca2+-coordination sphere, highlighting the contacts made by 
residues Glu80, Asn82, Asn105 and Asp106. These four residues are conserved amongst all 
human selectins. C. Close-up of the region where N- and C-termini meet – this region is the only 
site of interdomain interactions between the lectin and EGF-like domains. D. Close-up on the loop 
97-100 (on the left) and the corresponding region in E-selectin. The differences in this region are 




Aside of the carbohydrate-binding region, the point of particular interest is the link between 
the C-type lectin and the EGF-like domains, closely associated with the protein’s N-terminus 
(Fig. 1. 3. 2. C). There are very few noncovalent interactions between the lectin and the EGF-
like domains and most of them are conserved among the three selectins.73 The N-terminal 
Trp1 residue plays an important role in these interactions as a triple hydrogen bond donor 
and a hydrogen bond acceptor via its backbone oxygen atom. Another two residues worth 
noting here are Gln30, involved in the interdomain interactions via contacts with Glu135, and 
Ser121 that seems to play an important role in stabilising the interdomain hydrogen bond 
network. The latter residue is conserved only between L- and P-selectins – in E-selectin it is 
substituted with Ala121, suggesting that the interdomain interactions differ between the 
three proteins. 
There are other differences between the lectin domains that may account for some of the 
specific properties of each individual protein. One region that is especially worth noting is 
the loop between the residues 97 – 100 (Fig. 1. 3. 2 D). Residues found in this loop in E- and 
L-selectins are polar amino acids with long side chains reaching towards the binding side. In 
P-selectin these residues are replaced with either non-polar alanine and proline, or polar but 
much shorter serine. Presence of additional charged residues in this loop in E- and L-selectins 
may facilitate interactions with some of the carbohydrate ligands66.  
There may be other regions of the C-type lectin domain that contribute to the protein’s ligand 
binding affinity by mediating allosteric changes throughout the domain. Previous studies 
have proposed that one such region is a loop between the residues 83-89. This region has 
been shown to adopt an alternative conformation in some of the X-ray studies and has been 
suggested to enhance the ligand binding affinity of selectins via allosteric changes in domain 
conformation66,67,69,74. This topic will be discussed in more detail later in this work in the light 




1. 3. 2. 2. EGF-like domain 
 
The EGF-like domains are found in many extracellular proteins, involved in a variety of 




development and, as in case of selectins, cell adhesion. They occur in a variety of domain 
combinations, often found in multiple copies, although their biological role is still unsure75. 
The EGF-like domains are fairly small and compact, in general between 40 to 50 amino acid 
long. Although their sequence and conformation can vary between the different proteins, all 
of them feature three disulfide bridges with a signature connectivity between residues 122 
and 123, 127 and 142, as well as 144 and 153 (Fig. 1. 3. 3.)68. Selectin EGF-like domains are 
characterised by a series of loops and turns in the N-terminal region, with a two-stranded 
antiparallel β-sheet in the centre (Fig. 1. 3. 3.). The region between residues 135 – 138 is the 
only region of the EGF-like domain involved in interactions with the lectin domain. This 
region is quite well conserved among selectins, with the exception of Thr136 which is 


















Fig. 1. 3. 3. X-ray structure of the EGF-like domain from P-selectin66. Top of the figure 
shows a multiple sequence alignment of the EGF-like domain amino acid sequences from human 
selectins. A. Ribbon representation of the overall structure of the EGF-like domain with 
highlighted N- and C-termini and the region between residues 135-138, involved in interdomain 









1. 3. 2. 3. SCR domains 
 
Selectins contain between two to nine short consensus repeat (SCR) domains, otherwise 
known as the Sushi domains. Only two of selectin crystal structures published so far contain 
the SCR domains – the two structures produced in the study by Preston et al. – 4CSY and 
4C1667. Although the sequence conservation among selectin SCR domains is low, they all 
consist of 60 residues arranged into a compact β-sheet fold with conserved three disulfide 
bonds, one at each end of the domain and one in the centre67 (Fig. 1. 3. 4). Each SCR domain 
contains a conserved tryptophan residue which allows for formation of a tightly packed rigid 
core in the centre of the domain. The neighbouring SCR domains are connected by a linker 
containing a pattern of four hydrophilic-hydrophobic-hydrophobic-hydrophilic residues.  
Fig. 1. 3. 4. X-ray structure of the lectin, EGF-like and two SCR domains of E-selectin67. 
A. In this structure (4C16), E-selectin was co-crystallised with a glycomimetic structurally 
resembling sLex. Two SCR domains align linearly with the EGF-like domain. B. Detailed view of 
the first two SCR domains, highlighting the disulfide bonds, conserved tryptophans and 





Not much is known about the behaviour of the two E-selectin SCR domains upon ligand 
binding. In the two published structures, both of which were obtained in the presence of a 
ligand, these domains align in a linear fashion with the EGF-like domain. 4CSY structure 
allowed to establish that, upon binding to sLex, two consecutive SCR domains are rotated by 
90° relative to each other due to a stabilising interdomain interaction between the 
interdomain linker (residue Gly192) and SCR domain core (residue Val219) (Fig. 1. 3. 4. B). 
A similar stabilising interaction is also observed between the EGF-like domain (Gly147) and 




1. 3. 3. Selectin Ligands 
 
Selectins bind to carbohydrate determinants on glycoproteins. Although the three proteins 
share some of their ligands, they differ from each other in their binding affinities and often 
exhibit different binding preferences. This section will introduce the major selectin ligands, 
focusing on the interactions that have been evaluated by X-ray crystallography. 
All three selectins recognise a common carbohydrate determinant, sialyl LewisX (sLex). 
Although it is a low-affinity interaction, sLex has been identified as a minimal recognition unit 
necessary to enable cell adhesion under flow for all selectins76.  sLex is a tetrasaccharide of 
the following formula: NeuAcα(2→3)Galβ(1→4)[Fucα(1→3)]GlcNAcβ(1→R). Its structure is 
presented in Fig. 1. 3. 5.. 
 
 
Fig. 1. 3. 5. Chemical structure of the sialyl Lewis x (sLex). sLex is a tetrasaccharide that 





Although all selectins recognise sLex, the individual proteins differ in their affinity for this 
ligand. The interaction is by far the strongest in the case of E-selectin, with KD of 720 μM. The 
other two selectins exhibit binding affinities within the milimolar range, with KD of 3.9 mM 
for L-selectin and 7.8 mM for P-selectin77. The exact cause for these differences is unclear, 
however, X-ray studies of selectin-sLex complexes have provided structural detail that sheds 
some light on possible reasons for the variation in binding affinities. 
In crystal structures of P- and E-selectins, sLex is bound via the Ca2+-coordination site in the 
lectin domain, adopting similar conformation in both cases66,67. Fucose 3- and 4-hydroxyl 
groups coordinate the Ca2+ ion and hydrogen bond to amino acids also involved in Ca2+ 
coordination. Additional interactions come from galactose which forms hydrogen bonds to 
Tyr94 and Glu92 (Fig. 1. 3. 6). The interactions observed for the two proteins diverge at the 
sialic acid-binding site – position of this sugar residue seems to be affected by the differences 
in the loop between residues 97-100. E-selectin forms tighter contacts with sLex in this 
region, with Arg97 forming hydrogen bonds to glycosidic oxygen and the carboxylate group 
of sialic acid. In P-selectin this position is occupied by a serine residue and, although there is 
a hydrogen bonding interaction between Ser99 and 4-hydroxyl group of sialic acid, there are 
less contacts overall between the carbohydrate and protein residues than in the case of E-
selectin (Fig. 1. 3. 6)66. 
Many of selectin ligands bind, at least in part, via the sLex motif. Probably the best-studied 
selectin ligand is the P-selectin glycoprotein ligand-1 (PSGL-1) – a high-affinity ligand for L- 
and P-selectins, expressed on the surface of leukocytes and some of the activated endothelial 
cells. The binding affinity of P-selectin for PSGL-1 is 778 nm which is slightly stronger than 
its affinity for sLex determinant66. PSGL-1 is a 240-kDa transmembrane glycoprotein which 
contains multiple O-glycans and several N-glycans attached to two peptide chains extending 
into the extracellular space. The N-terminal region of the PSGL-1 peptide includes a sLex 
determinant and three sulfated tyrosine residues. The X-ray structure of P-selectin bound to 
PSGL-1 shows that the sLex motif binds to the lectin domain in the same manner as in the 
case of unconjugated sLex and that the sulfated tyrosines contribute to P-selectin binding by 
interacting with residues Arg85 and His11466. Indeed, multiple studies have shown that 
tyrosine sulfation plays an important role in the mediation of cell rolling and that at least one 
tyrosine needs to be sulfated to allow for the P-selectin-PSGL-1 binding76,78–81. However, 
there are some inconsistencies in the findings about the exact number of sulfated tyrosines 
required for binding, as well as their structural role, which has led to suggestions that there 




























Fig. 1. 3. 6. X-ray structure of sLex binding site in P- and E-selectins. Ribbon representation 
of sLex binding site in P-selectin (A) and E-selectin (B), based on the X-ray structures from Somers 
et al.66. Proteins are shown in blue, with the interacting residues highlighted in orange. 
Carbohydrate residues are shown in light grey. Most differences between the two binding sites 




In contrast to P- and L-selectins, E-selectin does not require sulfated tyrosines for binding to 
PSGL-1. It is possible that this behaviour is due to amino acid variants in its lectin domain 
that prevent it from forming stable interactions with the sulfates, however, the exact nature 
of these differences in binding is unclear66,79,80. E-selectins binds to PSGL-1 with much lower 
affinity than P- and L-selectins and the interaction between E-selectin and PSGL-1 is not 
required for cell attachment and rolling in vivo. This suggests that E-selectin binding to other 




spectrum of ligands, recognising a variety of fucosylated and sialylated glycolipids and 
glycoproteins. P- and L-selectins differ from E-selectin in that they prefer to bind to 




Fig. 1. 3. 7. Structure of P-selectin glycoprotein ligand-1 (PSGL-1). Schematic 
representation of the structure of PSGL-1, zooming in at the position of sLex motif (inset). Sulfated 




Whilst PSGL-1 is the only high-affinity ligand for P-selectin, both L- and E-selectins interact 
with other proteoglycans (Fig. 1. 3. 7.). Two major ligands for L-selectin are glycosylation-
dependent cell adhesion molecule-1 (GlyCAM-1) and CD34, belonging to a family of 
peripheral node addressin (PNAd). Both of them are mucin-like glycoproteins decorated with 
multiple O-linked carbohydrate chains, expressed in HEV cells in the peripheral lymph nodes 
and at some sites of inflammation. CD34 is a transmembrane protein that plays part in the 
initial attachment of leukocytes to endothelium, whilst GlyCAM-1 is a soluble molecule 
secreted into blood that likely acts as a signal that initiates cell adhesion. These two ligands 
are capped with sLex motif, although modified with a sulfate ester at C6 position of GlcNAc. 
























Fig. 1. 3. 8. Major selectin ligands and their expression sites. Schematic representation of 
major interactions that selectins are involved in, including the glycoproteins expressed on 




As mentioned above, E-selectin does not require sulfation for ligand recognition – the sLex 
motif is sufficient to support E-selectin-ligand binding84. Because of this lack of specificity, E-
selectin has been proposed to recognise a variety of sialylated ligands, including PSGL-1, E-
selectin ligand-1 (ESL-1), CD43, CD44 and glycolipids. It is also known to bind to L-selectin, 
depending on its glycosylation pattern85. Multiple E-selectin ligands are believed to 
collaborate with each other in mediation leukocyte rolling, facilitating the transition into 
slow rolling and controlling the velocity and arrest of the rolling cells on the endothelium84. 
Recent studies have shown that some of the E-selectin ligands may play different roles in 
adhesion of specific cell types. For example, PSGL-1 is involved in the attachment of mature 









1. 3. 4. Existing models for selectin-ligand binding 
 
 
1. 3. 4. 1. Selectins and ‘catch’ bonds 
 
In order to be able to fully understand the nature of selectin-ligand interactions, it is 
necessary to consider the natural environment selectins are found in. Located on the surface 
of leukocytes or vascular endothelium, these proteins are constantly exposed to the forces of 
the flowing blood. Their role is to recognise the carbohydrates on the interacting cell and to 
form a stable bond under such hydrodynamically challenging circumstances.  
Multiple reports have shown that selectin bonds are quite unique in their response to shear 
force. Intuitively, one would think that increasing the external shear force would gradually 
weaken the intermolecular bonds, eventually reaching the point when ligand dissociates 
from the protein. This is the behaviour most commonly found in nature and is the definition 
of a ‘slip’ bond. However, what many studies have reported is that, as force is increased, the 
initial response of selectin-ligand complexes is that their interaction lifetimes also increase 
and that there is an optimal shear force threshold at which cell tethering and rolling is the 
most efficient. Therefore, high shear force can actually stimulate selectin function, rather 
than inhibit it87–89. This finding was quite revolutionary and caused some scientific disputes, 
especially that bonds of such nature had never been proven experimentally. As a result, a 
new type of bond was defined – a ‘catch’ bond – that is a bond whose lifetime is prolonged by 
shear force88,89. 
Selectins were not the only proteins that displayed this highly unusual behaviour. Further 
experiments have shown that shear-induced mechanical force enhances the interactions 
between bacterial protein subunit FimH and target host cells, as well as between Ibα 
glycoprotein and platelets during their adhesion to the sites of injury90,91. The existence of 
catch bonds was confirmed in 2003 by Marshall et al., who used atomic force microscopy and 
flow-chamber experiments to show that increasing force first prolonged and then shortened 
the lifetimes of P-selectin complexes with PSGL-192. 
Since their discovery, several models have been developed to explain the nature of selectin-
ligand catch bonds in the light of selectin structure and interdomain interactions. The next 
section of this chapter will introduce the most important findings on the relationship 





1. 3. 4. 2. Lectin-EGF domain interface 
 
Ever since the first reported X-ray structure of E-selectin, scientists have been trying to 
answer the question about the relationship between the lectin and EGF-like domains and 
how it affects selectin function. At first it may seem that the contacts between the two 
domains are very limited and that the domain interface is located so far from the binding site 
that it should not have a strong influence over the ligand binding. However, it is now well-
established that the EGF-like domain does play a significant role in ligand binding and the 
adhesive processes.  
Several studies have been undertaken, aiming to shed the light at the structure-function 
relationship of selectins and to answer the question of involvement of the EGF-like domain 
in ligand binding. A study published in year 2000 by Dwir et al.. was the first one to prove 
that the EGF-like domain affects the kinetics of selectin-ligand binding93. In this study, L-
selectin mutant was expressed on the surface of leukocytes, with L-selectin EGF-like domain 
replaced with the same domain from P-selectin. In cells expressing the so-called LPL mutant 
cell adhesion was enhanced under shear stress and the shear threshold required for adhesion 
was lower than in the cells expressing the wild-type protein. In addition to these results, the 
study also observes that the EGF-like domain does not affect binding affinity in the absence 
of flow. Although the exact role of the EGF-like domain remained unexplained, the results 
clearly indicated that this domain is important for selectin-ligand binding under shear flow 
conditions, despite the fact that it does not interact directly with the ligand93.  
Another important finding came from the X-ray structure of the P-selectin lectin and EGF-
like domains, published by Somers et al. in the same year66. In this study, the P-selectin was 
crystallised in two different conformations – in more compact ‘bent’ conformation when not 
bound to any ligands or when bound to sLex, and in ‘extended’ conformation when bound to 
PSGL-1 (Fig. 1. 3. 9.). The switch from bent to extended conformation occurs via movement 
of the interdomain hinge, displacing the EGF-like domain with respect to the lectin domain. 
These X-ray studies of P-selectin provided the first clue that the protein can exist in either 
bent or extended conformation and that this conformational change may be related to ligand-
binding affinity under shear flow conditions. It was hypothesised that P-selectin has two 
states that support binding of different ligands: sLex in low-affinity bent conformation and 
PSGL-1 in high-affinity extended conformation. However, no experiments were undertaken 




changes are induced by the ligand binding or whether it is the external shear force that 



















Fig. 1. 3. 9. P-selectin lectin and EGF-like domains in bent and extended conformations, 
as reported in the X-ray structure by Somers et al.66. Bent conformation, observed upon 
binding to sLex, is represented in purple and the extended conformation, observed upon binding 




Six year later, two publications revealed important new information on the role of 
interdomain hinge in mediating the cell rolling73,94. By introducing modifications to the 
interdomain region of P- and L-selectins, it was possible to determine that flexibility of this 
region regulates protein’s ability to tether and roll the cells. Both groups, independently of 
each other, mutated residue 138 of L-selectin, by substituting glycine for asparagine, to see 
how it will influence the ligand binding and cell adhesion. This residue attracts special 
interest as it is not conserved in all three selectins. P-selectin differs from L- and E-selectins 
in that it has glycine rather than asparagine at position 138 and is missing an interdomain 
hydrogen bond between Asn138 and Tyr37. The hypothesis was that such a change would 




In Phan et al., cells expressing the N138G mutant rolled more slowly over PSGL-1-expressing 
surfaces than cells expressing the wild-type protein94. In Lou et al., cells expressing the 
mutant protein tethered to PSGL-1 coated surface at higher rates than those expressing the 
wild-type protein73. Another observation was that less shear force was required to activate 
bond formation, suggesting that hinge flexibility contributes to the ‘catch’ behaviour of 
selectin-ligand bonds. Additionally, in the study by Phan et al., a new glycosylation site was 
introduced at the domain interface of P-selectin, acting as a wedge that locks the protein in 
extended conformation. Cells expressing the modified protein displayed fivefold increase in 
the binding affinity for PSGL-1, with reduced rates of the bond formation and detachment. As 
a result of these changes, cells expressing the mutant protein were characterised by reduced 
rolling speeds and tethering frequencies94.   
Taken together, these studies show that the interdomain region does play an important role 
in selectin function. It can be concluded that higher flexibility of the hinge lowers the shear 
threshold required for adhesion, which is likely due to the higher number of possible 
arrangements of the lectin domain with respect to the EGF-like domain and, therefore, higher 
chance for carbohydrate binding. It was also shown that locking the protein in a single 
conformation can increase its binding affinity but by the same means also lower its ability to 
mediate cell rolling. Based on these findings, a new model for transitions between the 
conformational states of selectins was developed, known as the ‘sliding-rebinding’ model95. 
 
 
1. 3. 4. 3. Sliding-rebinding and allosteric binding models 
 
There are currently two leading models for the mechanism behind selectin-ligand catch 
bonds. In the sliding-rebinding model hinge extension does not lead to changes in the binding 
site conformation but it acts by tilting the ligand-binding interface in the direction of applied 
force (Fig. 1. 3. 10)95. Based on this model, the ligand does not bind to a single specific binding 
site but slides across the lectin domain surface, binding and dissociating from multiple 















Fig. 1. 3. 10. Schematic representation of the sliding-rebinding model. In this model, 
flexibility in the interdomain hinge region allows the C-type lectin domain to adjust its position in 
the flow condition. The ligand binding is a dynamic process in which the carbohydrate ligand 
slides across the domain surface, continuously breaking and forming new interactions. 
 
An alternative view is presented in the allosteric model. In this more traditional model the 
protein exists in two distinct states that are in equilibrium with each other – a lower affinity 
‘bent’ state and higher affinity ‘extended’ state. Transition to extended state causes allosteric 
changes in the conformation of the binding site by closing the loop between residues 83-89, 
which is thought to increase protein’s binding affinity (Fig. 1. 3. 9)67,69,74,96. 
There are unanswered questions about both models and neither of them is an ideal fit for the 
experimental results. It is possible that the actual mechanism for selectin binding is a mixture 
of these two models, where, although the extended state is a higher affinity state, the ligand 
binding is enhanced not by the allosteric changes within the binding site but by gradual 
mechanistic extension that reorients the lectin domain to allow for more efficient interaction 
with ligands as the cell rolls along the surface. The binding could then follow the sliding-
rebinding model, allowing the protein to gradually increase its interaction with ligands as the 




Indeed, a study by Dwir et al.. has shown that higher shear rate causes formation of more 
tethers on leukocytes97. This result has led to suggestions that, after the formation of initial 
tether, cell rotates over the adhesive surface, gradually finding more tethers, and where the 
enhanced shear rate increases probability of finding the ligand97. It is possible that the 
extended conformation is easier to access and allows for formation of more stable tethers 
which could complement the sliding-rebinding model. 
 
 
1. 3. 5. Selectins and cancer 
 
Although the primary function of selectins is mediation of cell rolling in inflammatory 
response, other cell types can bind to selectins when migrating to new tissues via circulatory 
system. It is well-known that cell-surface glycosylation pattern is altered in metastatic cancer 
cells, improving their adhesion ability. Often the changes in glycosylation include increased 
presence of sialic acids, suggesting involvement of selectins in metastatic cell adhesion 
processes98. Indeed, multiple studies have shown that selectins have the ability to bind to 
cancer cells and that they are involved in metastatic processes99–103. 
For the above reasons, selectins are attractive targets in design of drugs acting to inhibit 
metastasis by preventing adhesion of tumour cells to blood vessels. In fact, it has been shown 
that the inhibition of P-selectin leads to reduction in metastasis in vivo in different types of 
tumour104.  Heparin-related compounds have been shown to decrease metastasis in mice, 
likely through interaction with P-selectin. One of the recent studies used a holothurian GAG 
similar to heparin to decrease melanoma lung metastasis in mice44. This result is in 
agreement with the previous studies showing that sulfated GAG-like carbohydrates reduce 
metastasis by the inhibition of P-selectin24,42,105.  
 
 
1. 3. 6. Selectin-fCS binding 
 
As fCS shares structural similarity to the compounds described above, it has a potential to act 




properties. Indeed, fCS from L. grisea has been found to bind strongly to the L- and P-
selectins, inhibiting their binding to carbohydrate determinant sialyl Lewis x (sLex) as well 
as to the LS180 carcinoma cells42. The inhibition was four- to eightfold more potent than in 
case of heparin for P- and L-selectins and, as in case of heparin, no inhibition was observed 
for E-selectin42. In addition to these results, mouse models have been used to demonstrate 
that fCS is able to inhibit lung colonisation by adenocarcinoma cells in vivo42. 
High affinity of fCS oligosaccharides for selectins may be a result of an interesting structural 
arrangement of the monosaccharide subunits, discovered in the NMR studies of the fCS from 
H. forskali, described earlier in the chapter (Section 1. 2. 3). The results of these studies 
indicate that fucose residue may be stack on top of galactosamine, in an arrangement 
strikingly similar to the one found in sLex tetrasaccharide, where fucose has been found to 
stack on top of galactose ring by X-ray crystallography106 and NMR107. In both cases, fucose 
has been found to remain in close proximity to galactose (~2.5 Å) in a rigid arrangement, 
stabilised by non-polar van der Waals interactions107. In the analogous arrangement found 
in the fCS oligosaccharides, several sulfate groups are brought to close spatial proximity and 
a large negative patch is created. This accumulation of negative charge, along with the sLex-
like conformation of the repeating trisaccharide unit are likely the key properties that 
enhance the fCS-selectin interaction. 
Following these observations, a study was performed in collaboration with Prof. Feizi 
(Imperial College of London), using a microarray of fCS fragments to test their binding to L-, 
P- and E-selectins (Fig. 1. 3. 11)55. As the fCS samples extracted from the sea cucumber body 
wall are long polysaccharides (estimated MW ~120-140 kDa), they were cut into smaller 
oligosaccharide fragments by Cu2+-catalysed Fenton type (symbolised by letter F) and 
photochemical (P) depolymerisation55. Fragments of different lengths were produced, 
ranging from three (tri) to ten (deca) fCS units in each chain. Although each sample displayed 
a level of heterogeneity, the majority of fragments in each sample should be of the estimated 
molecular weight (MW). It must be noted that high-MW fragments were also heterogeneous 
in sequence as it is not currently possible to produce fragments of exactly the same 
composition by depolymerisation. To separate the fragments even further, each 
oligosaccharide type was divided into two subfractions – upper (U) and lower (L) by 
preparative thin layer chromatography (TLC)55. Fig 1. 3. 11 shows the results of the 
microarray study using these fragments. Each fraction was arrayed at two levels, 2 and 5 
fmol/spot in duplicate and the response was dose-dependent. The L, P and E-selectins were 
prepared as culture supernatants of IgM chimeras and their binding was detected with 




The results clearly show that all oligosaccharide fractions bind to L- and P-selectin but not to 
E-selectin. The response was higher for L-selectin than P-selectin. The lower affinities of 
some of the fragments, eg. tetra- and higher MW fractions, could be due to the higher 
heterogeneity of these fractions in monosaccharide sequence or degree of sulfation. Overall, 
the study confirmed that the fCS oligosaccharides from H. forskali bind to L- and P-selectins 
more strongly than sLex and that the binding affinity differs between oligosaccharides of 
different lengths55.   
 
Fig. 1. 3. 11. Results of microarray analysis of binding between the different fCS 
oligosaccharides and selectins. Fluorescence intensity levels for different fCS 
oligosaccharides produced by depolymerisation (columns 5-13) upon binding to L-, P- and E-
selectins. For comparison, fluorescent intensities for sLex and structurally closely related sLeA are 
also shown (columns 2 and 3 respectively). Columns 1 and 4 are control results for lacto-N-




Results of this microarray study confirm the literature findings on the strong affinity of L- 
and P-selectins for fCS. It is unclear why E-selectin presents such a dramatically different 
response to the other two proteins. Detailed structural studies would be needed to account 
for this difference, as well as to fully understand the nature of the binding between selectins 
and fCS oligosaccharides. In this work, the results of molecular dynamics and NMR studies of 
































































































Chapter 2: Aims 
 
Due to its diverse biological activities, fCS is a promising drug candidate that could be used 
in treatment of severe conditions such as inflammatory disease, cancer or HIV. 
Understanding the reason behind the strong affinity of L- and P-selectins for fCS 
oligosaccharides at the molecular level would provide a valuable contribution to the process 
of design and development of new selectin inhibitors. It could also be of great value to wider 
efforts of scientific community, providing data and tools to gain insight into other 
carbohydrate-protein complexes. 
The major aim of this work was to obtain structural information that would shed more light 
on the nature of fCS-selectin interaction. The initial goal was to express 13C, 15N – labelled 
recombinant selectin constructs and to use them in Nuclear Magnetic Resonance (NMR) 
studies. As will be explained in the following chapters, due to problems with protein 
expression, a different approach had to be taken and in later stages of the project Saturation 
Transfer Difference (STD) NMR was used, along with computational methods, to study the 
fCS-selectin interactions. 
 The secondary aim of this work was to develop new NMR tools to facilitate the analysis of 
complex carbohydrate samples. Heterogeneous nature of these samples makes them 
challenging to study by spectroscopic methods. Even with a large library of one- and two-
dimensional NMR experiments, structural elucidation of carbohydrate samples is hindered 
by the high amount of peak overlap in the NMR spectra. To target this problem, we developed 
a variation of the HSQC and HSQC-TOCSY experiments which uses principles of the G-matrix 
Fourier Transform (GFT) NMR to separate the overlapping signals.  
The experimental work undertaken to achieve the above aims will be described in the 
following chapters, starting with the protein expression experiments, followed by the STD 
experiments and computational studies of fCS-selectin interactions, and, finally, by the 













3. 1. Introduction 
 
 
This chapter will describe the work on expression of the 15N, 13C-labelled recombinant 
constructs of human selectins for structural studies of selectin-fCS interactions by NMR. 
Because the E-selectin has previously shown to have no affinity for the fCS oligosaccharides, 
all experiments described here were focused on the expression of L- and P-selectin 
constructs only. As selectins are large, transmembrane proteins, expression of the full-length 
protein was not considered feasible. The region of main interest was the extracellular part of 
the protein, in particular the C-type lectin domain, directly involved in the interactions with 
carbohydrate ligands, and the neighbouring EGF-like domain, believed to play a regulatory 
role in these interactions. The aim was to express two constructs for each selectin: a single-
domain construct, consisting only of the C-type lectin domain, and a double-domain 
construct, consisting of both the lectin and the EGF-like domains. Having these two 
constructs would not only allow us to determine which residues within the lectin domain 
mediate the interactions with the fCS oligosaccharides, but also to perform comparative 
studies on the binding between the single- and double-domain constructs and to assess the 
role of the EGF-like domain in these interactions. 
Double-domain selectin constructs have been previously expressed in the Chinese Hamster 
Ovary (CHO) cells for X-ray crystallography studies65,66. In the later studies of L-selectin 
glycosylation the protein was expressed in Human Embryonic Kidney (HEK293) cells108.  Use 
of mammalian cells is a sensible option, providing the most reliable machinery for 
transcription and translation of human proteins. However, as the main purpose of the 
planned experiments was to produce the 15N, 13C-labelled constructs, a simpler expression 
system was desirable, for which well-established protocols for the isotopic labelling of 
produced proteins exist.  
The School of Chemistry at the University of Edinburgh has expertise in protein production 
in two unicellular expression systems, the Escherichia coli and Pichia pastoris. The first of the 
two is the well-known bacterial expression system, used for fast, efficient and cost-effective 




produce folded and functional human proteins. Formation of disulfide bonds, often found in 
human proteins, requires the presence of oxidative environment within the cell. In 
eukaryotic cells, such environment is found in the endoplasmic reticulum (ER) – a system of 
membrane compartments which allow for synthesis and chemical modification of different 
biomolecules. In prokaryotic cells the ER is missing, which means that the majority of protein 
folding processes will take place in the cytoplasm – an environment in which the formation 
of disulfide bridges is not favourable109.  
P. pastoris is also a simple, unicellular organism but it has the eukaryotic organelles and 
machinery that supports synthesis and folding of complex proteins. Therefore, it is a more 
promising candidate for expression of recombinant selectin constructs. Like E. coli, the cells 
are easy to transform and are able to express recombinant proteins in high yields110,111. 
Additional benefit of using this expression system comes from the fact that the proteins can 
be secreted into the extracellular media for easy purification. A disadvantage of using this 
expression system is that P. pastoris cells replicate at slightly lower rates and need longer 
times for culture growth and protein expression than E. coli cells. However, P. pastoris 
expression system has been successfully used for production of a variety of recombinant, 
isotopically labelled human proteins for NMR studies110–113. It was therefore decided that the 
first set of expression tests will be performed in the P. pastoris expression system. 
 
 
3. 2. Selectin construct expression in P. pastoris 
 
3. 2. 1. Expression system 
 
Pichia pastoris is a methylotrophic species of yeast – it can utilise methanol as a sole source 
of carbon and energy. This unique ability to metabolise methanol allowed for development 
of an expression system for recombinant proteins, coupled to expression of alcohol oxidase 
(AOX1/AOX2) gene. This gene encodes for an enzyme that catalyses the first step in the 
methanol utilisation pathway – oxidation of methanol to formaldehyde. Expression of the 
AOX1 gene is controlled at the transcription level – alcohol oxidase will be produced only in 




cells can be cultured to high densities and are easy to transform, with protocols similar to 
those used for other commonly used species of yeast110. 
Recombinant proteins can be secreted into the medium in presence of the α-factor signalling 
sequence from S. cerevisiae. As only low levels of endogenous proteins are secreted, the 
recombinant proteins should constitute the majority of the total protein in the culture media 
and can therefore be easily purified. However, the efficiency of secretion and purification 
vary for different proteins and may be difficult in certain cases114.  
Several strains of P. pastoris have been developed, with slight differences in the genotype and 
phenotype characteristics. In the experiments described here, strain KM71H was used – the 
only P. pastoris strain that relies on AOX2 rather than AOX1 gene for methanol metabolism, 
also known as MutS strain. AOX1 gene is a much stronger gene and its deletion in KM71H 
strain significantly slows down methanol metabolism, reducing the cell growth rates. Lack of 
the AOX1 gene, however, has its benefits: in other strains, high rate of methanol metabolism 
leads to accumulation of toxic by-products such as hydrogen peroxide and formaldehyde. 
Such substances increase oxidative stress, inhibit cell growth and ultimately lead to cell lysis 
and release of proteases into the media115. In addition to that, strong expression of AOX1 
gene product may compete with the production of recombinant proteins116. Although 
slower-growing, KM71H strain allows to avoid the above problems and has been successfully 
used in production of several protein constructs at the University of Edinburgh. As AOX1 
gene is only introduced on the vector containing the recombinant protein, it triggers high-
levels of expression of the recombinant protein, in some cases offering higher yields than the 
Mut+ strains. Due to these benefits, as well as the long-standing experience of the use of 
KM71H strain for the recombinant protein expression at the University of Edinburgh (Barlow 
group), this strain was chosen as a suitable candidate for expression of selectin constructs. 
 
 
3. 2. 2. Construct design 
 
Two types of constructs were designed for expression of L- and P-selectins in P. pastoris: the 
single-domain (LS1, PS1) and the double-domain construct (LS2, PS2). The double-domain 
constructs were based on the example of constructs produced previously for the X-ray 
studies65,66. The N-terminus was conserved as in the full-length protein, with Trp1 being the 




in the case of P-selectin double-domain construct. The single-domain constructs were 
designed to be 35-residue shorter, terminating at residue Ser121. This decision was based 
on the direct involvement of Ser121 in the stabilising interactions with the protein’s N-
terminus, observed in the reported crystal structures. There is no defined border between 
the C-type lectin and the EGF-like domains and residue Ser121 was chosen as the terminal 
residue based on the fact that it is the last residue which is actively involved in stabilisation 
of the lectin domain fold. The amino acid sequences of all four protein constructs are included 
in Appendix 1. 
Selectin constructs designed here were inserted into the pPICZαB vector. This vector 
contains several elements designed to help in efficient expression of recombinant proteins. 
pUC bacterial origin of replication facilitates production of high number of copies of the 
plasmid. AOX1 promoter and terminator allow for controlled expression of the gene of 
interest, whilst a sequence encoding for resistance to zeocin allows to selectively culture only 
the transformed strains (Fig 3. 2. 1). The constructs were designed to be inserted into the 
vector with the use of PstI and XbaI restriction enzymes, at the site following the α-factor 
signal sequence to allow for protein secretion into the media. 
Fig. 3. 2. 1. Map of pPICZαB vector. The gene of interest is inserted after the AOX1 promoter 
and includes the N-terminal α-factor signalling sequence for protein secretion. Vector also 




3. 2. 3. Materials and methods 
 
3. 2. 3. 1. Plasmid preparation 
 
The recombinant DNA fragments were based on the sequences deposited in the Uniprot 
database (# 14151, # 16109), codon optimised for expression in P. pastoris, synthesised and 
subcloned into the pPICZαB vector by GenArtTM (Thermofischer Gene Synthesis Suite), with 
the use of the PstI and XbaI restriction sites. The received vial was centrifuged at 6000  g 
for 1 min at 4°C and the plasmids (5 μg) were resuspended in 50 μL of ultrapure water prior 
to transformation into E. coli cells. 
 
 
3. 2. 3. 2. Plasmid transformation into E. coli 
 
1 μL of the resuspended plasmid DNA was added into an aliquot (50 μL) of chemically 
competent Top10 cells. Cells were incubated on ice for 20 min, then heat-shocked for 30s at 
42 °C, returned on ice and diluted with 80 μL of S. O. C. medium, incubated for 1 h at 37 °C 
and plated at four different concentrations (5 μL, 10 μL, 20 μL and 40μL) on 15 mL LB agar 
plates with 25 μg/mL of zeocin (InvivoGen). Plates were allowed to dry and incubated 
overnight at 37 °C.  
The next day, transformed colonies (5 colonies per construct) were used to inoculate 5 mL 
of LSLB with 25 μg/mL zeocin. Cultures were grown for 8 h at 37 °C, with shaking at 200 rpm, 
transferred to 250 mL LSLB, incubated overnight at 37 °C with shaking at 200 rpm and 
harvested by centrifugation at 5000  g for 10 min at 4 °C. Pelleted cells were then used for 
plasmid preparation. Plasmids were prepared from the E. coli cultures using the QIAgen 
Plasmid Maxi Kit, according to manufacturer’s instructions. The final DNA samples were 
quantified (A260), linearised with SacI-HF® enzyme (New England BioLabs) for 3 h at 37°C 
and separated by electrophoresis on a 1 % TBE agarose gel, visualised with SybrSafeTM 
(Invitrogen), with 5 μL of HyperladderTM 1kb DNA GeneRuler (Thermo Scientific) as a 







3. 2. 3. 3. Extraction of the plasmid DNA 
 
To obtain high-purity DNA for the transformation of P. pastoris cells, the linearised plasmid 
DNA was extracted using phenol-chloroform method. Phenol:chloroform:isoamyl alcohol 
(25:24:1, Sigma) was added to equal volume of linearised DNA. The extraction mixture was 
centrifuged at 20 000  g for 1 min, the top layer transferred to a new tube and the bottom 
layer discarded. This procedure was repeated once. After the top layer was transferred again 
to a fresh tube, equal volume of 100 % chloroform was added to it. After another 
centrifugation step, the top layer was transferred again to a new tube and 0.1 volume of 3 M 
sodium acetate and 2 volumes of 100 % cold ethanol were added to it. The mixture was 
incubated at -20 °C overnight and centrifuged at 20 000  g for 30 min. Supernatant was 
discarded and pellet was washed with 400 μL of 70% cold ethanol. Sample was centrifuged 
at 20 000  g for 10 min and ethanol was removed by pipetting and air-drying. Pellet was 
resuspended in 12 μL of ultrapure water and DNA concentration was quantified (A260). 
 
 
3. 2. 3. 4. Plasmid transformation into P. pastoris 
 
The KM71H strain of P. pastoris was kindly provided by Dr McIntosh. A single colony was 
picked and used to inoculate 5 mL of YPD media. Cells were incubated for 24 h at 30 °C, with 
shaking at 220 rpm, used to inoculate 100 mL of YPD media at three different concentrations 
and incubated again overnight in the same conditions. On the next day, OD600 was measured 
and the cell culture that reached the value of 1.3 was used for further experiments. 
Cell culture was centrifuged at 1500  g for 5 min at 4 °C, supernatant was discarded and 
pellet was resuspended in 100 mL of ice-cold sterile water. This procedure was repeated one 
more time. Sample was centrifuged for the third time, supernatant discarded and pellet 
resuspended in 8 mL of ice-cold 1M sorbitol. This step was repeated but this time the cells 
were resuspended in 200 μL of ice-cold 1M sorbitol. 80 μL of the cells were added to 10 μL 
of linearised plasmid DNA and transferred to a pre-chilled electroporation cuvette. Cells were 
pulsed with electric current in the electroporation tray (Gene Pulser Cuvette, Bio-Rad) and 
immediately resuspended in 1 mL YPDS with 1 M sorbitol, transferred to a new tube and 




containing zeocin at three different concentrations (100 μg/mL, 200 μg/mL, 300 μg/mL) and 
incubated at 30 °C for 72 h. The colonies that grew at the highest zeocin concentration were 
used in the protein expression tests. 
 
 
3. 2. 3. 5. Small-scale protein expression tests 
 
A single colony of transformed P. pastoris strain was used to inoculate 5 mL of buffered 
glycerol complex medium (BMGY). Cells were incubated overnight at 30 °C with shaking at 
220 rpm. On the next day, the cell culture was transferred into 100 mL of BMGY and 
incubated for another 24 h at 30 °C with shaking at 220 rpm. The culture was then 
centrifuged at 3000  g for 5 min at 4 °C, supernatant discarded and pellet resuspended in 
25 mL of buffered methanol complex medium (BMMY). Methanol was added in 
concentrations ranging from 0.5 % to 1 % of the culture volume, at 24, 48, 66 and 72 h after 
the transfer to BMMY. Cells were harvested at 90 h from induction by centrifugation at 5000 
 g for 20 min at 4 °C. Supernatant was collected and used in protein purification tests. 
 
 
3. 2. 3. 6. Large-scale protein expression tests 
 
A single colony of transformed P. pastoris strain was used to inoculate 8 samples of 5 mL of 
buffered glycerol complex medium (BMGY). Cells were incubated overnight at 30 °C with 
shaking at 220 rpm. On the next day, the cell culture was transferred into 8 samples of 1 L of 
BMGY and incubated for another 24 h at 30 °C with shaking at 220 rpm. After that time, the 
cultures were centrifuged at 3000  g for 5 min at 4 °C, supernatant discarded and pellet 
resuspended in 8 samples of 125 mL of buffered methanol complex medium (BMMY). 
Methanol was added in concentrations ranging from 0.5 % to 1 % of the culture volume, at 
24, 48, 66 and 72 h after the transfer to BMMY. Cells were harvested at 90 h from induction 
by centrifugation at 5000  g for 30 min at 4 °C. Supernatant was collected and used in 




3. 2. 3. 7. Fermentation conditions 
 
Test fermentation was performed in the Bioflow 3000 fermentor at the University of 
Edinburgh. A single colony of the LS2 construct was used to inoculate 10 mL of BMGY. Cell 
culture was incubated for 2 days at 30 °C with shaking at 220 rpm. This culture was used to 
inoculate 200 of BMGY and incubated for 24 h at 30 °C with shaking at 220 rpm. 100 mL of 
the cell culture was added to the fermentor, containing 600 mL of autoclaved basal salts (27 
mL of 85 % H2PO4, 0.95 g CaSO4, 18.2 g K2SO4, 15 g MgSO4, 4.2 g KOH and 25 mL glycerol per 
1 L solution) and 2.6 mL of filter-sterilised PTM salts (BioWorld). The fermentation was run 
at 30 °C and pH was maintained at 5.0, using undiluted ammonium hydroxide. Dissolved 
oxygen (DO) was maintained above 20 % by adjusting agitation rate and pure oxygen supply. 
When the initial glycerol was depleted, as indicated by an abrupt increase in DO level, a 50 % 
solution of glycerol with 6 mL/L PTM salts was added to the fermentor. On day 2 from the 
start of fermentation growth, temperature was lowered to 20 °C and cells were induced with 
6 mL of a solution of methanol with 12 mL/L PTM salts. 12 mL of the methanol solution was 
added again after 8, 19, 28, 39, 47, 54 and 66 h from the start of induction. Cells were 
harvested by centrifugation at 5000  g for 30 min at 4 °C. 
 
 
3. 2. 3. 8. Small-scale protein purification tests 
 
10 – 20 mL disposable columns were used for the small-scale protein purification tests. The 
tested resins included SP Sepharose, SP-650M Toyopearl, Heparin Sepharose, Concavalin A 
(GE Healthcare). Supernatant from the P. pastoris cultures was diluted 1 in 6 and its pH was 
adjusted to be equal to pH of the cation exchange buffer, which ranged from 4.0 to 7.0. The 
buffer used was either 20 mM potassium phosphate or, in later experiments, 20 mM sodium 
acetate. In the cation exchange chromatography, column was equilibrated in five column 
volumes of the buffer and 30 – 60 mL of the supernatant was loaded onto the resin. The 
elution buffer contained sodium chloride in concentrations ranging from 0.1 M to 1 M. 






3. 2. 3. 9. Large-scale protein purification tests 
 
The purification system used for the large-scale protein purification tests was ӒKTA FPLC P-
920. The columns tested included SP Sepharose Fast Flow and HiLoad 16/600 Superdex 75 
(GE Healthcare). Supernatant from the P. pastoris cultures was diluted 1 in 6, 10 mM CaCl2 
and PMSF protease inhibitor (Sigma) were added and the pH was adjusted to be equal to pH 
of the purification buffer, which ranged from 4.0 to 7.0 for cation exchange chromatography 
and 7.4 for gel filtration. The buffer used was 20 mM sodium acetate or, in case of the gel 
filtration experiments, 20 mM Tris with 500 mM NaCl. In the cation exchange experiments, 
column was equilibrated in five column volumes of the buffer and 1 L of the supernatant was 
loaded onto the resin. The elution buffer contained sodium chloride in concentrations 




3. 2. 3. 10. SDS-PAGE analysis 
 
Protein MW and purity were assessed by SDS-PAGE. Selected fractions were deglycosylated, 
using the Endo-HF enzyme (New England BioLabs) according to manufacturer’s instruction. 
For the SDS-PAGE analysis, 15 – 20 μL of the sample was combined with 3 μL of the NuPAGE® 
LDS Sample Buffer (4X, Invitrogen) and 2 μL of the NuPAGE Sample Reducing Agent (10X, 
Invitrogen), heated for 3 min at 100°C and stored on ice before loading on the gel. 
The SDS-PAGE was run using the precast NuPAGE Novex 4 – 12 % Bis-Tris Protein Gels 
(Invitrogen) with the Precision Plus ProteinTM (Bio-Rad) or PageRuler Plus (ThermoFisher) 
molecular weight marker. 
 
 
3. 2. 3. 11. Western blot analysis 
 
Western blot was performed in order to selectively detect the L-selectin protein constructs. 




used as a positive control. SDS-PAGE was run as described in Section 3. 2. 3. 10.  XCell II Blot 
Module (Invitrogen) was used to transfer proteins from the SDS-PAGE gel onto the PVDF 
membrane (Bio-Rad). Transfer module was packed with 3 blotting pads and a filter paper 
(Bio-Rad) pre-soaked in transfer buffer (1x NuPage Transfer buffer, 10 % methanol). The 
membrane was soaked for 10 min in methanol, 5 min in transfer buffer and then placed on 
top of the SDS-PAGE gel and in the transfer module. Another filter paper was placed on top 
of the membrane, followed by another two pads, also pre-soaked in the transfer buffer. 
Transfer was performed at 30 V for 1 h. After the transfer, the membrane was placed in the 
Falcon tube containing 40 mL of 5 % (w/v) skim milk (Fluka Analytical) in PBS and incubated 
on the rollers for 2 h at 4 °C. The membrane was transferred to a new Falcon tube, containing 
10 mL of milk in PBS with a 1:200 dilution of primary antibodies (N-18, Santa-Cruz 
Biotechnology) and placed on the rollers at 4°C for overnight incubation. On the following 
day, the membrane was washed in 10 mL of PBS for 20 min, twice in 10 mL of 0.05% (v/v) 
Tween20 in PBS for 20 min and twice in 10 mL of PBS for 20 min. After the washes the 
membrane was placed in 10 mL of milk in PBS with a 1:5000 dilution of secondary antibodies 
(donkey anti-goat IgG-HRP, Santa-Cruz Biotechnology) and incubated on the rollers for 2 h 
at 4 °C. Following the incubation, the membrane was washed twice in 10 mL of PBS for 5 min, 
once in 20 mL of 0.05 % Tween20 in PBS for 20 min, 10 mL of PBS for 10 min and 10 mL of 




3. 2. 4. Results and discussion 
 
 
3. 2. 4. 1. Construct design and plasmid preparation 
 
Experiments described in this section aimed to express the recombinant L- and P-selectin 
constructs in P. pastoris strain KM71H. The initial tests attempted to find an optimal protocol 
for expression of these constructs using standard growth media. Had these attempts been 
successful, the next step would be to find suitable conditions for expression of the 15N, 13C – 
labelled protein in minimal media. The protocols described here were kindly provided by the 




The double-domain constructs were based on the constructs expressed previously by other 
groups for X-ray studies65,66. The preferred option was to express the protein constructs 
without any added tags as these can be problematic to cleave off and can interfere with NMR 
studies. For this reason, the only addition to the native protein sequence was the N-terminal 
α-factor secretion signal sequence. This sequence is necessary for protein secretion into the 
extracellular media and should be cleaved off by P. pastoris proteases prior to translocation 
through the cell membrane.  
The α-factor sequence adds sixty-six amino acid residues to protein’s N-terminus. There are 
two proteases that are responsible for the processing of this sequence and their recognition 
sites are also encoded within the pPICZαB vector. The first protease is a dibasic 
endopeptidase encoded by the Kex2 gene that cuts the peptide between arginine and 
glutamic acid within the terminal region of the α-factor signal sequence (Fig. 3. 2. 2). The 
second protease, a product of the Ste13 gene, is a dipeptidyl amino peptidase that removes 
the remaining glutamic acid and alanine residues (Fig. 3. 2. 2). Successful post-translational 
processing of the α-factor sequence is dependent on correct function of both of these 
proteases. However, in some cases the Ste13 protease displays low efficiency and can leave a 
permanent  two-residue tail at the protein’s N-terminus117.  
 
 
Fig. 3. 2. 2. Fragment of the pPICZαB vector genetic sequence. The red circles highlight the 
PstI and XbaI restriction sites used to for the cloning of selectin constructs into the vector. The 
green circles highlight the protease cleavage sites, necessary for the correct cleavage of the α-




Selectin constructs were designed to be cloned into the pPICZαB vector with the use of two 
restriction sites: PstI at the 5’ (N-terminal) site and XbaI at the 3’ (C-terminal) site of the 
protein sequence (Fig. 3. 2. 2). Although these restriction sites are required to insert the 
desired gene into the vector, the introduction of six extra bases onto the 5’ and 3’ ends of the 
gene sequence leads to addition of two amino acids onto protein’s N- and C-termini. These 
amino acids cannot be cleaved off and in some proteins can interfere with the folding 
processes and affect protein’s stability. However, similar approach has been used for 
successful expression of many proteins and this design was regarded as the most promising 
option for selectin construct expression NMR studies at the time.  
The genes were synthesised and cloned into pPICZαB vector externally by GenArtTM. The 
resulting plasmids were transformed into E. coli cells to generate high amounts of plasmid 
DNA for expression tests. The extracted DNA was sequenced and no mutations were found 
within any of the constructs. For efficient uptake by the P. pastoris cells, the plasmids needed 
to be linearised, using the SacI-HF restriction enzyme. The difference between the circular 
and linearised plasmid can be observed by agarose gel electrophoresis, where the linear 
plasmids will behave as larger molecules and will migrate through gel matrix more slowly 
than the circular plasmids. The majority of circular plasmids adopt a twisted coil 
conformation, making them appear smaller on the agarose gel. As presented on Fig 3. 2. 3, all 
of the plasmids were linearised successfully and migrated to the expected region on the gel 
(ca. 4 kb) after linearization.  
 
 
Fig. 3. 2. 3. Linearisation of the plasmid DNA. Agarose gels of the LS1, LS2, PS2 and PS1 
plasmid DNA before and after the linearisation reaction. Letter N indicates the DNA sample prior 






In the next step, the linearised DNA was transformed into P. pastoris by electroporation. The 
transformed cells formed colonies on agar plates containing up to 300 μg/mL of zeocin, 
proving that the transformation was successful. 
 
 
3. 2. 4. 2. Small-scale protein expression tests 
 
In the initial experiments, small-scale expression tests were performed on all of the 
constructs, aiming to identify the colonies that express the protein in the highest amounts. 
For this purpose, 100 mL cultures of individual colonies were grown, induced with 0.5% of 
methanol for 3 – 4 days and harvested by centrifugation. As the protein should be secreted 
by the cells, the supernatant was analysed by the SDS-PAGE. The expected molecular weight 
(MW) of the LS1 and PS1 constructs was approximately 14.5 kDa and of the LS2 and PS2 
constructs – 18.6 kDa, without taking glycosylation into account. Summary of the calculated 
MW and isoelectric point (pI) values for all constructs expressed in P. pastoris can be found 
in Appendix 1. 
Analysis of protein expression levels was hindered by the large amount of smearing observed 
on the SDS-PAGE (Fig. 3. 2. 4). The smearing appeared to be correlated to the amount of 
recombinant protein as it increased at longer induction times and was the most intense in 
the regions where selectin band was expected. Reasons for the smearing remain unclear but 
could be explained by the fact that the constructs may be forming complexes with other 
molecules such as nucleic acids or carbohydrates. Indeed, absorbance at 260 nm was 
measured and proved to be higher than the absorbance at 280 nm for most samples, 
indicating presence of nucleic acids.  In order to remove any N-linked glycans which could 
affect protein’s migration on the gel and contribute to the smearing, the supernatant samples 
were digested with the Endo-HF glycosidase. As the C-type lectin domain contains two N-
glycosylation sites, it is possible that there could be two glycan chains attached to this domain 
when produced in yeast cells. However, treatment with Endo-HF did not improve the clarity 
of SDS-PAGE results (Fig 3. 2. 4. B). 
In experiments undertaken later in the project, attempts were made to reduce the smearing 
on the SDS-PAGE by modifying the methods for sample preparation and conditions for the 
gel electrophoresis (Fig. 3. 2. 4. C). These tests included alterations to the amounts of the SDS 




electrophoresis voltage, incubation temperature for the SDS-PAGE samples, diluting or 
concentrating the samples.  Despite many efforts, it was not possible to lessen the smearing 
or to determine its cause. Further experiments explored different methods for purification 
of the expressed constructs to obtain a sample that is easier to analyse. 
 
 
Fig. 3. 2. 4. SDS-PAGE of the cell culture supernatant in small-scale expression tests.       
A SDS-PAGE analysis of crude supernatant for three of the PS1-expressing colonies (a, b and c) in 
1, 2 and 3 days after induction. All of the samples were treated with Endo-HF glycosidase and the 
samples from day 3 were concentrated 5-fold. B SDS-PAGE of crude supernatant for LS1, LS2 and 
PS2 transformants, prior to (N) and after (G) the treatment with Endo-HF glycosidase. All of the 
samples were concentrated 5-fold. C SDS-PAGE of a sample containing the LS2 protein, testing 
different methods of sample preparation in attempts to reduce the smearing. Sample prepared 
using standard methods (a) was compared with samples prepared with excess of the Endo-HF 
enzyme (b), by varying the sample concentration (c), ratios of the reducing agent and the SDS 
buffer (d – g) and by centrifugation, loading only the supernatant on the gel (h). The first lane is 
the MW marker in kDa. 
 
 
By analysing the SDS-PAGE results of the small-scale expression tests, it was not possible to 
clearly determine whether the protein constructs were expressed in P. pastoris, how high the 




next step was to express one of the protein constructs on a larger scale (4 L), in order to 
obtain higher amounts of the supernatant sample for more detailed analysis. As all of the test 
expression cultures were similar by SDS-PAGE, no priority was given to any of the constructs. 
 
 
3. 2. 4. 3. Large-scale expression tests 
 
The construct that was expressed in larger quantities was the double-domain L-selectin 
construct (LS2). Cells were cultured and induced as described previously and the collected 
supernatant was separated on the SP Sepharose resin in potassium phosphate buffer, pH 6.0. 
The calculated pI of the LS2 construct is close to 7.0 which meant that it should be possible 
to bind the protein to a cation exchange resin at pH 6.0. However, no protein was detected to 
bind to the column at this pH. Following this result, pH of the buffer and the supernatant was 
lowered to 4.0 to ensure that the protein binds this time. Indeed, at the lower pH, a large peak 
was detected in the fractions eluted from the column at approximately 0.3 – 0.7 M 
concentration of sodium chloride (Fig. 3. 2. 5. A). 
Fig. 3. 2. 5. SP Sepharose cation exchange chromatography of the LS2 supernatant from 
the large-scale growth. A Chromatogram of the fractions eluted with the salt gradient from 0 
M to 1 M NaCl. Fractions 18 – 38, analysed by the SDS-PAGE, are indicated by the green arrow.       
B SDS-PAGE of selected fractions with fraction numbers underneath. Dotted line indicates the 




Fractions  18 – 38 were analysed by SDS-PAGE (Fig. 3. 2. 5. B). A band appearing at MW close 
to 15 kDa was considered to be the one that most likely corresponded to the LS2 construct. 
One of the fractions containing this band (fraction 24) was used in a test gel filtration 
chromatography experiment. The other fractions containing this band (20 – 31) were 
combined and stored for future analysis at -20 °C. 
Gel filtration chromatography was performed in phosphate buffered saline (PBS) at pH 7.4. 
Several broad and merging peaks were observed (Fig. 3. 2. 6. A). A range of fractions from 
different regions of the chromatogram was analysed by SDS-PAGE. Fractions 40 – 90 
contained no bands that could correspond to the full-size LS2 construct – only smaller size 
bands were observed, which could indicate that protein was degraded prior to or during this 
purification step. Bands of ca. 15 kDa and 20 kDa were observed in fractions 32 – 38 (Fig. 3. 
2. 6. B).  These fractions were combined and stored for further analysis at -20 °C. 
 
 
Fig. 3. 2. 6. Gel filtration chromatography of the fraction 24 eluted from the cation 
exchange resin. A Chromatogram of the fractions eluted from the gel filtration column. 
Fractions 30-40, analysed by SDS-PAGE, are indicated with the green arrow. B SDS-PAGE of 
selected fractions with fraction numbers underneath. Dotted line indicates the region where the 
LS2 band was expected. The first lane is the MW marker in kDa. The strong band at ca. 75 kDa, as 
well as two weaker bands between 37 – 50 kDa resulted from the excessive amount of Endo-HF 





Bands observed at lower MW in both experiments were considered to be LS2 fragments, 
produced by proteolytic cleavage. No protease inhibitors were used during this large scale 
protein preparation and purification, which may have caused protein degradation during and 
after the culture growth. In order to minimise this problem in the future experiments, PMSF 
was added to the supernatant after the harvest. EDTA was not used as a protease inhibitor 
because of its chelating affinity for divalent cations. It was expected that presence of Ca2+ ions 
may be important for stability and binding properties of the C-type lectin domain. For this 
reason, it was also decided, that in the further experiments, use of phosphate buffers, which 
also sequester calcium ions, would be avoided. Sodium acetate buffers were used instead 
from that point onwards.  
Due to the problems with identification of the LS2 bands on SDS-PAGE, western blotting 
experiments were performed on the fractions from both the cation exchange and the gel 
filtration chromatography experiments. A single band was detected only in the combined 
fractions from the SP Sepharose chromatography and not in the fractions collected from the 
gel filtration. The band appeared at ca. 20 kDa, which was close to the estimated MW of 18.6 
kDa (Fig 3. 2. 7). It should be noted that such band was not observed on any of the SDS-PAGE 
gels, suggesting that the protein may be present in very small quantities and its detection 
may only be possible by the western blot. This, in turn, would suggest that there is a problem 
with expression of this construct in P. pastoris as it is not being produced in high enough 












Fig. 3. 2. 7. Western blot of the fractions from chromatography experiments. The first 
two lanes correspond to the fractions collected after the gel filtration (GF). The next two lanes 
correspond to the fractions collected after the cation exchange chromatography (CE). The positive 
control (PC) was a cell extract containing the full-size L-selectin – the proteins did not transfer 
well onto the membrane but a strong band corresponding to the full-size L-selectin can be 




As the combined fractions from cation chromatography were shown to contain the LS2 
construct by western blot, another gel filtration experiment was performed, using a 10-fold 
concentrated sample. The conditions of this experiment were the same as previously, except 
for the higher amount of the loaded protein. However, since in the previous experiment the 
collected fractions did not prove to contain the desired construct, other regions of the gel 
filtration chromatogram were going to be explored.  
The results were similar to those from the previous experiment –broad overlapping peaks 
were present on the chromatogram and the SDS-PAGE analysis, although cleaner than before, 
did not show any presence of the LS2 construct. Only small protein fragments were observed, 
strengthening the hypothesis that the protein was degraded prior to or during the 
chromatography experiment (Fig. 3. 2. 8). After 5-fold concentration of some of the fractions, 
the protein could be observed on the gel but only as a weak band that disappeared from the 
gel after a two hours of staining, indicating that the background noise was too high for 




Fig. 3. 2. 8. Gel filtration chromatography on combined fractions 20 – 31 from cation 
exchange chromatography. A Chromatogram of the fractions eluted from the gel filtration 
column. Fractions 49-80, analysed by SDS-PAGE, are indicated with green arrow. B SDS-PAGE of 
selected fractions with fraction numbers underneath. Dotted line indicates the region where the 




Interestingly, the small protein fragments (< 10 kDa) were present throughout the majority 
of collected fractions. This should not be the case in a correctly calibrated and well-
functioning gel filtration column – all low-MW fragments should be eluted in the final stages 
of the experiment, after the larger proteins were eluted. This raised suspicions that there 
may be technical issues with the column that interfere with the result of this experiment. The 
exact reason for these problems was never confirmed. 
The three most prominent low-MW contaminants were analysed by mass spectrometry and 
one of them was identified to be a fragment of the degraded construct. The identified peptide 
corresponded to residues 98-111 of the human L-selectin. The other fragments could not be 
identified but it is likely that they were also fragments of the LS2 construct. 
 
 
3. 2. 4. 4. Small-scale protein purification tests on the LS2 construct 
 
Further small-scale expression experiments were undertaken in attempt to establish a more 
suitable protocol for LS2 construct expression and purification. The aim of these tests was to 
increase the yields of produced protein and to minimise its degradation. In these 
experiments, cell cultures were fed with higher than previously amounts of methanol (1%) 
and PMSF was added to the supernatant immediately after harvest to prevent proteolysis.  
Unfortunately, the LS2 construct, when expressed on a small scale, presented high amount of 
smearing on all SDS-PAGE gels, which hindered protein identification in the chromatography 
tests. Smearing in this case was so severe, that no individual bands could be observed. 
Although protein purification was attempted on SP Sepharose column pH 4.0 and pH 5.0, as 
well as on the Heparin column at pH 5.0, no clear bands could be observed below 20 kDa. 
Resins from both columns were also tested by SDS-PAGE for presence of any proteins that 
may still be bound after the elution with 1M NaCl. No bands were observed. 
An interesting observation came from the comparison of the fractions eluted from the SP 
Sepharose resin under the Ca2+-rich (addition of CaCl2) and Ca2+-deficient (presence of EDTA) 
conditions. Peaks in the UV absorbance for those two tests occurred at similar time points: 
in fractions 3 – 6 and 7 – 12. However, the levels of absorbance for the two observed peaks 
were different in the two cases. In the Ca2+-rich environment, A280 absorbance for the peak 




Opposite trend was observed for the peak observed in fractions 7 – 12 (Fig. 3. 2. 9). In 
addition to these findings, analysis by SDS-PAGE showed much reduced smearing for the 
Ca2+-rich samples, when compared to the Ca2+-deficient fractions. Unfortunately, no clear 
bands were observed even after concentrating the samples 5-fold, which might be attributed 
to the small amount of protein present in the fractions. However, these tests clearly show 
that the concentration of Ca2+ ions affects the protein’s behaviour in the purification tests and 
is an important factor to consider in future experiments. 
 
 
Fig. 3. 2. 9. UV absorbance (A280) of the fractions eluted from the SP Sepharose resin 
under Ca2+-rich and Ca2+-deficient conditions. Sample of the supernatant from P. pastoris 
LS2 growth was passed through SP Sepharose resin after the addition of CaCl2 (blue line) and 




Despite the efforts to modify the conditions for cell growth and protein purification, it was 
not possible to establish a protocol that would allow to obtain the LS2 constructs pure from 
any contaminants and in high enough yields to allow for further studies.  
In the next set of experiments, small-scale expression and purification tests were performed 




3. 2. 4. 5. Small-scale protein purification tests on the LS1 construct 
 
The LS1 construct was prepared on a small-scale (300 mL) using the same protocols as 
described previously, with 1% methanol used for the induction of protein expression and 
PMSF added to the resulting supernatant to inhibit protease activity. 10 mM calcium chloride 
was also added to the supernatant to stabilise the protein. 
In the first experiment, SP Sepharose resin was tested in sodium acetate pH 4.0. As in the 
previous tests, the UV absorbance (A280) of the fractions was monitored and selected 
fractions were analysed by SDS-PAGE. Multiple protein bands were observed in the region 
between 15 and 20 kDa, indicating that there were many proteins within the P. pastoris 
supernatant binding to the resin at this pH. As calculated pI of the LS1 construct was 8.6, 
which is higher than the pI of the majority of proteins normally found in the P. pastoris 
supernatant, it should be possible to find experimental conditions in which the LS1 construct 
binds to a cation exchange resin more selectively. 
Three different cation exchange resins were tested at pH 7.0 (SP Sepharose, SP Toyopearl 
650M and Heparin Sepharose). No protein was detected in the eluted fractions at this pH. It 
was therefore decided that a lower pH value should be used at which LS1 construct binds to 
one of these resins more selectively than at pH 4.0. The arbitrary choice was pH 5.6, lying 
half-way between the pH 4.0 and 7.0. At this pH, purification on the SP Sepharose resin 
showed more promising results, with a strong band at ca. 17 kDa, close to the calculated 
molecular weight of the LS1 construct (14.5 kDa), and with fewer bands eluting at the same 
time (Fig. 3. 2. 10). However, a strong band was also observed in the column flow-through at 
14 kDa and it is possible that this band, rather than the band in eluted fractions, could 
correspond to the LS1 construct. Due to the unavailability of L-selectin-specific antibodies at 
the time, it was not possible to confirm which of the two bands corresponded to the LS1 
construct. Nevertheless, this purification method was found to be the most suitable from all 
of the cation exchange methods tested on the small-scale and it was used in the large 
expression tests. 
It is worth noting that the smearing on the SDS-PAGE was greatly reduced in the LS1 samples, 
showing that this protein behaves differently to the LS2 construct. However, as in the case of 
the LS2 construct, multiple high intensity bands were observed at low MW values (Fig. 3. 2. 
10. B), suggesting that high levels of degradation are observed also for the LS1 construct 




could increase the expression levels and reduce the proteolysis. Therefore, in the next 
experiment, a larger scale growth in a fermenter (0.7 L) was attempted. 
 
Fig. 3. 2. 10. UV absorbance (A280) of the fractions eluted from SP Sepharose resin at 
pH 4.0, 5.6 and 7.0 with SDS-PAGE of selected fractions. A LS1 supernatant was applied to 
the SP Sepharose resin at three different pH values: 4.0 (green line), 5.6 (blue line) and 7.0 (yellow 
line) and change in A280 was recorded using a bench-top UV spectrophotometer. B SDS-PAGE of 
selected fractions eluted at pH 5.6 with fraction numbers underneath. Dotted line indicates the 
region where the LS1 band was expected. The first lane is the MW marker in kDa. The second lane 




3. 2. 4. 6. Fermenter growth of the LS1 construct 
 
 
In the fermenter growth yeast cells are cultured under controlled conditions, which means 
that they are able to reach densities higher than in the flask growth, leading to increased 
protein production levels. During the LS1 fermentative growth, temperature was maintained 
at 30 °C initially and at 20 °C after the induction with 1% methanol. pH was maintained at 5.0 
and dissolved oxygen levels were kept above 20% by constant agitation. Protein expression 
level in the cell culture media was monitored on each day of the induction. A gradual increase 
in band intensity was observed for a band at close to 15 kDa which could correspond to LS1, 
as well as two low-MW bands that likely correspond to protein degradation products (Fig. 3. 
2. 11). This result suggests that LS1 construct may be degraded during the culture growth 













Fig. 3. 2. 11. SDS-PAGE of the P. pastoris fermentation media at different time points of 
the methanol induction. Numbers above the lanes indicate the number of hours after the start 
of induction. Dotted line indicates the region where the LS1 band was expected. The first lane is 




Culture supernatant was harvested as before and PMSF and 10 mM calcium chloride were 
added. During the purification, protocols from the small-scale tests were followed. In the first 
step, the supernatant was loaded onto the SP Sepharose column at pH 5.6. The eluted 
fractions were monitored by UV and SDS-PAGE (Fig. 3. 2. 12. A). Fractions 17 – 20, 21 – 23 
and 24 – 29 were collected into three separate samples that were analysed by the western 
blot (Fig. 3. 2. 12. B). The highest intensity response was detected in the sample containing 
fractions 17 – 20. This sample was purified further by gel filtration chromatography. 
 
Fig. 3. 2. 12. SDS-PAGE and western blot of the fractions eluted from the SP Sepharose 
column at pH 5.6. A SDS-PAGE of selected fractions. Numbers above the lanes indicate the 
fraction number. Dotted line indicates the region where the LS1 band was expected. The first lane 
is the MW marker in kDa. The second lane is the raw supernatant after the harvest (S) and the 
third lane is the column flow-through (F). B Western blot of the combined fractions 17 – 20, 21 – 
23 and 24 – 29. The last three lanes correspond to the column flow-through (F), the sample before 





Gel filtration experiment on fractions 17 – 20 was performed at the Edinburgh Protein 
Production Facility (EPPF) to avoid technical problems experienced during the small 
expression tests. The column was equilibrated in 20 mM Tris pH 7.4 with 500 mM NaCl and 
10 mM CaCl2 and the sample was concentrated down to 250 μL. Two high-intensity 
overlapping peaks were observed in the initial part of the chromatogram, between the 
fractions B3 and B6, and a low-intensity peak later in the chromatogram, between fractions 
C5 and C6 (Fig. 3. 2. 13. A). These fractions were analysed by SDS-PAGE, however, the bands 
in the initial analysis were very weak and the samples needed to be concentrated 
approximately 5-fold. Under the reducing SDS-PAGE conditions all of the fractions contained 
low-MW proteins. As fractions B3 – B6 were eluted at retention times that would normally 
correspond to elution of larger proteins, this result suggested that the expressed proteins 
may be aggregating . For this reason, the same fractions were compared under the reducing 




Fig. 3. 2. 13. Gel filtration chromatography on combined fractions 17 – 20 from the 
cation exchange chromatography. A Chromatogram of the fractions eluted from the gel 
filtration column (A280 in blue, A260 in red). Fractions B5 – B6, analysed by SDS-PAGE, are indicated 
with green arrows. B SDS-PAGE of selected fractions with fraction numbers above the lanes. 
Letter R indicates samples prepared in the reducing conditions. Dotted line indicates the region 





In the SDS-PAGE experiment it can be clearly seen that the proteins are aggregating and 
behaving as a larger protein of approximately 28 kDa. Such MW value would suggest that the 
LS1 construct may form dimers in the buffer used for the gel filtration experiment. In addition 
to that, high-intensity low-MW bands were observed in all of the analysed fractions, 
indicating high-levels of protein degradation. It is possible that these low-MW fragments are 
also aggregating with the full-size protein which would explain why their separation by the 
gel filtration is not possible. 
A few more small-scale experiments were undertaken in order to try and reduce the protein 
degradation levels. Nine more freshly transformed P. pastoris colonies were tested for higher 
LS1 expression levels with less degradation. However, none of the colonies expressed the 
full-size construct at a level significantly higher than the colony used in the earlier tests. In 
another experiment, induction in the presence of 0.1 mmol AEBSF protease inhibitor was 
attempted. Unfortunately, this experiment also was not successful. It is likely that the high 
degradation levels occurred due to the construct not being folded correctly and being treated 
as a misfolded protein by the cells. The reason for this could lie in the construct design – the 
N-terminal region of the C-type lectin domain may be crucial to the protein’s stability. 
Presence of the α-factor signalling sequence and the additional two amino acids at this site 
could disturb the folding processes and destabilise the protein. It is therefore possible that P. 
pastoris is not a suitable system for selectin domain expression, at least not with the construct 
design used in the experiments described here.  
 
 
3. 2. 5. Conclusions 
 
After numerous test expression experiments of the L-selectin domain constructs in P. 
pastoris, conclusions were made that due to high levels of protein degradation observed in 
all of the samples, low yields of produced protein and problems with the purification of both 
the single- and double-domain constructs, expression tests in P. pastoris would not be 
continued. Change of strategy was required and, for this reason, a new expression system 






3. 3. Selectin construct expression in E. coli 
 
3. 3. 1. Expression system 
 
Escherichia coli has many advantages over other expression systems and is usually the first-
choice method for protein production. Bacterial cells are characterised by the fast growth 
kinetics and high cell density cultures can be achieved within a short time from inoculation. 
The E. coli cells can be easily transformed with the recombinant DNA within just a few 
minutes. This expression system is also relatively inexpensive, as the culture media can be 
prepared from a few readily available ingredients. 
Despite the differences between the eukaryotic and prokaryotic cells, it is possible to express 
the eukaryotic proteins in the E. coli cells. However, expression of such proteins may require 
some additional steps, for example redirection of the recombinant protein into periplasm 
post-translation or co-expression of fusion proteins or chaperones that aid in the protein 
folding processes. Periplasm is a region between the inner and outer cell membranes that 
provides oxidising environment necessary for formation of disulfide bridges. However, 
translocation of protein into periplasm requires a signalling sequence to be attached to 
protein’s N-terminus and, in many cases, this step has a low success rate, leading to 
accumulation of misfolded intermediates in the cytoplasm109.   
To aid with the problems in disulfide bond formation, new strains of E. coli have been 
developed. For example, the OrigamiTM strains have mutations in two cytoplasmic enzymes, 
the thioredoxin reductase (trxB) and glutathione reductase (gor) which disrupt the function 
of these reductases, enhancing disulfide bond formation in the cytoplasm109. 
When the proteins expressed in bacterial cytoplasm are not folded correctly, they tend to 
form insoluble aggregates known as the inclusion bodies. Alternative experimental approach 
utilizes this fact and involves extraction of the inclusion bodies from bacterial cells followed 
by their solubilisation and refolding. As the inclusion bodies contain almost exclusively the 
protein of interest, refolding can yield high amounts of pure protein. However, finding the 
suitable refolding conditions for a specific protein can be a challenging, time and cost-
consuming process as there are many variables that can be altered and as every protein 




Acknowledging that there are multiple options for expressing eukaryotic proteins in E. coli, 
a set of experiments was undertaken as part of this project, testing different methods and 
experimental conditions in order to express correctly folded selectin constructs. These 
expression tests and their results are described in the following sections of this chapter. 
 
 
3. 3. 2. Construct design 
 
The vector used in the design of L-selectin constructs was pET26b (+) (Fig 3. 2. 1). This vector 
features the ColE1 origin of replication for high-copy number of the plasmid, the multiple 
cloning site (MCS), a promoter recognised by T7 RNA polymerase and the lac operon 
sequence. In this type of vector, the gene of interest is cloned behind the T7 promoter and 
protein expression can be induced by either lactose or its non-hydrolysable analogue, 
isopropyl β-D-1-thiogalactopyranoside (IPTG). The second option is usually preferred, as the 
presence of thiol bond in IPTG structure prevents this compound from being metabolised by 
the cell and allows to maintain constant concentration for induction of protein expression122. 
The pET26b (+) vector also features kanamycin resistance to selectively grow only the cells 
that contain the recombinant plasmid. 
Two types of L-selectin constructs were designed for expression in E. coli, a one-domain 
construct (LS1), consisting of residues from Trp1 to Ser121, and a two-domain construct, 
consisting of residues from Trp1 to Glu158.  Expression of the P-selectin constructs was not 
attempted at this stage. As in this expression system the protein constructs need to be 
purified from cell extracts containing many different proteins, His6-tag was added to the C-
terminus of both constructs.  
One of the main issues with using the E. coli cells to express selectin domains is the presence 
of two disulfide bridges in the C-type lectin domain and three disulfide bridges in the EGF-
like domain. As mentioned above, bacterial cytoplasm has a reducing environment, in which 
the formation of disulfide bonds is unfavourable. Along with the inability of bacterial cells to 
perform post-translational modifications, this issue leads to formation of unstable protein 
intermediates that aggregate inside the cells, forming the so-called inclusion bodies112.  For 
this reason, a C-terminal thioredoxin (Trx) fusion tag was included in the construct design, 
aiming to enhance protein’s solubility and facilitate protein folding processes. Trx is an 




target protein. It is also believed to support formation of disulfide bridges via its intrinsic 
oxido-reductase activity123. The Trx-tag is relatively large in size (11.7 kDa) and the TEV-
protease cleavage site was included in the construct to allow for the removal of both the Trx- 
and His6-tags from the purified constructs. The NdeI and XhoI restriction sites were used for 





















Fig. 3. 3. 1. Map of pET26b (+) vector. The gene of interest is inserted after the T7 promoter, 
lac operator and the ribosome binding site (RBS), between the NdeI and XbaI restriction sites. 













3. 3. 3. Materials and methods 
 
 
3. 3. 3. 1. Plasmid preparation 
 
 
The recombinant DNA fragments were based on the sequence deposited in the Uniprot 
database (# 14151), codon optimised for expression in E. coli, synthesised and subcloned 
into the pET-26b (+) vector externally by GenScript, with the use of the NdeI and XhoI 
restriction sites. The received vial was centrifuged at 6000   g for 1 min at 4°C and the 
plasmids (4 μg) were resuspended in 20 μL of ultrapure water and vortexed for 1 min prior 
to transformation into E. coli cells. 
 
 
3. 3. 3. 2. Plasmid transformation into E. coli 
 
 
1 μL of resuspended plasmid DNA was added into an aliquot (50 μL) of chemically competent 
Top10 or DHα cells. Cells were incubated on ice for 20 min, heat-shocked for 30 s at 42 °C, 
returned on ice and diluted with 80 μL of S. O. C. medium. The cells were incubated at 37 °C 
for 1 h and plated at four different concentrations (5 μL, 10 μL, 20 μL and 40 μL) on 15 mL 
LB Agar plates with 30 μg/mL of kanamycin. The plates were allowed to dry and incubated 
overnight at 37 °C.  
The next day, transformed colonies (5 colonies per construct) were used to inoculate 5 mL 
of LB with 30 μg/mL of kanamycin. The cultures were grown overnight at 37 °C, with shaking 
at 200 rpm, before harvesting by centrifugation at 5000  g for 10 min at 4 °C. Pelleted cells 
were then used for plasmid preparation. Plasmids were prepared from the E. coli cultures 
using the QIAgen Plasmid Mini Kit, according to manufacturer’s instructions. The final DNA 
samples were quantified (A260) digested with ClaI enzyme for 30 min at 37°C and separated 
by electrophoresis on a 1% TBE agarose gel, visualised with GelRedTM (Biotum), with 5 μL of 
HyperladderTM 1kb DNA GeneRuler (Thermo Scientific) as reference and sequenced at 





3. 3. 3. 3. Protein expression tests 
 
BL21 (DE3), BL21 Star (DE3), BL21 (DE3) pLys and LEMO21 (DE3) E. coli strains used for 
the protein expression tests were obtained from the Edinburgh Protein Production Facility. 
OrigamiTM (DE3) strain (Novagen) was purchased from Merck Millipore. All strains were 
transformed with the plasmid DNA using the procedure described in Section 3. 3. 3. 2. 
Transformed colonies were used to inoculate 100 mL of LB with 30 μg/mL of kanamycin. In 
the OrigamiTM cell cultures 12.5 μg/mL of tetracycline was used in addition to kanamycin. 
The initial culture was incubated overnight with shaking (200 rpm) at 37°C. On the next day, 
the culture was diluted into four flasks containing 150 mL of fresh media to OD600 values 
between 0.1 – 0.2. The new cultures were incubated at varying temperatures (RT, 30 °C or 
37 °C) with shaking (200 rpm) until the OD600 reached levels between 0.6 and 0.8. At this 
point, isopropyl β-1-thiogalactoparanoside (IPTG) was added to each flask at three different 
concentrations (0.1 mM, 0.5 mM and 1 mM). One flask was taken aside and incubated in the 
same conditions as the other flasks but without the addition of IPTG. After the induction was 
completed, cells were harvested by centrifugation at 5000  g for 15 min. 
 
 
3. 3. 3. 4. Preparation of cell extracts and SDS-PAGE analysis 
 
Pellet from 50 mL cell culture was resuspended in 2 mL of BugBuster®, incubated with 
shaking (200 rpm) for 10 min at room temperature and centrifuged at 5000  g for 20 min. 
Supernatant was kept for analysis of soluble protein expression. For the SDS-PAGE analysis, 
50 μL of the supernatant was combined with 50 μL of the NuPAGE® LDS Sample Buffer (4X, 
Invitrogen), heated for 3 min at 100 °C and stored on ice before loaded on the gel. 
Pellet was resuspended again in 2 mL of BugBuster® (Novagen). Lysozyme (Sigma) was 
added to the sample at 1 KU/mL. Solution was vortexed and incubated at room temperature 
for 5 min. BugBuster® was diluted 1 in 10 with ultrapure water and added to the sample in 
6:1 ratio. The sample was vortexed for 1 min and spun at 5000  g for 15 min at 4 °C. 
Supernatant was discarded and pellet was resuspended in 10 mL of 1:10 diluted BugBuster® 
solution and the centrifugation step was repeated. Supernatant was discarded and pellet was 




of the sample was combined with 50 μL of the NuPAGE® LDS Sample Buffer (4X, Invitrogen), 
heated for 3 min at 100 °C and stored on ice before loading on the gel. 
The SDS-PAGE was run using the precast NuPAGE Novex 4 – 12% Bis-Tris Protein Gels 
(Invitrogen) with the Precision Plus ProteinTM (Bio-Rad) or PageRuler Plus (ThermoFisher 
Scientific) molecular weight marker. 
 
 
3. 3. 3. 5. Preparation of the inclusion bodies 
 
In order to prepare the inclusion bodies for the in vitro refolding tests, BL21 pLys strain 
transformed with LS1 plasmid was used to inoculate 100 mL of LB media with 30 μg/mL of 
kanamycin. The starter culture was incubated overnight with shaking (200 rpm) at 37 °C. 
Next day, the starter culture was diluted into 2 - 8 flasks containing 500 mL LB with 30 μg/mL 
of kanamycin to OD600 values between 0.2 – 0.3 and incubated with shaking (200 rpm) at 
37°C. Once the OD600 reached the levels between 0.6 – 0.8, cultures were induced with 1 mM 
IPTG and incubated for 4 h with shaking (200 rpm) at 37°C. Cells were harvested by 
centrifugation at 5000 g for 20 min and the weight of the pellet was recorded. 
Each pellet from the 500 mL culture was resuspended in 25 mL of the lysis buffer (50 mM 
Tris, pH 8.0, 250 mM NaCl, 2 mM EDTA, 0.1% TritonTM X-100, 0.1 mM PMSF) and sonicated 
for 10 – 15 min with 30 s intervals. When the sonication was completed, samples were 
treated with DNAse (0.01 mg/mL, New England BioLabs) and lysozyme (0.1 mg/mL, Sigma) 
and incubated for 20 min at room temperature. The insoluble fraction was harvested by 
centrifugation at 5000  g for 15 min, supernatant was discarded and pellet was 
resuspended in the lysis buffer and sonicated as before. Centrifugation step was repeated, 
but this time pellet was resuspended in the lysis buffer without TritonTM X-100. Samples 








3. 3. 3. 6. Solubilisation and purification of inclusion bodies 
 
Each pellet prepared from 500 mL culture was resuspended in 25 mL of solubilisation buffer 
(6 M guanidine-HCl, 250 mM NaCl, 20 mM Tris, pH 8.0, 10 mM CaCl2) with 20 mM β-
mercaptoethanol (β-ME, Sigma). Samples were incubated on a mixing rotor for 1 h at room 
temperature and centrifuged at 5000  g for 10 min. Supernatant was transferred to a new 
sample tube and centrifuged again. The new supernatant was transferred to another sample 
tube, passed through a 0.45 μM filter and incubated overnight with 2 – 3 mL of HisPurTM Ni-
NTA resin (Thermofisher Scientific) on the rollers at 4°C. 
Next day, the resin was transferred to a 20 mL disposable column and flow-through was 
collected. Resin was washed with 20 mL of the solubilisation buffer and 20 mL of 
equilibration buffer (8 M urea, 250 mM NaCl, 20 mM Tris, pH 8.0, 10 mM CaCl2). The first 
batch of proteins was eluted in 10 mL of the equilibration buffer containing 0.2 M imidazole, 
the second batch in 10 mL of the same buffer containing 0.5 M imidazole, and the third batch 
was eluted in 10 mL of the same buffer containing 1 M imidazole into fractions of 1.5 mL each. 
To elute any remaining proteins, resin was incubated in 10 mL of the buffer containing 1 M 
imidazole for 10 min. To ensure that all protein was bound and eluted from the resin, the 
resin was washed with the solubilisation buffer and incubated again overnight with flow-
through collected after the first incubation. Next day, all purification steps were repeated.  
Protein concentration in the individual fractions was estimated from A280, using the 
corresponding buffer as a blank. Fractions were analysed on SDS-PAGE and fractions 
containing the recombinant protein were combined into one sample. 
 
 
3. 3. 3. 7. Protein refolding tests by infinite dilution 
 
For the refolding tests using the dilution method, collected protein fractions were diluted in 
the refolding buffer to less than 10 μM concentrations. None of the refolding solutions 
exceeded the volume of 250 mL. Dilution was performed slowly, adding the protein 
dropwise, with 15 – 20 s intervals between every drop and with fast, constant stirring. 
Different variants of the refolding buffer were tested, all containing 20 mM Tris (pH 8.0), 100 




Thermofisher Scientific) was added to each refolding solution. The optional components of 
the buffer included urea (1 – 3M), arginine (500 mM), DTT (2 – 5 mM), reduced glutathione 
(1 – 35 mM), oxidised glutathione (0.1 – 1 mM), 5% (v/v) glycerol. The refolding solution was 
incubated at room temperature for up to 72 h, filtered and then transferred to a SnakeSkinTM 
Dialysis Tubing (Thermofisher Scientific) and dilalysed three times against 10:1 volume of 
the refolding buffer without the additives. At all stages, samples (1.6 mL) were collected for 
TCA precipitation to monitor the efficiency of the refolding reaction. 
 
 
3. 3. 3. 8. On-column protein refolding test 
 
Harvested cell pellets were resuspended in ultrapure water (5 mL per 1 g pellet) and 
sonicated for 30 min using 15 s intervals. Sample was centrifuged at 5000  g for 30 min 
and the supernatant was removed. Pellet was resuspended in a 10 mL of solution of a few 
grams of methionine and 1mM EDTA, sonicated for 5 min using 15 s intervals and centrifuged 
again. Methionine wash was repeated two times. Five (5 – 10 mL) volumes of 1:1 mixture of 
acetone and water with 0.2% TFA were added to the pellet and the sample was incubated 
overnight. Next day, 2 mL of HisPurTM Ni-NTA resin (Thermofisher Scientific) was placed in 
a 20 mL disposable column and equilibrated with 20 mL of the binding buffer (100 mM Tris, 
pH 8.0, 250 mM NaCl, 10 mM CaCl2). A range of buffers with varying urea concentrations (0 
M, 1 M, 2 M, 3 M, 4 M, 5 M, 6 M, 7 M and 8 M) were prepared from the binding buffer. 10 mL 
of each of these buffers was passed slowly through the column, starting with the 8 M urea 
concentration and finishing with the 0 M urea concentration. Protein was eluted and 
analysed as described in Section 3. 3. 3. 7. 
 
 
3. 3. 3. 9. TCA precipitation 
 
In order to analyse the samples from protein refolding experiments, TCA precipitation was 
performed to remove the denaturing agents and concentrate the protein. For each sample, 
20 μL of the sample was mixed with 980 μL of water and 100 μL pre-chilled 100% 
trichloroacetic acid (TCA) and incubated on ice for 1 h. Samples were centrifuged at 14 000 




acetone. Samples were centrifuged again for 5 min, supernatant was discarded and pellet 
was air dried. 15 μL of the NuPAGE® LDS Sample Buffer (4X, Invitrogen) was added to the 
pellet and mixed with the pipette. For the reduced samples, 2 μL of the NuPAGE® Sample 
Reducing Agent (Invitrogen) was added to the sample and the sample was heated at 100 °C 








3. 3. 4. 1. Construct design and plasmid preparation 
 
In the experiments described here, expression of L-selectin constructs in E. coli cells was 
attempted. As in the case of the earlier expression tests in P. pastoris, the major aim of the 
tests described here was to find a method that could be optimised to allow for expression of 
a doubly labelled protein for NMR experiments. 
The L-selectin construct design for expression in E. coli was similar to that used for 
expression in P. pastoris and to the constructs expressed previously for the X-ray studies65,66. 
However, in this study, addition of any tags onto the protein’s N-terminus was avoided. 
Instead, a fusion protein was added to the C-terminus of the constructs, in order to target the 
challenges associated with expression of human proteins in the prokaryotic system. As 
described in section 3. 3. 2, the fusion protein chosen here was thioredoxin (Trx) – a protein 
tag widely used to enhance solubility and stimulate disulfide bond formation in the expressed 
protein. Because the fusion protein could interfere with the NMR studies, construct was 
designed in such a way that the Trx tag, along with the His6-tag, could be removed by TEV 
protease, once all the expression and purification steps are completed.  
Cloning reactions were performed externally (GenScript) and the resulting plasmids were 
transformed into E. coli cells to generate high amounts of plasmid DNA for expression tests. 
For each recombinant strain, five colonies were tested for the presence of the inserted 
plasmid, using ClaI digestion enzyme. Each plasmid has exactly one recognition site for this 
enzyme and digestion with ClaI should linearise the plasmids. The difference between the 




differently through gel matrix. Circular plasmid will most likely occur in the supercoiled 
conformation, which is the native conformation of plasmids in vivo. In this conformation, the 
DNA is tightly twisted which causes it to behave like a smaller DNA fragment and to travel 
more quickly across the agarose gel. In some cases DNA can be nicked on one strand and the 
twists may be relieved, forming more open conformation. In such cases, the plasmid will 
travel through the gel matrix very slowly, appearing to be of size slightly higher than 
expected. As presented on Fig 3. 3. 2, both forms of plasmid DNA were observed in the 
different preparations from E. coli. When digested with ClaI enzyme, plasmids migrated on 
the agarose gel as expected for the linear DNA fragment of the length of between 5700 – 5800 
bp. Because the supercoiled form of the plasmid is more efficient in transforming the 
bacterial cells than the nicked form, only samples containing mostly the supercoiled DNA 


















Fig. 3. 3. 2. Linearisation of the plasmid DNA. Agarose gels of four different DNA samples 
from the Mini prep for the LS1 construct, before (on the left from the ladder) and after (on the 
right from the ladder) the linearisation reaction. Two different forms of DNA were observed – the 
supercoiled form in samples A and B and the nicked form in samples C and D. All fragments 
migrated to the same region on the gel after linearisation. 
 
 
3. 3. 4. 2. Soluble protein expression tests 
 
In the initial set of expression tests, attempts were made to express well-folded, soluble L-
selectin constructs in the E. coli cytoplasm. The majority of experiments focused on the single 




soluble form in the bloodstream. Therefore, it should be easier to express it as a soluble 
protein within the bacterial cytoplasm than the more complex two-domain construct which 
contains five disulfide bridges. The soluble protein could be extracted and purified from the 
cells using a His-Trap resin and, following the removal of the fusion tag, used for the 
structural NMR studies.  
In the first experiment, three E. coli strains were transformed with the recombinant L-
selectin DNA – BL21 (DE3) and its two variants, BL21 Star (DE3) and BL21 (DE3) pLys. BL21 
(DE3) is one of the E. coli strains most commonly used for expression of recombinant 
proteins. BL21 Star (DE3) is a similar strain but with enhanced ability to express high levels 
of protein due to enhanced mRNA stability. BL21 (DE3) pLys is another variant that increases 
expression efficiency for proteins that are under control of the T7 promoter.  
In order to test different induction conditions, three different IPTG concentrations (0.1 mM, 
0.5 mM and 1 mM) were used for induction of protein expression in each strain. Expression 
levels of the LS1 construct in the soluble and insoluble fraction of the cell extract were 
analysed by SDS-PAGE after 3 h from induction at 37 °C (Fig. 3. 3. 3. A, B and C). Calculated 
molecular weight of the construct was 28 kDa (see Appendix 2) and in all of the strains a 
strong band was observed in the corresponding region on the SDS-PAGE. However, the band 
was only observed in the insoluble fraction of the cell extract which means that the protein 
was not folded correctly and aggregated in inclusion bodies. Construct was expressed at all 
IPTG concentrations, with no significant increase in expression levels at higher IPTG 
concentrations. The LS1 band was not observed in the extract from cells that were not 
induced with IPTG. 
Following these results, expression in OrigamiTM strain was attempted using identical 
conditions. As the OrigamiTM strain enhances production of disulfide bridges, expression in 
this strain could produce higher amounts of fully-folded, soluble protein. After 3 h from 
induction, protein expression levels in soluble and insoluble fractions were analysed by SDS-
PAGE (Fig. 3. 3. 3. D). However, the results were similar to those observed in other bacterial 


























Fig. 3. 3. 3. SDS-PAGE of the soluble and insoluble fractions after small-scale expression 
tests of the LS1 construct in four different E. coli strains. Four strains were tested for 
expression of the LS1 construct in the soluble (S) and insoluble (IS) fractions: BL21 (DE3) (A), 
BL21 Star (DE3) (B), BL21 pLys (DE3) (C) and OrigamiTM (DE3) (D). Numbers above the lanes 
indicate the IPTG concentration used for the induction of protein expression. Dotted line indicates 
the region where the LS1 band was expected. The first lane is the MW marker in kDa. 
 
 
Another E. coli strain transformed with the LS2 DNA was the LEMO21 (DE3) strain. This 
strain contains all the main features of the BL21 (DE3) but is designed to allow for tunable 
expression of difficult proteins. This is achieved by modulation of the levels of lysozyme lysY 
which varies at different L-rhamnose concentrations. Two different L-rhamnose 
concentrations were tested (0.5 mM and 1 mM) but yet again – no soluble protein was 
detected in the cell extracts. 
Changes to induction conditions can sometimes shift the equilibrium towards production of 
soluble protein. For this reason, the next set of experiments tested how modified induction 
conditions influence the soluble protein content of the cell extract. Several different variants 
of induction conditions were tested. In the first few tests the length and temperature of 
induction were varied.  
A common approach aiming to increase the solubility of expressed protein is to grow the 
cultures at reduced temperatures. At higher temperatures large amount of proteins are being 
produced which increases the likelihood of protein aggregation. In addition to that, 




processes to be favoured at higher temperatures. There are also chaperones within the E. coli 
cytoplasm whose activity increases at temperatures close to 30°C. Maintaining high levels of 
activity of these chaperones and preventing protein aggregation could aid in the protein 
folding processes and increase the soluble fraction of the expressed protein120. 
Cells were induced again with three different concentrations of IPTG.  This time, protein 
expression was induced at 30°C and at room temperature. Protein expression levels were 
measured as previously after 3h, 5h and 20 h from induction. Small changes in the levels of 
soluble protein were detected in the samples incubated at room temperature but the levels 
of insoluble protein were still very high (Fig. 3. 3. 4). A larger scale expression test (1 L) with 
overnight induction at room temperature was undertaken. Unfortunately, attempts to purify 
the protein from this expression test were not successful, likely due to the very low 









Fig. 3. 3. 4. SDS-PAGE of the soluble and insoluble fractions after small-scale expression 
tests of the LS1 construct at room temperature. Expression of the LS1 construct in the 
soluble (S) and insoluble (IS) fractions in BL21 Star (DE3) strain after 5 h (A) and 20 h (B) 
induction at room temperature. Numbers above the lanes indicate the IPTG concentration used 
for the induction. Dotted line indicates the region where the LS1 band was expected. The first lane 
is the MW marker in kDa. 
 
 
The next set of experiments tested whether heat-shocking of the E. coli cells prior to 
induction could help to produce soluble protein. Exposing the cells to either hot or cold 
temperatures for a short time can lead to production of the heat shock proteins, including 
chaperones that assist in protein folding processes and stabilise unfolded intermediates, 
protecting the cells from the effects of extreme temperature conditions. It is possible that 
presence of such proteins could increase the production of soluble recombinant selectin 




high (42°C) temperatures for 30 min prior to induction with IPTG. Unfortunately, these tests 









Fig. 3. 3. 5. SDS-PAGE of the soluble and insoluble fractions after small-scale expression 
tests of the LS1 construct with modified induction conditions. Expression of the LS1 
construct in the soluble (S) and insoluble (IS) fractions in the BL21 Star (DE3) and OrigamiTM 
(DE3) strains after heat-shocking the cells at 4 °C (C) or 42 °C (H) prior to induction and after 
inducing at either early (E) or late (L) stages of the culture growth. Samples were taken at 5 h (A, 
C) and 20 h (B, D) from induction. Dotted line indicates the region where the LS1 band was 
expected. The first lane is the MW marker in kDa. 
 
 
Finally, tests were performed to assess whether inducing the cells at different time points 
could affect the production of recombinant protein. At different stages of the culture growth, 
processes regulating protein expression and folding undergo changes. Typically, induction 
should be performed after the cells have entered the exponential growth phase but before 
the cell density grows to high levels and the culture starts to enter the stationary phase. Such 
optimal region corresponds to optical cell density (OD600) levels of approximately 0.6 – 0.8 
and this was the time point of induction for all previously described E. coli expression tests. 
Here, in one set of expression tests the cells were induced at OD600 of 0.2 – 0.3, corresponding 
to transition from the lag phase into exponential growth phase. In another set of expression 
tests the cells were induced at OD600 of values higher than 1.0, when the culture has high cell 
density and begins to enter the stationary phase. Sadly, no change was detected in the 




These experiments concluded the studies on expression of soluble LS1 construct in E. coli 
cells. A similar set of tests was performed on the two-domain L-selectin construct (LS2). 
Unfortunately, despite the high expression levels, this construct was expressed solely in the 
insoluble fraction of the cell extract.  
It is worth noting that the presence of the thioredoxin fusion tag did not help with soluble 
expression of either of the constructs. There are several factors that could contribute to this 
outcome. First of all, the most optimal site for attachment of the fusion tags is the protein’s 
N-terminus, where they can aid in the initiation of translation processes119. Due to the 
unusual fold of the selectin N-terminus and the problems observed in selectin expression in 
P. pastoris after the attachment of the α-factor secretion sequence at the protein’s N-
terminus, the constructs for E. coli expression were designed in the way where all tags were 
attached to the C-terminus. Success rate of the fusion partner is also dependent on the 
protein-fusion tag combination. Therefore, to find optimal conditions for expression of a 
given protein, a range of different fusion partners should be tested. Due to the time and 
financial limitations of this project, it was not possible to perform such an extensive research 
on the suitability of different fusion partners for selectin expression in E. coli. 
Although the attempts to express the two L-selectin constructs in the soluble fraction were 
unsuccessful, both L-selectin constructs were expressed in high amounts in the E. coli cells. 
If a method was developed that would allow to extract the insoluble proteins and induce their 
transition into the correct conformation, it could be possible to obtain the constructs suitable 
for the NMR studies in high enough yields. Therefore, further experiments focused on the 
search for optimal conditions for refolding of the L-selectin constructs from inclusion bodies. 
 
 
3. 3. 4. 3. Protein refolding tests 
 
Protein refolding becomes increasingly more common as a tool that helps to express difficult 
proteins in the E. coli expression system. Many different approaches to protein refolding have 
been explored but the most common ones involve refolding by infinite dilution, dialysis or 
on-column refolding121,122. In all three methods, the inclusion bodies need to be isolated from 
the cells and solubilised with the use of denaturants such as urea or guanidinium-HCl. These 
strong chaotropes weaken the noncovalent interactions between the proteins, preventing 




dithiotheitol (DTT) or β-mercaptoethanol (β-ME) are used to break disulfide bonds. After the 
solubilisation step, the proteins need to be refolded into their native conformation. This 
process involves several steps in which the concentration of denaturant is gradually 
decreased to allow for formation of a new set of noncovalent interactions. Buffers used for 
refolding experiments should provide oxidising environment to support the formation of 
disulfide bridges. In the infinite dilution and dialysis methods, protein concentration is 
maintained at very low levels throughout the experiments in order to prevent protein 
aggregation. Finding the optimal refolding environment to fulfil all of the above conditions 
for a given protein can be a challenging, trial-and-error process121,122. 
The dilution method is the most frequently used approach for protein refolding. After 
solubilisation and purification of inclusion bodies, the denatured protein is diluted in large 
volumes of the refolding buffer to concentrations below 10 μM and incubated with stirring 
for up to 72 h. The underlying principle of this method is that at very low concentrations, 
protein folding reactions will be favoured over the aggregation as collisions between 
individual protein molecules will be largely reduced. In the presence of oxidising reagents 
formation of disulfide bridges will be encouraged and the protein is likely to find a stable 
refolded conformation121. The experiments described here are based on the protocols kindly 
provided by Mr. Christopher Weir. 
The LS1 construct was expressed in high yields in the E. coli cells. Therefore, it was possible 
to extract large amounts of unfolded protein from the inclusion bodies (ca. 25 mg per 1 L of 
bacterial culture). As the inclusion bodies consist mostly of the unfolded recombinant 
proteins, the extracted proteins are normally quite pure at this stage. To isolate the LS1 
construct, the solubilised inclusion bodies were bound to the His-Trap resin, incubated 
overnight and eluted with imidazole buffer. The protein migrated to the expected MW region 
on the SDS-PAGE (28 kDa) under reducing conditions and appeared to be free from any major 





Fig. 3. 3. 6. SDS-PAGE of the fractions eluted from the His-Trap resin after the 
solubilisation of LS1 inclusion bodies. Fractions were eluted with 1 mM imidazole. Numbers 
below the lanes indicate the fraction numbers. Dotted line indicates the region where the LS1 
band was expected. The first lane on each gel is the MW marker in kDa. 
 
 
Because upon the transfer to refolding buffer the protein is suddenly exposed to an 
environment with reduced amounts of denaturing agents, it is very important that the 
protein is added in small portions and is quickly mixed into the buffer to prevent aggregation. 
During the experiments described here, care was taken to ensure that the protein additions 
were performed in very small portions (< 10 μL), with 15 – 20 s time interval between each 
added portion, and that efficient stirring was maintained throughout the whole duration of 
the experiment. 
In the first instance, a series of small scale refolding tests was performed to assess the most 
suitable refolding conditions. Three different urea concentrations were tested (0 M, 1 M and 
2 M), along with three different ratios of the reduced to oxidised glutathione (10:1, 2:1, 1:1). 
Glutathione is a thiol compounds found in the endoplasmic reticulum in eukaryotic cells that 
plays and important role in formation of disulfide bridges123. Oxidised glutathione (GSSG) 
acts as an oxidant facilitating the formation of disulfide bridges and reduced glutathione 
(GSH) acts as a reducing agent, cleaving the misplaced bridges in the process known as 
disulfide shuffling. Therefore, appropriate ratio of the two is important for correct protein 
folding123.  
Samples from all of the tests were subjected to SDS-PAGE analysis under non-reducing and 
reducing conditions. It is expected that, if the refolding is successful, a strong band will be 
observed under both conditions, with slight difference in migration between the reduced and 
non-reduced samples. Unfortunately, in this set of tests, strong bands in the reducing gel 




observed after 24 h and practically no bands could be seen after 72 h from the start of 
refolding reaction (Fig 3. 3. 7). 
 
Fig. 3. 3. 7. SDS-PAGE of the samples taken during the small-scale refolding tests by 
infinite dilution on LS1 construct. Nine different buffers were tested with the concentrations 
of urea varying between 0 M, 1 M and 2 M (Numbers below the lanes) and the ratio of the reduced 
to oxidised glutathione varying between 10:1 (a), 2:1 (b) and 1:1 (c). SDS-PAGE was run under 
non-reducing (A, C) and reducing (B, D) conditions. Samples for the gels shown here were taken 
at 0 h (top) and 72 h (bottom gels) from the start of refolding reaction and prepared by TCA 
precipitation. Dotted line indicates the region where the LS1 band was expected. The first lane is 
the MW marker in kDa. 
 
 
One of the refolding tests was performed on a larger scale (1 L), using the refolding buffer 
consisting of 20 mM Tris (pH 8.0), 150 mM NaCl, 10 mM CaCl2, 1 M urea and a 10:1 ratio of 
reduced to oxidised glutathione. The aim of this experiment was to test whether some of the 
protein may be refolded, however, in too small amounts to be detected on a smaller scale. 
The protein was allowed to refold for 72 h and then dialysed into a buffer that did not contain 
any denaturing agents or other refolding additives. During the dialysis process the protein 
formed visible aggregates. Nevertheless, the dialysis was completed and the protein sample 




is still protein present in the filtered sample. The sample was passed through a HisTrap FF 
column to allow for its further purification and concentration from the large refolding 
volumes. However, it was not possible to elute the protein from the column – the protein has 
likely formed aggregates between the resin molecules and blocked the flow of the buffer 
through the column. 
Additional small-scale tests were performed, using 2 – 5 mM DTT, 5% glycerol, increased salt 
concentration or a mixture of all these factors, still without any positive results. Following 
these tests, the refolding buffer composition was modified to include 5 mM DTT in addition 
to 150 mM NaCl and a 10:1 ratio of reduced to oxidised glutathione. With the use of this 
refolding buffer, more promising results were observed – presence of the LS1 construct was 
detected in the samples prepared under both the reducing and non-reducing conditions (Fig. 
3. 3. 8). After 72 h, the refolding reaction was stopped and the sample was divided into eight 















Fig. 3. 3. 8. SDS-PAGE of the samples taken during the small-scale refolding tests on LS1 
construct with 5 mM DTT in the refolding buffer. The refolding reaction was performed in 
20 mM Tris, pH 8.0 with 150 mM NaCl, 10 mM CaCl2, 1 M urea, 10 mM reduced glutathione, 1 mM 
oxidised glutathione and 5 mM DTT. Samples for SDS-PAGE were prepared under reducing (R) 
and non-reducing (NR) conditions, after TCA precipitation. Two different dilutions of the protein 
sample in the refolding buffer were tested: 1 in 250 and 1 in 50. A Samples taken at the start of 
the refolding reaction. B Samples taken after 72 h of the refolding reaction. Dotted line indicates 







During the dialysis step, the refolding solution is dialysed against the buffer that does not 
contain any denaturing agents. The proteins that are correctly folded should remain stable 
after the buffer exchange and can be purified and concentrated for further experiments. 
However, if the proteins are not folded correctly or if partially folded intermediates are 
present in the solution, in absence of the denaturing agents, they will be likely to aggregate 
and return to the insoluble form.  
Buffers used in the dialysis tests explored different salt concentrations and combinations of 
additives that could stabilise the recombinant protein in the new buffer and push any 
unstable intermediates towards folding into correct conformation. Unfortunately, in the 
majority of tests, large amounts of visible aggregates were observed after just a few hours of 
dialysis. The only two tests where the amount and size of aggregates were significantly 
reduced, were the tests in which L-arginine was included in the dialysis buffer. The positive 
effect of arginine on the LS1 construct stability was confirmed by SDS-PAGE, where a clear 
band can be observed under both reducing and non-reducing conditions, even after filtering 
off the larger aggregates, proving that the soluble protein is still present in the solution (Fig. 
3. 3. 9). In later tests, it was established that the concentration of arginine as low as 50 mM is 












Fig. 3. 3. 9. SDS-PAGE of the samples taken before and after the dialysis in buffer 
containing 250 mM L-arginine. On the left-hand side are the samples collected after the 
refolding experiment was completed. On the right-hand side are the samples collected after the 
dialysis into the new buffer (20 mM Tris, 150 mM NaCl, 10 mM CaCl2, 250 mM arginine, pH 8.0) 
was completed. Samples for SDS-PAGE were prepared under reducing (R) and non-reducing (NR) 
conditions, after TCA precipitation.  In each case, one of the samples was passed through syringe 
filter prior to TCA precipitation to remove larger aggregates (F). Dotted line indicates the region 






L-arginine is an amino acid well-known for its inhibitory role in protein aggregation and it is 
frequently used to enhance the refolding efficiency124. Although the exact mechanism for its 
action is still unknown, it is suspected that arginine interacts with the protein surface 
residues, minimising the protein-protein interactions that lead to aggregation. Similarly to 
guanidinium-HCl, arginine contains a guanidinium group which may account for its 
denaturant-like activity. It has also been suggested to interact with the hydrophobic protein 
residues via the three methylene groups in its side chain (Fig. 3. 3. 10)125,126.  
 
Fig. 3. 3. 10. Chemical structure of L-arginine. Presence of the guanidinium group and the 




Despite the fact that protein aggregation was largely reduced in the presence of L-arginine, 
it was not possible to confirm whether the LS1 construct is truly folded in the correct 
conformation, or whether even the soluble form of the protein is actually a misfolded 
intermediate and the presence of arginine simply prevents the aggregation of otherwise 
misfolded proteins. Filtered sample obtained from dialysis was, in fact, analysed by mass 
spectrometry and it was not possible to identify individual peaks that could correspond to 
the soluble LS1 species. It is likely that small aggregates were still present in the sample, 
despite the presence of arginine. This suspicion was confirmed when, within a day after the 
dialysis, visible aggregates started to form in the sample stored at 4°C. 
Several other tests were performed, attempting to optimise the refolding and dialysis buffers 
in order to increase the refolding efficiency. Yet again, no positive results were obtained. At 
this point, an alternative protocol for protein refolding was provided by Dr Karen McClymont 
from the University of Glasgow.  In this method, the protein is refolded whilst bound to the 
Ni-NTA resin by subsequent washes with buffers containing gradually decreasing urea 




of denaturing agent is decreased, aggregation should be prevented and the protein should 
have more freedom to explore different folding options and find the correct conformation.  
Although the idea of on-column refolding sounds very promising and works well for some 
proteins, the tests on LS1 refolding were, yet again, unsuccessful. Similarly to what was 
observed in earlier refolding tests, elution of the protein from the Ni-NTA resin was not 
possible as the resin solidified after treatment with the refolding and elution buffers. A likely 
explanation for this behaviour is that the protein did not fold correctly when bound to the 
resin and started to form aggregates as it was being eluted. 
Finally, an experiment was performed, attempting to combine different aspects of the two 
protocols discussed above. In this experiment, the pellets were prepared and solubilised as 
in the infinite dilution protocol. However, the refolding method from the second protocol was 
used – the on-column refolding – but this time with decreasing guanidine-HCl concentration. 
It was thought that the protein may be more stable in the guanidine-HCl buffer and that this 
buffer could better support the folding. Unfortunately, the results were similar to those 
observed in case of the on-column refolding with urea-based buffers. The resin formed a solid 
aggregate and no protein was detected in the eluted fractions.  
 
 
3. 3. 5. Conclusions 
 
Despite many different methods and varied conditions used in the expression, purification 
and refolding experiments for different selectin constructs, it was impossible to establish a 
strategy that would be suitable for expression of these constructs in either yeast or bacterial 
cells. Large amount of time and resources have been spent on this project, yet none of the 
results were promising enough to allow for expression of the isotopically labelled proteins 
necessary for the in-depth NMR studies. For this reason, from this point onwards, direction 
of the project was changed, exploring the use of Saturation Transfer Difference (STD) NMR 
and molecular dynamics for the studies of fCS-selectin interactions. This involved continuing 
expression experiments collaboration with the Oxford Protein Production Facility (OPPF) to 
investigate the possibility to express the selectin constructs in mammalian cells. This work 





3. 4 Selectin construct expression in HEK293 cells 
 
Because of the described problems with expression of selectin constructs in the yeast and 
bacterial cells, an option of using an alternative expression system was considered. Selectin 
constructs expressed previously by other groups were produced in mammalian systems and 
a possibility exists that, due to the complex fold of the lectin and EGF domains, held by 
multiple disulfide bonds, as well as the post-translational modifications that often help in the 
regulation of protein folding, expression of selectin constructs in simple, unicellular 
expression systems may not be achievable.  
Isotopically labelled eukaryotic proteins have been previously produced in mammalian cells. 
For instance, Chinese hamster ovary (CHO) cells were used as a host for expression of 13C,15N-
labelled human chorionic gonadotropin and human embryonic kidney (HEK293) cells were 
used to produce 15N and 13C,15N-labelled rhodopsin127,128. However, mammalian expression 
systems are not a preferred option for expression of isotopically labelled proteins due to the 
challenges in development and optimisation of efficient experimental protocols for each 
protein and the high costs of the isotopically enriched media required for mammalian cell 
culture129,130.  
Despite these limitations, establishing protocols for selectin production in mammalian cells 
could allow us to obtain the desired selectin constructs which could then be used in some of 
the NMR experiments, such as STD, or in further crystallographic investigations of selectin-
ligand interactions. If an efficient method for selectin construct production in mammalian 
cells was found, future research could lead to development of protocols for their isotopic 
labelling to allow for more in-depth NMR studies. For these reasons, collaboration with the 
Oxford Protein Production Facility (OPPF) was established, as this institution has a 
longstanding experience in production of proteins from a diverse range of organisms in a 
variety of expression systems. During this collaboration, a set of selectin constructs for 
expression in HEK293 cells was designed. A visit to OPPF laboratories undertaken as part of 
this PhD project involved work on molecular cloning of those constructs into pOPIN vectors 
and their subsequent transfection into HEK293 cells for small-scale expression tests. These 
tests allowed to identify a construct suitable for the large-scale expression experiments, 






3. 4. 1. Expression system 
 
Mammalian cells used in the selectin expression tests described below were human 
embryonic kidney cells (HEK293). This cell line originated from the kidney cells of a human 
embryo and was the first human cell line transfected with sheared adenovirus DNA. A 4.5-
kilobases long fragment of the viral genome inserted into chromosome 19 of the HEK cells, 
disrupting their morphology and causing them to lose the kidney cell characteristics131. For 
this reason, HEK293 cells are not a good in vitro model of kidney cells. They are, however, a 
popular platform for stable transfection and expression of human proteins as they are easy 
to grow in culture and transfect132. Since their creation in 1973, HEK293 cells and their 
derivatives have been one of the most frequently used cell lines in molecular biology, used 
for production of adenoviral vaccines, recombinant proteins, as well as in electrophysiology 
and neuropharmacology, for analysis of neural synapse formation. Protocols for transfection 
of HEK293 cells are well-established and the OPPF routinely uses this cell line for expression 
of recombinant proteins133. It was therefore decided that the HEK293 could be a suitable host 




3. 4. 2. Construct design 
 
The OPPF has developed a suite of expression vectors (pOPIN) for high-throughput cloning 
of protein constructs. The pOPIN vectors utilise multiple promoter systems to allow for 
protein production in all major expression systems without the need to make multiple, host-
specific vectors for each construct. The vectors use the pUC origin of replication to obtain 
high yields of plasmid from E. coli, as well as the cytomegalovirus (CMV) enhancer, chicken 
β-actin promoter and rabbit β-globin poly-A site to increase the protein transcription levels. 
All of the pOPIN vectors include a cleavable His-tag and offer a variety of fusion proteins to 
facilitate protein expression and purification134.  
Six selectin constructs were designed, each to be cloned into two types of pOPIN vectors 
suitable for the use in insect and mammalian cells. The first type of vector used in selectin 




the desired construct decorated with C-terminal His6-tag to allow for one-step purification. 
The second vector used was pOPINEneo-3C-2Strep-His8 (Fig. 3. 4. 1. B) – a variant of pOPING 
that contains neomycin phosphotransferase gene, a selectable mammalian marker that 
confers resistance to the antibiotic G-418, and that allows for expression of a cleavable C-
terminal streptavidin-tag followed by a His8-tag for production of ultrapure proteins. Both 
vectors contain a signalling sequence that allows for secretion of the transcribed constructs 
into extracellular media. 
Fig. 3. 4. 1. Maps of vectors used in mammalian expression tests. Vector maps of pOPING 
(A) and pOPINEneo-3C-2Strep-His8 (B), highlighting the characteristic features of these vectors 
such as the promoter and enhancer elements that help to increase levels of protein expression 




Each vector was used to express two types of P- and L-selectin constructs – a single domain 
construct, consisting of residues Trp1 – Ser121, and a two-domain construct, consisting of 
residues Trp1 – Val156. As the UniProt entry P14151 for L-selectin contains a ten-residue 
long propeptide, additional two types of constructs were designed for this protein, with the 
propeptide sequence preceding residue Trp1. Each construct was assigned an OPPF number 
for internal reference – the constructs and their numbers are listed in Table 3. 4. 1.. 
 
 





3. 4. 3. Materials and methods 
 
3. 4. 3. 1. Fusion cloning of DNA constructs 
 
The L- and P-selectin gene blocks were based on the sequences deposited in Uniprot database 
(# 14151 and # 16109, respectively) and synthesised by the Integrated DNA Technologies. 
Primers were designed to allow for In-FusionTM cloning of the gene constructs into prepared 
pOPIN vectors. PCR was performed in 50 μL, using the Phusion Flash Master Mix (F-548L, 
OPPF no. Protein Vector Propeptide Sequence 
20306 P-selectin pOPING N/A Trp1 - Val156 
20307 P-selectin pOPINEneo-3C-2Strep-His8 N/A Trp1 - Val156 
20309 P-selectin pOPING N/A Trp1 - Ser121 
20310 P-selectin pOPINEneo-3C-2Strep-His8 N/A Trp1 - Ser121 
20311 L-selectin pOPING Yes Trp1 - Val156 
20312 L-selectin pOPINEneo-3C-2Strep-His8 Yes Trp1 - Val156 
20313 L-selectin pOPING Yes Trp1 - Ser121 
20314 L-selectin pOPINEneo-3C-2Strep-His8 Yes Trp1 - Ser121 
20315 L-selectin pOPING No Trp1 - Val156 
20316 L-selectin pOPINEneo-3C-2Strep-His8 No Trp1 - Val156 
20317 L-selectin pOPING No Trp1 - Ser121 




Thermoscientific) according to manufacturer’s instructions, with 30 pmol of each forward 
and reverse primers, appended with the In-FusionTM extensions as appropriate, and 1 μL of 
genomic DNA (50 ng/μL) as a template per reaction. Amplifications were performed in the 
Veriti PCR Thermal Cycler (ABI) under the following conditions: 10 s at 98 °C, followed by 29 
cycles of 1 s at 98 °C, 5 s at 60 °C and 8 s at 72 °C. The PCR programme ended with a final 
extension of 2 min at 72 °C. The resulting PCR products were separated by electrophoresis 
on a 1% TBE agarose gel, visualised with SybrSafeTM (InVitrogen), with 5 μL of HyperladderTM 
1kb (BioLine) as a reference, purified using the Agencourt AMPure XP magnetic-bead based 
purification method (Beckman) according to the manufacturer’s instructions and eluted in 
50 μL of EB buffer (10 mM Tris pH 8.0), with yields assessed by electrophoresis. 
2 μL of the purified PCR product (10 – 100 ng) and 100 ng of the linearised pOPIN vector 
were mixed with 1 μL Fusion Enzyme, 2 μL 5x Fusion Buffer (Quick-Fusion Cloning Kit, 
Biotool) and 4 μL of water. Samples were incubated at 37 °C for 30 min. 40 μL of TE buffer 
(10 mM Tris pH 8.0, 1 mM EDTA) was added to stop the reaction. 
 
 
3. 4. 3. 2. Transformation into E. coli and plasmid preparation 
 
2.5 μL of the Fusion Reaction product was added to an aliquot (20 μL) of the E. coli OmniMaxII 
cells. The cells were incubated on ice for 30 min, then heat-shocked for 30 s at 42 °C, returned 
on ice and diluted with 120 μL of Power Broth (PB). The cells were incubated at 37 °C for 1 h 
and plated at two different concentrations (50 μL and 5μL) on 1 mL LB Agar plates with 100 
μg/mL Ampicillin, 0.02% w/v X-Gal and 1mM IPTG. The plates were allowed to dry and 
incubated overnight at 37 °C. 
The next day, transformed colonies (5 colonies per construct) were used to inoculate 1.2 mL 
of PB with 100 μg/mL Ampicillin in 96-well, deep-well plates (BD Falcon). The cultures were 
grown overnight at 37 °C, with shaking at 200 rpm, before harvesting by centrifugation at 
5000 g for 10 min at 4 °C. Pelleted cells were then used for plasmid preparation. Plasmids 
were prepared from the E. coli cultures in a 96-well format, using a QIAgen BioRobot 8000 
and QIAgen Turboprep kits, according to manufacturer’s instructions (QIAgen). The resulting 
plasmids were screened using 25 μL PCR mix, with 12.5 μL of the Phusion Flash Master Mix 
(F-548L, Thermoscientific), 10 pmol of the forward primer, and 1 μL of plasmid DNA per 




following conditions: 10 s at 98 °C, followed by 29 cycles of 1 s at 98 °C, 5 s at 60 °C and 8 s 
at 72 °C. The PCR programme ended with a final extension of 2 min at 72 °C. The PCR products 
were separated by electrophoresis on a 1% TBE agarose gel, visualised with SybrSafeTM 
(InVitrogen), with 5 μL of HyperladderTM 1kb (BioLine) as reference. 
 
 
3. 4. 3. 3. Transfection into HEK293 cells 
 
HEK293 cells were maintained in DMEM (Sigma), supplemented with 10% foetal calf serum 
(Sigma, Poole, UK), 1x non-essential amino acids and 1mM glutamine (InVitrogen). For 
expression screening, cells were seeded in 24-well plates, at a density to give 75-80% 
confluent cells at the time of transfection. The cells were incubated overnight at 37 °C in a 
5% CO2/95% air environment. On the next day, the culture media were discarded and 
replaced with 1 mL DMEM, supplemented with 2% v/v foetal calf serum, 1x non-essential 
amino acids and 1 mM glutamine. For each transfection reaction, 2 μL of 1.33 mg/mL 
GeneJuice® (Novagen) and 60 μL of serum-free DMEM were mixed. Approximately 1 μg of 
plasmid DNA was added to the mix and incubated at RT for 10 min. The mix was then added 
to the cells which were then incubated at 37°C for 72-96 h in a 5% CO2/95% air environment. 
Secretion of protein into the media was analysed by harvesting the culture media at 72 h and 
96 h post-transfection and running the samples (10 μL) on NuPage Bis-Tris gel (Invitrogen). 
Following transfer to PVDF membranes, His-tagged proteins were detected by western 
blotting using an anti-His6 monoclonal antibody (clone BMG-His-1, Roche Diagnostics) in 










3. 4. 3. 4. Scale-up and purification 
 
Plasmid DNA for the large-scale transient transfection of HEK293 cells was prepared from a 
1 L culture of E. coli cells, following the protocols from the PureLink HiPure Megaprep kit 
(Invitrogen). 4x20 mL of HEK293 cells were transferred to roller bottles for 300 mL scale-
up. 75 mL of DMEM, supplemented with 10% v/v foetal calf serum, was added to each roller 
bottle and incubated at 37 °C for 3 days in the roller rig. After the incubation, the culture 
media were discarded, 60 mL of fresh DMEM, supplemented with 2% foetal calf serum, was 
added to each roller bottle and the cells were returned to incubator for 10 min. In a sterile 
container, 0.6 mg of plasmid DNA were added to 30 mL of serum-free DMEM. 30 mL of serum-
free DMEM, containing 1 mg of polyethylenimine (PEI) were added to the mixture and 
incubated at RT for 10 min. 15 mL of the transfection cocktail were added to each roller bottle 
and returned to the incubator. The cell cultures were grown for 5-6 days and the secreted 
proteins were harvested by removing the media from the roller bottles and centrifuging at 
6000 g for 20 min. The supernatant was filtered through a 0.45 μm bottle top filter and stored 
at 4 °C until purification. 
Secreted proteins were purified using an automated in-house protocol, implemented on 
ӒKTA Xpress instrument (GE Healthcare), using previously described programmes135. 
Briefly, batches of media (100 mL) were passed through a 5 mL HisTrap column (GE 
Healthcare), each followed by a 20 mL wash of 50 mM Tris-HCl, 500 mM NaCl, 30 mM 
imidazole, pH 7.5, until all media were loaded. The column was washed with a further 20 mL 
of loading buffer, before elution of bound proteins in 50 mM Tris-HCl, 500 mM NaCl, 500 mM 
imidazole, pH 7.5. The eluted protein peak was automatically collected in a sample loop and 
re-injected onto a pre-equilibrated HiLoad 16/60 Superdex 75 column (GE Healthcare). 
Protein was subjected to size-exclusion chromatography in 20 mM Tris-HCl, 200 mM NaCl, 
pH 7.5 and fractions collected using a peak detection algorithm. Fractions containing the 
protein of interest at > 95% pure by SDS-PAGE were pooled, quantified (by A280nm), snap 











3. 4. 4. Results and discussion 
 
3. 4. 4. 1. Construct design and plasmid preparation 
 
As outlined in section 3. 4. 2., four types of constructs were designed for P-selectin and eight 
types were designed for L-selectin for expression in HEK293 cells. Construct design was 
similar to the design of constructs used in the previous expression tests. The higher number 
of L-selectin constructs is due to the presence of the propeptide sequence in the Uniprot gene 
entry for this protein that could play an important role in the regulation of protein synthesis. 
Propeptides are commonly found in higher organisms, expressed at the protein’s N-terminus 
to assist in the folding processes and guide the protein to its destination within the cell. Once 
its role in post-translational processes is completed, the propeptide is cleaved and plays no 
further role. It is unclear why the propeptide sequence is found only in L-selectin and not in 
P-and E-selectins but its potential role in the protein folding has to be considered. For this 
reason, four of the designed L-selectin constructs included the additional ten-residue 
propeptide sequence at the protein’s N-terminus. 
Primers were designed to allow for the In-FusionTM cloning of the gene fragment of interest 
into the appropriate vector. This method of cloning is fast, efficient and allows for flexible 
design of gene inserts for cloning into any vectors. For purpose of the In-FusionTM cloning, 
15-bp extensions homologous to the vector sequence at the site of insertion were 
incorporated into the primers. After PCR amplification with such a set of primers, the gene of 
interest will contain these extensions and can be incorporated into the homologous site 
within the linearised vector. 
PCR amplification was successful for all constructs, as confirmed by agarose electrophoresis 
(Fig. 3. 4. 2. A). The resulting DNA fragments were purified using magnetic beads, inserted 
into linearised pOPING and pOPINEneo-3C-2Strep-His8 vectors and transformed into E. coli 
cells for generation of high amounts of plasmid DNA, required for transfection of HEK293 
cells. For each recombinant strain, five bacterial colonies were tested for the presence of the 
inserted plasmid. Of the five colonies, two that expressed the plasmid (colonies 3 and 4) were 





Fig. 3. 4. 2. Agarose electrophoresis of DNA fragments after PCR amplification (A) and 
of plasmids used for transfection of HEK293 cells (B). A DNA fragments generated in PCR 
amplification of selected gene sequence for each selectin construct, after the addition of vector-
homologous extensions for the In-FusionTM cloning. B Plasmids produced from E. coli after the 
cloning reaction. Shown here are only the results from colonies 3 and 4 that were subsequently 
used to transfect HEK293 cells. Numbers above the lanes refer to unique OPPF identifiers of the 




3. 4. 4. 2. Small-scale expression tests in HEK293 cells 
 
Transfection of selectin constructs into the HEK293 cells was tested on a small scale, using 
enhanced Green Fluorescent Protein (eGFP) and an internal standard, OPPF 6218, as positive 
controls. eGFP expression levels were monitored using fluorescent microscopy. In the cells 




cells were expressing eGFP (Fig 3. 4 .3. A). Furthermore, proportion of cells expressing eGFP 
increased to more than 90% (Fig 3. 4. 3. B) after 72 h from transfection. These results confirm 
that the cells used for transfection were healthy and that there were no issues with the 
transfection protocol for this set of constructs.  
 
 
Fig. 3. 4. 3. Results of test expression of selectin constructs in HEK293 cells (colony 3). 
eGFP expression levels measured by fluorescent microscopy at 24 h (A) and 72 h (B) after 
transfection. C Western blot of the HEK 293 culture media from the cells transfected with plasmid 
DNA from colony 3, harvested after 72 h from transfection, with the MW marker on the right hand 
side (kDa). The lane labels refer to unique OPPF identifiers of the constructs (see Table 3. 4. 1.). 
OPPF 6218 is included as a positive control.  
 
 
As the recombinant proteins should be secreted into the culture media, western blot was 
performed on the culture media harvested at 72 h. Three constructs from colony 3 showed a 
strong single band on the western blot – all corresponding to the L-selectin 1-domain 
constructs, 20313, 20314 and 20318 (Fig. 3. 4. 3 C). Plasmid DNA used for transfection of 
these constructs was sequenced and constructs 20313 and 20318 were confirmed to have 
the correct genetic sequence. Construct 20313 was found to contain a single missense 




Construct 20313 had a stronger signal on the western blot than 20318, indicating that its 
expression levels were slightly higher. In addition to that, 20313 is the construct of a simpler 
design, using only one tag (His6-tag), which simplifies the purification process. For these 
reasons, it was decided that construct 20313 will be used for the scale-up expression in 
HEK293 cells. Interestingly, this is the construct in which the propeptide sequence was 
included, confirming that this sequence is likely to play a role in the regulation of protein 
expression. 
Two attempts were made to transfect the colony 4 plasmid DNA into HEK 293 cells. However, 
in each attempt, numbers of the cells were low and the eGFP was expressed in less than 10% 
of the cells. All of the proteins showed none or very low expression levels when tested by a 
western blot. Due to time constraints, the focus of further experiments was on the positive 
results from transfection with the plasmid DNA from colony 3 and on the scale-up expression 
of the construct 20313. 
 
 
3. 4. 4. 2. Large-scale expression of the construct 20313 
 
Based on the results from the small-scale expression tests, a large scale (300 mL) expression 
of the construct 20313 was attempted. The procedure was based on the standard OPPF 
protocols that are used routinely for protein expression in HEK293 cells. The culture media 
were collected and purified by the His-Trap and gel filtration chromatography and collected 
fractions were analysed by SDS-PAGE. As shown in Fig 3. 4. 4, B, fractions A3 – A12 were 
characterised by a band on SDS-PAGE at approximately 30 kDa. Although this number is 
higher than the calculated molecular weight of the construct 20313 (16 kDa), it is likely that 
the protein is glycosylated which would significantly increase its mass. L-selectin has two N-
glycosylation sites within the lectin domain and either or both of them could be glycosylated 
with carbohydrate chains that would account for the additional 14 kDa.  
The corresponding region in the gel filtration profile shows a large peak in absorbance value 
(18 mAU) at retention volume of 55 mL, followed by an even larger peak (24 mAU) at 60 mL. 
Such a profile would indicate the presence of two species that are close in molecular weight. 
As the band seen on the SDS-PAGE is also not very well defined, it is possible that there are 
two species of similar mass present in the fractions from that region. This could be possible 




genetic sequence for the construct is known and there can be no splice variants present in 
the sample, the most likely explanation is the difference in protein glycosylation. There are 
many options on the types of glycans that can be attached to protein post-translation, varying 
in structure and size. Slight changes in the structure of these glycans could lead to multiple 











Fig. 3. 4. 4. Results of the gel filtration chromatography of construct 20313. A Gel 
filtration profile of the culture media from cells expressing construct 20313, following 
purification on the His-Trap column. Green arrow indicates the region corresponding to fractions 
A3 – A12 which were combined into the final protein sample. B SDS-PAGE of fractions collected 
in the gel filtration experiment. The first lane from the right is the MW marker (kDa). The lane 







Previous studies of L-selectin glycosylation in HEK293 cells have shown that the N-glycan 
structures found on the lectin domain are mainly diantennary-type glycans, terminating with 
either Gal or GalNAc residues and containing antennary Fuc residues. One of the glycan 
determinants shows similarity to Lex determinants and has a potential to inhibit E-
selectin108. The pattern of glycosylation can vary between the different cell types and 
contributes to regulation of cell-cell interactions – L-selectin is believed to interact with the 
endothelial selectins via its N-glycans85,137. Analysis of protein glycans is a very complex field 
in itself as there are many variants of glycans that can be attached to the protein which leads 
to a large number of potential combinations. There are methods that can be used to study 
protein glycosylation, such as the affinity-based assays or MS analysis. The first method 
requires testing multiple receptors and enzymes in order to determine the type of glycan, 
whilst the latter one requires the glycans to be cleaved off the protein surface and purified136. 
Such work was too extensive to be undertaken as part of this project and therefore the exact 
nature of the glycosylation of 20313 construct remains unknown. 
Fractions A3 – A12 eluted from the gel filtration column were collected and delivered to the 
University of Edinburgh. Overall yield of the protein obtained in this experiment was 0.5 mg. 
The received protein sample (0.7 mg/mL) was used in the selectin-fCS interaction studies by 




3. 4. 5. Conclusions 
 
Selectin expression tests in HEK293 cells have resulted in production of 0.5 mg of a single 
domain L-selectin construct. The construct is likely glycosylated, as indicated by the 
molecular weight of the produced protein which is higher than expected. Expression of the 
L-selectin single domain construct has never been reported before and protocols described 
here, used for successful expression of this construct, could be of importance for future 
research on selectin-ligand interactions. Comparative studies on the binding properties of 
the single-domain construct when compared to the previously expressed double-domain 
constructs could reveal important new information about the role of the EGF-like domain in 
the interactions between selectins and their ligands. It is also possible that, based on this 
research, protocols for expression of a similar but isotopically labelled protein construct 












There are many NMR techniques that can be used to study protein-ligand interactions. Some 
of them require a sample of soluble protein labelled with isotopes 13C and 15N. Some others, 
that are ligand focused, do not require labelled protein. Saturation Transfer Difference (STD) 
NMR belongs to the second category in that it allows to look at the changes in the ligand 1H 
signals upon binding to protein. For this reason, it does not require an isotopically labelled 
sample and very small amounts of protein are sufficient for successful experiments. With a 
simple 1D homonuclear experiment, STD allows to identify the ligand moieties in direct 
contact with the protein surface, providing valuable structural information about the 
protein-ligand interaction in question. 
STD NMR was originally designed to allow to screen a library of carbohydrates for binding 
affinity towards wheat-germ agglutinin138. However, during the screening process, it was 
discovered that this technique allows not only to detect the binding but also to deduce the 
binding epitope of ligands, an approach which is known as epitope mapping. Regions within 
the ligand that are in close contact with the protein showed strong STD signal, whilst the 
regions located further away from the protein surface showed low intensity or no STD signal 
at all. Thanks to these observations, STD NMR is now a commonly used technique in the 
discovery and design of new pharmaceutical products139,140. 
In the STD NMR, excess of ligand is added to the protein and two experiments are performed. 
In the first experiment, a reference 1H spectrum is obtained, where a radio-frequency (RF) 
pulse is applied in the off-resonance region from both the protein and the ligand signals, 
usually at around 30 – 40 ppm139. In the second experiment, the protein signals are saturated 
by a selective (on-resonance) RF pulse in a region far from the ligand signals, usually in the 
region between -4 and 1 ppm. Care needs to be taken to not saturate the ligand signals in the 
on-resonance experiment. Therefore, if methyl protons are present in the ligand, it may be 




difference spectrum. No ligand signals are found below 0 ppm, whilst there is still a 
significant linewidth of protein signals which allows for selective saturation139. Alternatively, 
selective saturation can occur at around +10 ppm, if the ligand has no signals in the aromatic 
region. In both instances, all of the protein signals are saturated as saturation is able to 
spread across the protein surface by spin diffusion. If the ligand molecule is positioned close 
to the protein surface, magnetisation will be transferred to it via 1H-1H cross relaxation. 
Protons that are located closer to the protein surface will experience more saturation and 
protons that are located further away will experience less or no saturation. Saturation will 
cause the signal intensity to decrease. This effect can be observed when the spectra from the 
two experiments are subtracted139,140. The difference spectrum should contain only the 









Fig. 4. 3. 1. Schematic representation of the principles of STD NMR. When the protein is 
saturated with a selective RF pulse, the saturation is transferred onto the bound ligand. The parts 
of the ligand that are closer to the protein surface will experience stronger saturation transfer 
and, therefore, will show a stronger signal in the STD difference spectrum. The non-binding 





The efficiency of any STD experiment depends on the binding kinetics for the given ligand, 
specifically on the off rate koff. Fast off rate allows the ligand to quickly dissociate from the 
protein and transfer the magnetisation into solution140. This way, if the large excess of ligand 
is present in the sample, one binding site can saturate many ligand molecules within a short 
space of time. The ligand is normally used in an approximately 100-fold molar excess over 
the protein to allow for this effect to take place. This in turn allows for very small (less than 
10 µM) amounts of protein to be used in the STD experiments140. If koff rates are too low (less 




saturation transfer becomes inefficient. An additional problem with tight binding is that, as 
ligand resides in the binding site for a long time, saturation spreads further across the ligand 
and it becomes impossible to distinguish which protons are those closest to the protein 
surface139. On the other hand, if koff rates are too high (more than 10 000 s-1), the binding 
becomes too weak and not enough ligand molecules make it to the binding site140. The koff 
values optimal for the STD experiments can be translated to KD values in the range of 1 mM 
to 0.1 μM. These are estimated KD values, based on the assumption that the on rate kon is 
equal to 107 s-1.140,141  
Success of the STD experiment is dependent on the koff for the ligand, as well as the T1 
relaxation for free ligand in solution. Saturation times typically range from 1 – 2 s. Ligands in 
solution lose saturation mostly by T1 relaxation, which is usually in order of 1s for a small-
molecule ligand140. Longer T1 relaxation times of the ligand will result in accumulation of 
saturated ligand molecules in solution and, therefore, in amplification of the STD signal. Large 
saturation transfer effects will be observed for ligands with large values of koff and long T1 
relaxation times.  These effects have been previously demonstrated for carbohydrate ligands 
where a monosaccharide ligand characterised by high koff rate and longer T1 relaxation time 
showed STD effects close to 3-fold higher than those observed for a larger carbohydrate 
ligand with a lower koff rate and shorter T1 relaxation time142.  
Another important condition for a successful STD experiment is that the protein needs to 
have a molecular weight of at least 10 kDa. In fact, the larger molecular weight, the better 
STD effect is going to be. This is due to the fact that lager proteins are characterised by slower 
tumbling in solution and therefore longer correlation time τc, which facilitates efficient spin 
diffusion across the protein surface140. Therefore, saturation will be spread more easily for 
larger protein molecules. 
STD NMR has been widely used to study the protein-ligand interactions and one of the first 
applications was to study the interaction between a type of lectins known as agglutinins and 
carbohydrate ligands141,142.  For example, a study performed in 1999 by Mayer and Meyer 
allowed to define the binding epitope of Lewisb-hexasaccharide to wheat germ agglutinin, 
using 1D 1H STD experiments, along with a 2D variant, STD-TOCSY142. Similar methods were 
applied to study the binding of GAGs and sLex-type carbohydrates to proteins of the immune 
system in later years139,143,144. In the study undertaken as part of this PhD project, STD 
experiments were used to investigate the binding between the fCS oligosaccharides from H. 
forskali and four different recombinant selectin constructs. Three different constructs were 




4.2. Material and methods 
 
 
Recombinant L-selectin constructs were purchased from R&D Systems (ADP2, 200 μg) and 
Creative BioMart (SELL-7019H, 100 μg). Recombinant P-selectin construct was purchased 
from Creative BioMart (SELP-474H, 100 μg). The fCS oligosaccharide samples from sea 
cucumber species H. forskali were provided by Glycomar Ltd.  
All experiments were performed in Shigemi tubes without the plunger. In each experiment, 
100 μg of the protein was dissolved in 450 μL of a 10:1 H2O/D2O mixture, producing a sample 
of ~4 – 7 µM concentration, depending on the construct used. Sodium azide (0.01 %) was 
added to the protein sample to prevent bacterial growth. 
All STD NMR experiments were performed on a Bruker AVANCE III-600 (1H: 600 MHz, 13C: 
150 MHz) instrument equipped with a TCI cryo probe. Protein/ligand molar ratios were 
varied from 1:50 to 1:100. The pulse sequence was BRUKER stddiffesgp.3, with water 
suppression via a double-pulsed field gradient spin echo (2 ms sinc pulses). The following 
parameters were used: 12 ppm sweep width, 4 s or 8 s relaxation delay (D1), 4 s 
presaturation time that was incorporated into the saturation delay and 1.36 s acquisition 
time. The on- and off-resonance irradiation was set to -4 ppm and 30 ppm, respectively. The 
irradiation was performed by 78 repetitions of 50 ms Gaussian pulses applied at γB1/2π = 
180 Hz. 16 scans were accumulated per one of the 128 averaging cycles, using one-scan 
alternate accumulation into on- and off-resonance spectra. The overall spectrometer time 
was 10.6 hours per experiment.  
The pulse sequence used for the 2D STD-TOCSY experiment was BRUKER stdmlevesgpph. 2D 
STD-TOCSY acquires on- and off-resonance saturation in an interleaved manner, where the 
two transients are subtracted in computer memory. The experiment was recorded with 
MLEV-17 spin lock field of 40 ms and the relaxation delay of 7.5 s. 256 t1 increments were 
collected and the following parameters were used: 12 ppm sweep width in f2 and 8 ppm in 
f1, 7.5 s relaxation delay (D1), 4s presaturation time and 27 ms acquisition time t1max. The 
on- and off-resonance irradiation was set to -4 ppm and 30 ppm, respectively. The irradiation 





4.3. Results and discussion 
 
 
A series of STD experiments was undertaken on four different selectin constructs. Three of 
them were the commercially available constructs consisting of the extracellular domains of 
L- and P-selectins. The fourth protein used in these experiments was the single-domain L-
selectin construct produced at the Oxford Protein Production Facility (see Section 3. 4). The 
fCS sample used in the STD experiments was a depolymerised fCS (dfCSVI) consisting of a 
mixture of small oligosaccharide fragments, estimated to have an average MW of 4.8 kDa. 
In each experiment, a 1H NMR spectrum was recorded before and after the addition of dfCSVI 
to the protein sample. The STD spectra were recorded with selective irradiation at -4 ppm. 
After subtraction of this spectrum from the reference spectrum, peaks with different 
saturation levels were identified and assigned to the individual protons in the fCS 
trisaccharide. In this way, it was possible to determine the fCS protons spatially close to the 
protein surface with their relative degree of saturation. Data obtained for each of the 
constructs is presented below. 
 
 
4. 3. 1. fCS binding to the L-selectin construct SELL-7019H 
 
The first selectin construct studied by STD experiments was the recombinant human L-
selectin (SELL-7019H) purchased from Creative BioMart. This construct consisted of 
residues Met1 – Asn332 which constitute the full extracellular part of the protein, including 
the lectin, EGF-like and the SCR domains. The predicted molecular weight of this protein is 
34.5 kDa. However, as the L-selectin produced in mammalian cells is glycosylated, the true 
molecular weight of the construct is between 55 – 65 kDa.  
The reference 1H spectrum and the STD difference spectrum of the SELL-7019H with dfCSVI 
is presented in Fig. 4. 3. 2. As can be seen in this spectrum, dfCSVI interacts with the 
extracellular domains of L-selectin. Based on the chemical shifts, it was possible to identify 





Fig. 4. 3. 2. STD experiment on the mixture of fCS and the SELL-7019H construct. 
Reference 1H spectrum (bottom) and the STD difference spectrum (top) of the SELL-7019H 
sample containing dfCSVI. 
 
Fig. 4. 3. 3. Expanded section of the NMR spectra from Fig. 4. 3. 2.  
Comparison of the STD response for the GalNAc acetyl and Fuc methyl signals. The STD difference 





Strong response upon selective saturation of the protein signals was observed for the methyl 
signals of the galactosamine (GalNAc) and fucose (Fuc) residues. Figure 4. 3. 3 shows an 
expanded view of these signals – it can be seen that the response in GalNAc acetyl signals is 
stronger than the response observed in fucose signals. To confirm that this is a true response 
initiated by the saturation transfer, in another experiment, selective irradiation was 
performed at 10 ppm – a region far from the chemical shifts of methyl groups. In this 
variation of the STD experiment, response of the same intensity as in the case of irradiation 
at -4 ppm was recorded for all of the signals, proving that the methyl signals are not the result 
of irradiation of carbohydrate signals but of the saturation transfer from the protein. To allow 
for full relaxation of the methyl signals, experiments with double the relaxation delay (D1 = 
8 s) were also performed, as slowly relaxing signals, such as the methyl protons, can give a 
false response if insufficient relaxation is allowed. This was not the case and identical spectra 
were obtained, proving that the methyl signals are true STD enhancements.  
Assignment of the fCS signals was possible as the oligosaccharide sample used in the STD 
experiments was previously studied by NMR in the Uhrín group and the STD 1H reference 
spectra could be compared to the assigned NMR spectra for this sample. All fCS samples have 
been assigned using a range of 1D and 2D NMR experiments. Although the samples are 
heterogeneous, it is possible to identify groups of peaks that correspond to specific atoms 
within the fCS units, for example allowing to distinguish different types of sulfated fucoses. A 
list of all assigned peaks for this fCS sample is presented in Table 4. 3. 1. 
 










*Δ designates terminal GlcA residue produced via β-eliminative and photochemical depolymerisation . 




The 1H 1D spectrum, aligned with the STD 1H reference spectrum for this fCS sample, is 
shown in Fig. 4. 3. 4. Comparison of these two spectra also allowed to identify impurities 
present in the protein sample used in this experiment. 
 
Fig. 4. 3. 4. 1H NMR spectrum of the fCS sample used in this STD experiment. 
The 1H spectrum of this fCS sample (top) is aligned with the reference spectrum from the STD 
experiments, obtained after the addition of SELL-7019H (bottom). 
 
 
The STD difference spectrum contained multiple signals from fucose. Amongst the fucose 
signals, the strongest response was recorded for the fucose methyl protons which appear on 
the spectra as a set of overlapping peaks between 1.28 – 1.43 ppm. Fucose in fCS can exhibit 
different sulfation patterns and the multiple peaks observed in this region correspond to 
different types of fucose from oligosaccharides of different lengths and sulfation patterns. 
STD response is recorded for more than one type of fucose and comparison of peak 
intensities to those in the original 1H spectrum shows that the level of response varies 
between the different types of fucose (Fig. 4. 3. 5). Besides the signals of the methyl protons, 
response for the anomeric protons of both 2,4- and 3,4-sulfated fucose residues was also 
observed, slightly higher for Fuc2,4S (5.69 ppm) than for Fuc3,4S (5.35 ppm) signal.  
Although response was also recorded in other regions of the spectrum, it was not always 




possible to establish that the signals in the region between 3.56 – 3.76 ppm most likely 
correspond to H2 and H3 of the glucuronic acid (GlcA). Strong response was also observed 
for the H4 signal of the unsaturated glucuronic acid (ΔGlcA) resulting from the 
depolymerisation of the fCS polysaccharide via β-elimination reaction. 
 
Fig. 4. 3. 5. Magnification of the fucose methyl region of the 1H and STD difference 
spectra of fCS-SELL-7019H complex. The STD enhancements vary for different types of fucose 
residues as shown by the differences in intensities of individual peaks in the reference 1H 
spectrum (black) and the STD difference spectrum (blue). 
  
 
The absolute values of the STD enhancements are very low (less than 1%). However, the 
identified regions of the spectra were integrated and the values of integrals were normalised 
to 100 % for the GalNAc CH3 signals which showed the strongest STD response. This allowed 
to calculate the relative values of STD enhancement for all identified peaks and thus to gain 
information about the relative contribution of individual regions within the fCS to L-selectin 





Fig. 4. 3. 6. Structure of the fCS trisaccharide with relative degrees of saturation of 
individual protons involved in L-selectin binding. Relative percentage saturation (shown 
in green) for each proton was calculated with respect to the GalNAc CH3 signal, based on the 




4. 3. 2. 2D STD-TOCSY experiment on fCS binding to L-selectin 
 
In order to aid the identification of the peaks in the regions of high overlap, a 2D 1H-1H STD-
TOCSY experiment was also performed. Due to technical difficulties, it was only possible to 
perform this analysis on an alternative commercially available L-selectin construct, ADP2. 
This construct consists of the same portion of the native protein as the SELL-7019H 
construct. However, the sample contained small-molecule additives which obscured some of 
the fCS signals and thus the use of SELL-7019H constructs was preferred for the 1D STD 
experiments.  
Similarly as in the case of the 1D STD experiments, in 2D STD-TOCSY experiments two 2D 
TOCSY spectra are obtained – one with off- and one with on-resonance irradiation of the 
protein signals. The two spectra are then subtracted from each other which allows to observe 
correlations between the protons which are in contact with the protein138. Use of 2D STD 
methods can be helpful in cases where mixtures of ligands are used and the STD signals are 
overlapped in the 1D spectrum140. 2D STD TOCSY has been used previously for epitope 
mapping in protein-carbohydrate systems, for example to study interactions of sialic acid 




The 2D STD-TOCSY experiment allowed to detect the correlation between some of the 
protons in the overlapped regions of the 1D spectrum (Fig. 4. 3. 7). A set of cross peaks at 
1.36-1.40/4.85-4.90 ppm was identified as a correlation between the fucose CH3 and H5 
proton signals. This means that the Fuc H5 protons are also located close to the protein 
surface. Other identified correlations were between the Fuc2,4S H2 and H3 protons 
(4.50/4.16 ppm), GlcA H1 and H2 protons (4.50/3.61 ppm) and a terminal GalNAc with a β-
reducing end H2 and H3 protons (4.28/3.99 ppm). Therefore, it was possible to obtain 
further information on the regions of fCS that interact with L-selectin. Cross peaks at 3.94-
3.98/4.52-4.57 ppm could not be identified with confidence as they could correspond to 
correlation between either Fuc3,4S H2 and H3 or ΔGlcA H2 and H3 protons. 
Fig. 4. 3. 7. 2D STD-TOCSY experiment on the mixture of fCS and the ADP2 construct. 
2D STD-TOCSY was performed on the L-selectin ADP2 sample containing dfCSVI to confirm the 
identity of some of the peaks in the regions of high overlap. The identified cross-peaks are 
highlighted in green. The cross-peaks circled in red could correspond to either Fuc3,4S H2/H3 or 









4. 3. 3. fCS binding to the single-domain L-selectin construct 
 
Further insight into fCS binding to L-selectin was obtained from the 1D STD experiment on 
the single-domain construct produced at the OPPF. By comparing the results of this 
experiment with the results obtained for a larger extracellular construct SELL-7019H, it was 
possible to confirm that the binding occurs via the C-type lectin domain. Slightly lower 
response was recorded for the fucose signals (66% Fuc H1, 50% Fuc CH3) than in the case of 
the larger SELL-7019H construct. GlcA H2 and H3 signals were obscured by a strong signal 
from the contaminant present in the protein sample (Fig 4. 3. 8).   
The above results suggest that the absence of the EGF-like domain does not affect the position 
of fCS oligosaccharides on the protein surface and only slightly reduces the strength of the 
fCS-selectin interaction. 
 
Fig. 4. 3. 8. Comparison of the STD difference spectra for the single domain (top) and 
the multiple domain (bottom) L-selectin constructs. The two spectra were obtained using 
the same experimental conditions and the same amount of dfCSVI. High intensity peak at 3.64 
ppm (labelled with an asterisk), obscuring possible response from GlcA H2 and H3, is a signal 
from a contaminant carried over from the protein production. It was not possible to determine 






4. 3. 4. fCS binding to the P-selectin construct SELP-474H 
 
The final STD experiment tested the binding of dfCSVI to the P-selectin construct SELP-474H, 
analogous to the L-selectin construct SELL-7019H used in the previous experiments. This 
construct consists of the residues Met1 – Ala771 and includes all of the P-selectin 
extracellular domains. As P-selectin contains more SCR domains than L-selectin, the size of 
this construct is larger, with calculated molecular weight of 81.3 kDa and the apparent weight 
of 120 kDa due to glycosylation. 
The 1H reference and the STD difference spectra for this construct are shown in Fig. 4. 3. 9. 
As in the case of L-selectin, strong response was recorded for some of the peaks, proving that 
the fCS oligosaccharides interact with the extracellular domains of P-selectin. 
 
Fig. 4. 3. 9.  STD experiment on the mixture of fCS and the SELP-474H construct. 




The observed response was similar to response recorded for the L-selectin constructs. Again, 
the strongest response was seen for the methyl signals of GalNAc residues. Fucose methyl 




3,4S anomeric protons and H4 of ΔGlcA. As in the case of L-selectin, signals between 3.57 and 
3.87 ppm likely correspond to GlcA H2 and H3 protons.  
As before, relative percentage saturation was determined, by integration of the identified 
signals and normalisation to GalNAc methyl proton signals to 100% (Fig. 4. 3. 10). The 
relative saturation values were similar for both proteins, suggesting that the mode of binding 
of fCS, as well as the binding affinity, are similar for L- and P-selectins. 
 
Fig. 4. 3. 10. Structure of the fCS trisaccharide with relative degrees of saturation of 
individual protons involved in P-selectin binding. Relative percentage saturation (shown 






Experiments described in this chapter confirmed that fCS oligosaccharides bind to both L- 
and P-selectins. By performing STD experiments on four different selectin constructs, it was 
possible to identify the protons in direct contact with selectin surface. It was also possible to 
compare the binding between the single- and multiple-domain L-selectin constructs and 
between the analogous L- and P-selectin constructs. No significant differences were observed 
in the fCS binding by any of these recombinant proteins.  
Strong response recorded for GalNAc methyl protons suggests that the N-acetyl group of this 




suggest that this residue also plays an important role in fCS-selectin interaction. In all of the 
samples, STD enhancement was identified for the Fuc anomeric protons. The 2D STD-TOCSY 
experiment also confirmed the contribution from the Fuc H2, H3 and H5 protons, indicating 
that fucose is surrounded by the L-selectin residues from all sides. Other identified regions 
within the fCS included H1 and H2 protons of the GlcA and H2 and H3 protons of the terminal 
GalNAc residue. Experiments with the use of isotopically labelled protein would be required 



























As shown in the previous chapters, studies of the protein-carbohydrate interactions can be 
very challenging. Carbohydrate-protein complexes are notoriously difficult to crystallise. 
Moreover, X-ray structures offer limited amount of information as they do not provide many 
clues on the internal dynamics. Detailed studies by NMR require availability of an isotopically 
labelled protein which is not always easy to obtain. For this reason, it is becoming 
increasingly more common to apply computational methods to study protein-carbohydrate 
binding. Software and algorithms used for the in silico studies are becoming more and more 
sophisticated, allowing to produce fairly reliable predictions about the behaviour of the 
complex under study. 
In absence of an X-ray or NMR structure of the protein-ligand complex, the approach that can 
be used is to computationally dock the ligand to the existing protein structure by using the 
available PDB files. Molecular docking uses a set of algorithms to scan through many possible 
bound complexes and rank them according to an energy scoring function. Predicted 
contributions from the hydrogen bonding, electrostatic and Van der Waals interactions, 
repulsive forces, desolvation and torsional entropy are summed together to estimate the free 
energy of binding (ΔGbind)146.  Complex with the lowest ΔGbind is ranked the most stable and 
is returned as the most likely candidate, along with a few slightly less stable options. Different 
docking programmes use different types of scoring functions to rank the results. Their main 
limitation is the requirement for fast calculation as the algorithm needs to be able to scan 
through thousands of complexes. Because of this limitation, the binding energy calculations 
are often inaccurate and the software may struggle to correctly rank the results with similar 
ligand conformations146,147. The task becomes even more challenging in the case of 
carbohydrate ligands which are characterised by high flexibility and additional anomeric, 
exoanomeric and gauche effects which are not currently incorporated into the docking 




protein interactions on multiple occasions, for example in investigation of heparin-binding 
proteins150–153.  
AutoDock and AutoDock Vina are two commonly used molecular docking programmes, 
frequently applied in the studies of protein-carbohydrate complexes150–152,154.  Autodock is a 
suite of non-commercial software that uses a genetic-type algorithm to explore different 
ligand conformations and rank them with the use of empirical free energy force field155,156. 
Autodock Vina is an improved version of the Autodock, applying a modified global search 
algorithm and a more efficient scoring function which largely improves the speed and 
accuracy of the docking calculations147. In both programmes, the ligand is treated as flexible, 
with a possibility to restrain some of the bonds, and the receptor is treated as rigid, with an 
option to assign some of the residues as flexible. Although it would be preferable to treat both 
the ligand and the receptor as flexible, such approach is computationally challenging and is 
not currently implemented in the AutoDock software.   
Several factors can decrease the accuracy of the docking. As protein-GAG interactions are 
electrostatic in nature, with poor geometric complementarity between the oligosaccharides 
and their binding sites, there are many possibilities for a single oligosaccharide fragment to 
bind to the protein surface. In some of the previous studies, multiple orientations were 
identified for GAG ligands as equally plausible based on the estimated energetic 
contributions150. Some proteins have multiple sites able to recognise GAGs and the residues 
that participate in the interaction are often characterised by long, flexible side chains that 
can adopt many conformations, difficult to explore using the docking software. Current 
docking algorithms are optimised for docking of small molecules and lack the tools that 
support docking of carbohydrate ligands. Finally, as the docking algorithms are stochastic in 
nature, there is no guarantee that they will succeed in finding the global minimum154. 
For the above reasons, it is important to have a method that allows to verify the docking 
results and identify the most likely binding conformations. One of the strategies used to 
validate and optimise the docking results is to perform molecular dynamics (MD) simulations 
on the obtained complexes. In MD experiments, all atoms are allowed to move which means 
that the whole system is represented more accurately. The amino acid side chains are treated 
as flexible and the protein is free to move and alter its conformation to adjust to the changes 
induced by the ligand binding. By allowing such changes to occur in many steps, MD 
simulation is a useful tool for checking the stability of the complex and finding its local 
minimum146,157. Moreover, availability of the carbohydrate-specific force fields allows for 




the interaction. MD simulations provide an opportunity to explore the movement of flexible 
loops within the protein, investigate interdomain dynamics and to observe whether the 
position of the ligand in the binding site undergoes any changes with time. 
An important factor that affects the accuracy of MD predictions is the precision of the force 
fields determining the energy terms and force constants used to predict the atomic 
movement, bond lengths, angles and torsions, as well as the non-bonding interactions. Force 
fields optimised for MD simulations of proteins and carbohydrates are gathered in the Amber 
Molecular Dynamics Package which also contains numerous programmes and tools for the 
preparation, set-up and analysis of MD simulations on biomolecules158,159. Currently, the best 
available force field for MD simulations of proteins is ff14SB160, whilst the force field 
optimised for carbohydrates is GLYCAM-06, developed by the Woods group161,162. The 
combination of these two force fields have been used previously to model the interactions 
between carbohydrates and proteins such as the fibroblast growth factor-2, chondroitinase 
AC, hemagglutinins and galectin-3154,163,164. 
As Autodock and Amber packages were previously used to investigate GAG binding by a 
variety of receptor proteins, they should be suitable for the studies on the binding of fCS by 
selectins. Through a collaboration with Prof. Wood’s group at the University of Georgia, our 
group has acquired protocols that allow for preparation of appropriate input files, as well as 
for molecular docking in Autodock Vina and molecular dynamics simulations on the 
produced protein-ligand complexes using Amber MD package. With the use of these 
protocols, it was possible to build different fCS oligosaccharides and to test the nature of their 
binding to selectins by molecular docking. Results were validated by MD simulations which 
also provided further insight into the dynamic behaviour of selectin domains and their 
carbohydrate ligands. 
In the following sections, computational studies on selectin-ligand binding will be described. 
In the first set of experiments, protocols for preparation of the receptor and ligand files, 
docking experiments and MD simulations were verified using the sLex-E-selectin complex for 
which the X-ray structure was known66. This was followed by producing different types of 
the fCS oligosaccharides and docking them to different selectin structures. Results of these 
experiments were verified and analysed with the use of MD simulations to provide new 
information on the nature of the fCS-selectin binding and conformational behaviour of 






5. 2 Materials and Methods 
 
 
5. 2. 1. PDB file preparation for MD and docking studies 
 
The initial three-dimensional structures of the sLex and fCS oligosaccharides were generated 
using the Carbohydrate Builder available on the GLYCAM Website. Protein structures used 
in the docking experiments and MD simulations were extracted from the X-ray structure files 
deposited in the Protein Data Bank (entries 1ESL and 1G1T for E-selectin, 1G1Q for P-
selectin). The produced structures were prepared for MD simulation using tLEaP module of 
AMBER 2014 software suite. Sulfate charges were obtained from the GLYCAM Website. The 




5. 2. 2. MD simulation set-up 
 
All MD simulations were performed using the CUDA implementation of PMEMD in the 
AMBER 14 Software Suite159,165,166. Structures were solvated in a truncated octahedron 
periodic box filled with TIP3P water molecules and neutralised by counterions. Prior to MD 
simulation, energy minimisation was performed in 5000 steps of steepest descent followed 
by 5000 steps of conjugate gradient using nonbonding cut-off of 10.0 Å with no restraints. 
The minimisation steps were followed by a heating phase, where the system was brought 
from 5 to 300 K over 50 ps. A simulation of 10 – 100 ns was performed in the isothermal-
isobaric ensemble (NPT) with Langevin temperature coupling with collision frequency 
parameter γ = 5 ps-1 and Berendsen pressure coupling with a time constant of 1.0 ps. The 
SHAKE algorithm was used to constrain all bonds that contain hydrogen atoms. A 10 Å cut-
off was applied to treat non-bonded interactions, the Particle Mesh Ewald (PME) method was 
introduced for long-range electrostatic interactions treatment and the long-range van der 
Waals interactions were estimated by a continuum model. Molecular graphics and analysis 





5. 2. 3. Docking experiments 
 
Protein and carbohydrate files were prepared in AutoDockTools (ADT) 1.5.6 and the docking 
experiments were performed in AutoDock Vina 1.1.2.147. Gasteiger charges were assigned to 
both protein and ligand files. Hydrogen atoms were added to the protein using ADT and 
GLYCAM hydrogens were retained in the ligands. Size of grid box was varied, depending on 
the size of the carbohydrate ligand, to always include the full C-type lectin domain, with the 
Ca2+-coordination site at the centre and allocating enough space for the ligand to explore 
different conformational states in solution and positions along the protein surface. The 
protein was kept rigid in all of the experiments.  
 
 
5. 2. 4. Free energy calculation 
 
Molecular Mechanics Linearisead Poisson-Boltzman on (MM-PBSA) method was used to 
calculate the free binding energy for the produced protein-carbohydrate complexes. In this 
method, the following terms are used to calculate the free energy of protein-ligand binding 
in solution (ΔGbind,solv): the free energy of protein-ligand binding in vacuum (ΔGbind, vac), the 
free energy of the protein-ligand complex in solution (ΔGcomplex, solv) and the free energies of 
solvation of the unbound protein (ΔGprotein,solv) and ligand (ΔGligand,solv). From these terms, the 
free energy of binding is calculated using Equation 1. 
∆𝐺𝑏𝑖𝑛𝑑,𝑠𝑜𝑙𝑣 = ∆𝐺𝑏𝑖𝑛𝑑,𝑣𝑎𝑐 + ∆𝐺𝑐𝑜𝑚𝑝𝑙𝑒𝑥,𝑠𝑜𝑙𝑣 − [∆𝐺𝑝𝑟𝑜𝑡𝑒𝑖𝑛,𝑠𝑜𝑙𝑣 + ∆𝐺𝑙𝑖𝑔𝑎𝑛𝑑,𝑠𝑜𝑙𝑣]  
Each of the three solvation free energy terms is calculated by solving the linearised Poisson-
Boltzman equation and adding an empirical energy term for hydrophobic contributions as 
shown in Equation 2. 
∆𝐺𝑠𝑜𝑙𝑣 = ∆𝐺𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑠𝑡𝑎𝑡𝑖𝑐,𝜖=80 + ∆𝐺𝑒𝑙𝑒𝑐𝑡𝑟𝑜𝑠𝑡𝑎𝑡𝑖𝑐,𝜖=1 + ∆𝐺ℎ𝑦𝑑𝑟𝑜𝑝ℎ𝑜𝑏𝑖𝑐  
The free energy of binding in vacuum can be obtained by calculating the average interaction 
energy between the receptor and ligand and taking the entropy change upon binding into 
account (Equation 3) 168,169. 







However, the entropy calculations are computationally costly and in cases where only a 
comparison of states of similar entropy is required, this term can be omitted169,170. For this 
reason, in the calculations presented here, normal mode analysis for entropy term was not 
performed. 
The average interaction energies for receptor and ligand were obtained from a set of 
uncorrelated snapshots collected from MD simulation, using the mm_pbsa.pl module of 
Amber 14. For each complex, ΔGbind was calculated for 300 snapshots from the MD trajectory 
file, taken every 10 ps for the first 3 ns of the simulation. The final ΔGbind value was the 



























5. 3. Results and discussion 
 
 
5. 3. 1. Sialyl Lewis X and its interaction with E-selectin  
 
In order to establish the suitability of computational protocols for the studies of fCS-selectin 
interactions, it was deemed necessary to test the procedures on a known carbohydrate ligand 
with experimental data on its binding to selectins. The obvious choice for selectin studies 
was the sLex tetrasaccharide for which crystal structures, in complex with either E- or P-
selectin, are available. As the interaction with E-selectin is known to be stronger, sLex binding 
to this protein was explored in the first set of tests. The main aim of this control study was to 
build the sLex tetrasaccharide using GLYCAM-Web Carbohydrate Builder and to establish 
whether it is possible to predict its binding site on selectin surface using the molecular 
docking software Autodock Vina. Provided that the docking experiments were successful, the 
most suitable docked structure would be minimised and further evaluated by MD simulation 




5. 3. 1. 1. Preparation of the sLex tetrasaccharide 
 
GLYCAM-Web Carbohydrate Builder is an on-line tool developed by the Woods group at the 
University of Georgia that allows the users to build and minimise a carbohydrate structure 
of interest, saving the coordinates into a PDB file in a format suitable for the use with Amber 
MD Package. sLex tetrasaccharide was built using the formula DNeup5Aca2-3DGalpb1-
4[LFucpa1-3]DGlcpNAcb1-OME. Minimisation produced a conformation that was further 
minimised with the use of Amber MD Package under GLYCAM06 force field. MD simulation 
in explicit water was performed for 40 ns. Data obtained from this simulation was analysed 
to provide information about the stability of the produced structure, its conformation and 
dynamic behaviour in solution.  
The temperature and energy of the system remained stable throughout the simulation (plots 
are included in Appendix 3). The Root Mean Square Deviation (RMSD) with respect to the 




included in the calculation. The RMSD plot presented fluctuations of about 1.5 Å over the first 
10 ns of the simulation. At close to 10 ns, a sudden change of about 2 Å was observed, after 
which the system reached a plateau, dropping back to the initial level after about 5 ns (Fig. 5. 
3. 1. A). Such a sudden change in RMSD from average value of 1.56 Å to 3.46 Å occurred two 
more times, each time reaching a stable plateau at the higher RMSD values. This indicates the 
presence of two distinct conformations where one seems more energetically stable than the 
other (Fig. 5. 3. 1. A).  
 
Fig. 5. 3. 1. MD simulation of the produced sLex tetrasaccharides. A. Plot of RMSD for sLex 
tetrasaccharide over a 40-ns MD simulation. B. The lowest energy conformation of sLex 
tetrasaccharide from the 40-ns simulation. 
 
 
Following the analysis of the values of dihedral angles over the course of the simulation, 
changes in RMSD values were correlated to changes in the value of dihedral angle ϕ for 
glycosidic linkage Neu5Acβ2⟶3Gal from the average value of 59° to -51° (Fig. 5. 3. 2). This 
result shows that the linkage between sialic acid and galactose is highly flexible and leads to 
existence of two major conformations of the free tetrasaccharide that are in constant 
exchange throughout the simulation. Based on the RMSD fluctuations for each of the two 
species, it appears that the conformations with ϕ of ca. 59° for this linkage are energetically 
more stable than those with low ϕ values. Analysis of the X-ray structure 1G1T confirms this 
observation, as the observed dihedral angle ϕ value for this linkage was 57° (Table 5. 3. 1). 
All of the other glycosidic dihedral angles remained stable, with overall fluctuations of less 
than 40°, which indicates that the remaining two glycosidic linkages did not undergo any 




Fig. 5. 3. 2. Changes in dihedral angles for sLex tetrasaccharide. A. Changes in dihedral 
angle ϕ for glycosidic linkage NeuNAcβ2⟶3Gal of sLex tetrasaccharide over a 40-ns MD 
simulation. B. Overlay of two conformations of sLex tetrasaccharide observed at 1 ns (green) and 
10 ns (yellow). 
 
*All measurements were made using the following definition of dihedral angles: ϕ = O5 – C1 
– OX – C’X, ψ = C1 – OX – C’X – C’(X-1).  






















φ -55 -66 -85 -68.4 ± 0.4 
ψ 120 135 136 130.9 ± 0.3 
Fucα1⟶3GlcNAc 
φ -45 -73 -77 -69.0 ± 0.2 
ψ -95 -91 -97 -96.0 ± 0.3 
NeuNAcβ2⟶3Gal 
φ N/A** N/A** 57 22 ± 24 
ψ N/A** N/A** -130 -121 ± 5 
Table 5. 3. 1. Average dihedral angles from the 40-ns MD simulation, compared to the 




The average values of dihedral angles for the linkages between glucosamine and galactose 
(Galβ1⟶4GlcNAc) and glucosamine and fucose (Fucα1⟶3GlcNAc) were also measured and 
compared to the values previously reported in literature, as well as to the values extracted 
from the X-ray structure (Table 5. 3. 1.). The average values were within 25° from the 
experimentally obtained values and it was concluded that the computationally produced 
oligosaccharide is in a good enough agreement and therefore suitable for the docking studies.  
Uncertainty of the mean calculation was also determined using the block averaging 
technique, where the MD trajectory was divided into 10 ns blocks and the mean value of 
dihedral angles was calculated for each block. Linkages Galβ1⟶4GlcNAc and 
Fucα1⟶3GlcNAc were characterised by low uncertainty values, consistent with low amount 
of fluctuations observed for these bonds. Uncertainty was higher for the linkage 
Neu5Acβ2⟶3Gal, indicating the higher flexibility of this bond. 
All conformations occurring over the 40 ns simulation were clustered using the UCSF 
Chimera Cluster tool. This tool uses pair-wise RMSD fit calculation to cluster all of the 
included conformations into groups based on their similarity. Total of 4000 conformations 
were used for this calculation, using every 10th frame in the simulation.  This procedure 
allowed to explore the conformational space of sLex tetrasaccharide and to isolate the most 
commonly occurring conformations to be used in the docking studies. sLex oligosaccharide 
proved to be highly flexible in solution, with over 180 clusters identified. Comparison of the 
clusters showed that there is high similarity in the values of dihedral angles φ and ψ for two 
of the linkages, Galβ1→4GlcNAc and Fucα1→3GlcNAc, between all of the clusters (Fig. 5. 3. 3. 
A). Only the linkage NeuNAcβ2→3Gal allows to distinguish between different clusters due to 
its high flexibility (Fig. 5. 3. 3. B). The most populated cluster (Cluster I) represented 10% of 
the included conformations, with Clusters II – V representing 7%, 5%, 4% and 3% of the 
population, respectively. As there is a high overlap between the clusters in the values of 
dihedral angles, it would be difficult to identify a single conformation unique for each cluster. 
Five representative conformations were chosen based on the values of dihedral angles 







Fig. 5. 3. 3. Distribution of dihedral angles φ and ψ within the simulated sLex 
tetrasaccharide. A. Plot of ψ versus φ for the glycosidic linkages Galβ1→4GlcNAc (squares) and 
Fucα1→3GlcNAc (triangles). B. Plot of ψ versus φ for the glycosidic linkage NeuNAcβ2→3Gal. Five 
clusters are represented in yellow, red, grey, blue and green for Clusters I to V respectively. 20 
representatives were chosen at random from each cluster as data points for this plot. All 
measurements were made using the following definition of dihedral angles: ϕ = O5 – C1 – OX – 




5. 3. 1. 2. Docking experiments on sLex and E-selectin 
 
The five sLex conformations prepared in the previous section were docked to existing X-ray 
structures of E-selectin. Oligosaccharides were docked initially to E-selectin from the crystal 
structure 1G1T and then to E-selectin from the structure 1ESL. These two structures have 
slight differences in the conformation of some of the loops and amino acid side chains and 
therefore may produce slightly different results upon docking to sLex. The protein was kept 
rigid in all experiments.  
All carbohydrate bonds were treated as rotatable in the docking experiments, remaining 
within the limit of maximal number of 36 rotatable bonds advised for docking in Autodock 
Vina147. Diagram in Fig. 5. 3. 4 shows the approximate size of the search box. It was important 
to ensure that the search box is large enough to allow the software to explore different 
possible binding sites, as well as to allow the carbohydrate linkages to freely rotate, exploring 













Fig. 5. 3. 4. Approximate size of the search box explored in the docking experiments. 
The light grey cube represents the search box specified for the docking software to explore 
possible binding sites and conformations of sLex. E-selectin is shown in dark blue. 
 
 
For each docking experiment, Autodock Vina returned nine results, ranked according to the 
scoring energy function. A mixture of results was obtained for each input sugar conformation, 
with the majority of results identifying the Ca2+-coordination site as the sLex-binding site. 
Each of the starting sLex conformations generated a slightly different set of results, with many 






Fig. 5. 3. 5. Two sets of the docking results for sLex tetrasaccharide and E-selectin. 
Autodock Vina returns nine results for each docking experiment. In the above figure, nine results 
obtained after docking the sLex conformations I (A) and II (B) to E-selectin structure 1G1T are 
superimposed. Each colour represents a different docking output from the same experiment. The 




None of the results were identical to those reported in the X-ray studies. As described in 
Section 1. 3. 3., X-ray studies have determined that the sLex tetrasaccharide coordinates Ca2+ 
ion via Fuc 3- and 4-hydroxyl groups.  Only in a few of the docking outputs Ca2+ ion was 
coordinated by fucose and in all of them mode of Ca2+ coordination was different to that 
observed in the X-ray structure. Nevertheless, these structures were evaluated by a set of 
short (10 – 15 ns) MD simulations using Amber MD Package. Structures that remained stable 
throughout the simulation were put forward for a longer MD run. Although a few candidates 
made it through the first set of the simulations, only one was found that did not dissociate or 
weakened significantly during a longer simulation. This complex was one of the results 
produced during the docking of sLex to the E-selectin structure 1ESL.  
The total simulation time for the most stable complex was 70 ns. The complex remained 
stable throughout the full duration of the simulation, with RMSD maintaining the average 
value of 1.52 Å with respect to the lowest energy structure. The calculated free binding 
energy for this complex was equal to -15.7 ± 0.4 kcal mol-1. The negative value of binding 
energy confirms that the complex is favourable. From to the relationship presented in 
Equation 4 and the experimentally determined value of KD for the E-selectin-sLex binding 
(720 nM), it was possible to calculate the theoretical value of ΔGbind. 
∆𝐺𝑏𝑖𝑛𝑑 = 𝑅𝑇𝑙𝑛𝐾𝐷    (4) 
The calculated value for KD was -4.28 kcal mol-1 which is a little higher than the value 
calculated by the molecular dynamics software. However, the values are close enough to 
conclude that the energy values calculated by the software can be used to estimate the 
strength of the interactions between selectins and carbohydrate ligands.  It was also noted 
that ΔGbind decreased at longer simulation times, indicating that the complex became more 
stable after the first 30 ns of the MD run. The conformation of sLex oligosaccharide and the 
protein-ligand interactions were compared to those reported in the X-ray structure 1G1T by 
visual assessment and by comparing the interactions formed by individual carbohydrate 




Fig. 5. 3. 6. Comparison of the docking result to the X-ray structure complex. A Ribbon 
representation of the complex obtained after docking of sLex tetrasaccharide to E-selectin 
structure 1ESL. Shown here are the interactions after the initial minimisation of the complex. B 
The experimentally obtained complex between sLex and E-selectin from X-ray structure 1G1T. 
Proteins are shown in blue, with the interacting residues highlighted in orange. Carbohydrate 
residues are shown in light grey. Hydrogens are not shown here for clarity. 
 
The sLex-E-selectin interactions identified in this complex show many similarities to those 
reported in the X-ray structure 1G1T. The majority of these interactions remained stable 
throughout the 70 ns simulation and the carbohydrate remained firmly bound to the protein. 
Large proportion of the interactions occurs via fucose residue which not only coordinates the 
Ca2+ ion via FucO2 and FucO3 atoms (mean value of 2.79 Å and 2.68 Å, respectively), but also 




FucOH2 group forms a stable H-bond to Asn105 (2.90 Å), FucOH3 – to Asn83 (1.88 Å), 
FucOH4 – to Glu107 (1.85 Å) and FucO5 – to Lys111 (2.98 Å). A similar network of H-bonding 
interactions was observed in the X-ray structure, involving residues Asn105, Asn83 and 
Glu107. In addition to the interactions mediated by fucose, there is also an H-bonding 
interaction between GalO4 and Tyr94 (2.57 Å) and between the carboxyl group of sialic acid 
and Arg97 (2.91 Å). These last two interactions were also observed in the X-ray structure. 
Therefore, the computational methods used in this study allowed to replicate the network of 
interactions determined experimentally to a satisfactory level. To simplify comparison of the 
interactions between the two complexes, a schematic representation of these interactions in 














Fig. 5. 3. 7. Schematic representation of the interactions in the docked and the X-ray 
complexes. A Interactions observed in the docked complex after the initial minimisation. E-
selectin residues are shown in blue. B Interactions observed in the experimentally obtained 
complex from X-ray structure 1G1T. E-selectin residues are shown in green. This diagram is 
provided to simplify the views presented in Fig. 5. 3. 5. and does not reflect the conformation of 




The main difference between the two structures lies in the orientation of sialic acid residue 
with respect to the binding site. In the X-ray structure, the carbohydrate conformation is 
more open, with sialic acid facing away from the Ca2+ ion. In the docked structure, sialic acid 
is folding in towards the Ca2+ ion, producing steric hindrance that forces fucose to approach 
the Ca2+-coordination site from a different angle to what was observed in the X-ray studies. 
In addition to that, in the docked result, fucose coordinates Ca2+ ion via 2- and 3-hydroxyl 
groups, rather than 3- and 4-hydroxyl groups. Despite these differences, sLex remains 
strongly bound to the protein in such conformation, suggesting that in theory it could be 
possible for such a mode of binding to occur in nature.  
Table 5. 3. 2. compares the dihedral angles between the oligosaccharides in these two 
complexes. It can be seen that there is a small variation in the values of dihedral angle ϕ for 
all glycosidic linkages and a large variation in the values of ψ for the glycosidic linkages 
Galβ1⟶4GlcNAc and Fucα1⟶3GlcNAc. These differences in dihedral angles account for the 
observed differences in the sLex orientation around the Ca2+-coordination site. As the values 
of ψ in the docked complex are largely different to those reported for the free tetrasaccharide 
at equilibrium, adopting the proposed bound conformation might involve high energy cost 












*All measurements were made using the following definition of dihedral angles: ϕ = O5 – C1 
– OX – C’X, ψ = C1 – OX – C’X – C’(X-1).  
 
 
Although there are significant differences between the docked complex and the X-ray 
structure, there are some similarities that indicate that the docking algorithm works 
reasonably well. Most importantly, Autodock Vina was able to correctly identify the binding 
Glycosidic linkage Dihedral angle* X-ray Docked complex 
Galβ1-4GlcNAc 
Φ -85 -69 
Ψ 136 -58 
Fucα1-3GlcNAc 
Φ -77 -103 
Ψ -97 93 
Neu5Acβ2-3Gal 
Φ 57 58 
Ψ -130 -110 
Table 5. 3. 2. Comparison of carbohydrate dihedral angles between the X-ray 




site in the majority of cases as located around the Ca2+ ion. Furthermore, a few of the residues 
involved in the binding of sLex were also correctly identified by the docking algorithm. These 
similarities prove that Autodock Vina can be used to predict the binding site and the amino 
acid residues involved in the binding of a sLex-type oligosaccharide by selectins. 
Further docking experiments were performed to establish how the input conformation of the 
carbohydrate affects the docking result. sLex tetrasaccharide from the X-ray structure 1G1T 
was extracted and docked to both E-selectin files as it was thought that using the true bound 
conformation may improve the accuracy of the docking algorithm. However, similarly to 
previous docking experiments, a mixture of results was obtained, with large variation in the 
orientation of the ligand in the binding site (Fig. 5. 3. 8).  
 
Fig. 5. 3. 8. Docking results for different combinations of the input files. Nine docking 
results returned by the Autodock Vina are superimposed for four different combinations of the 
input files. A and C present docking results for computationally produced sLex conformation I and 
protein structure 1G1T and 1ESL, respectively. B and D present docking results for the sLex 
conformation extracted from the X-ray structure 1G1T and protein structure 1G1T and 1ESL, 
respectively. The protein is shown in a surface representation, with positively charged residues 




None of the docked complexes offered a more suitable match for the existing X-ray structure 
than the complexes produced upon docking of the computationally produced 
tetrasaccharide. Use of an input conformation identical to the true bound conformation of 
sLex in the docking experiments did not significantly improve the results. After comparison 
of the docking results for the different sLex conformations, it was concluded that, in the case 
of a fully flexible oligosaccharide ligand such as sLex, use of different starting conformations 
of the carbohydrate does not significantly improve the accuracy of the docking results. 
Autodock Vina is optimised for the docking of small molecule ligands with a minimal number 
of rotatable bonds and the large number of rotatable bonds in the carbohydrate ligands leads 
to large variability in the docked results without a single strongly preferred orientation. 
Fig 5. 3. 8 shows how the docking results are distributed around the binding site, highlighting 
the positively and negatively charged amino acid residues. As these are the residues that 
participate in H-bonding and electrostatic interactions, it is of no surprise that the 
carbohydrate preferentially binds to the regions rich in those residues. No clear preference 
for binding to positively charged residues over the negatively charged residues was observed 
for sLex. It is also noteworthy that, occasionally, results include structures that bind in 
different regions of the protein (Fig 5. 3. 8. B, C, D). However, in the case of sLex, such 
outcomes were statistically rare, their binding regions did not overlap with each other and 
they were treated as outliers and not studied in any more detail.  
Docking experiments on sLex showed that there are many possible outcomes of the docking 
algorithms that are energetically similar to one another and that it may be difficult to 
distinguish between these candidate conformations without the help of experimental data. 
As such data for the fCS-selectin interaction is very scarce, it may not be possible to determine 
the exact binding site and carbohydrate conformation with confidence. However, MD 
simulations could be used to test the stability of the proposed binding modes and to use this 










5. 3. 1. 3. MD study of the X-ray structures of sLex-E-selectin complex 
 
For comparison, the sLex-E-selectin complex from PDB entry 1G1T was also minimised and 
simulated for 50 ns using the same protocol as for the docked complex. This experiment 
allowed to study the stability and dynamic behaviour of the complex obtained in the X-ray 
experiments and compare it to the docked sLex-E-selectin complex.  
Protein-ligand interactions reported in the X-ray studies were monitored over the course of 
the MD simulation. Fucose interactions with the Ca2+ ion proved to be very stable, with only 
slight oscillations of less than 0.5 Å. The distances between the Ca2+ ion and FucO3 and O4 
both maintained the average value of 2.75 Å. The sLex-Ca2+ interaction was stabilised by H-
bonding interactions between fucose and Glu107 (average of 2.45 Å) and Asn105 (2.82 Å). 
Arg97 maintained a stable interaction with the carboxyl group of sialic acid of the mean value 
of 2.79 Å and Tyr94 maintained a weak electrostatic interaction with GalO4 (3.83 Å). These 
results showed that several intermolecular interactions remained viable throughout the full 
duration of the simulation. However, the remaining interactions identified in the X-ray 
studies dissociated within the first 2 ns of the simulation. 
RMSD over the 50 ns simulation was calculated with respect to the lowest energy structure. 
Although the overall RMSD remained stable throughout the majority of the simulation 
(average value of 1.94 Å), a sudden change of close to 2 Å occurred just before 40 ns. The 
RMSD was unstable after this point, returning to the initial level towards the end of the 
simulation. RMSD contributions of sLex and the E-selectin were also calculated and allowed 
to establish that the changes in RMSD by the end of the simulation must correspond to 
conformational changes within the protein (Fig. 5. 3. 9. A).  
This sudden change in the value of RMSD was correlated to a conformational change in the 
interdomain hinge of E-selectin. For the first 37 ns of the simulation, the C-type lectin and the 
EGF-like domains maintained the so-called ‘bent’ conformation, with the interdomain angle 
of approximately 115 - 120°. At 39 ns, this angle began to increase, as the EGF-like domain 
rotated away from the lectin domain, to reach a value of 154° at 45 ns (Fig. 5. 3. 9. B). This 
value of the interdomain angle is consistent with the literature reports of the so-called 
‘extended’ conformation in the X-ray and MD studies on E-selectin67. After 45 ns, the EGF-like 
domain started to rotate back towards the lectin domain, returning to the initial ‘bent’ 
conformation. It is noteworthy that the switch between the bent and extended conformations 
has been linked in literature to the change in orientation of the loop 81-89 and believed to 




not switch to the position reported in the literature at any point of the simulation and no 
correlation was observed between the interdomain movement and the stability of protein-
ligand interactions. 
Fig. 5. 3. 9. MD simulation of the sLex-E-selectin complex from the X-ray structure 1G1T. 
A. RMSD plot over 50 ns MD simulation for individual E-selectin (blue) and sLex (green) 
contributions. B. Ribbon representation of E-selectin at 0 ns (yellow) and 40 ns (purple) into the 
simulation. Transition between the bent and extended conformations can be observed. No 
rearrangement is observed in the loop 81 – 89, previously implied to play a role in conformational 
switch between bent and extended conformations. 
 
 
The binding free energy was also calculated for the X-ray 1G1T complex, using the same 
protocol as for the docked complex. However, in this case ΔGbind had a positive value of 4.5 ± 
0.3 kcal mol-1. It is surprising that the value is positive, since positive free binding energy 
values are normally indicative of the complex being unfavourable in vivo. However, it has to 
be emphasised that this is only a predicted value, based on the molecular force fields and 




interactions are inherently weak and, therefore they may be difficult to predict with the use 
of existing MD force fields, more suitable for studies on stronger-affinity complexes. The MM-
PBSA calculations also suffer from inaccuracies in prediction of the entropy contributions, 
which may cause the ΔGbind values to be overestimated169,173. Therefore, the calculated value 
of ΔGbind is only an estimate and it cannot be treated as an accurate measure of the free 
binding energy. However, as the same protein-ligand combination is used, the values of ΔGbind 
can be compared to provide an indication of relative stability of each complex. 
1G1T is not the only available X-ray structure of the sLex-E-selectin complex, though it is the 
highest resolution structure available to date. In a more recent study by Preston et al., X-ray 
structure of a larger E-selectin construct, in complex with sLex, was obtained (PDB entry 
4CSY)67. In this study, the ligand was co-crystallised with the protein, rather than soaked into 
protein crystals, which means that this structure may be a more accurate representation of 
the actual conformational state of the protein upon interaction with sLex. The main difference 
when compared to the previous structure, is that the E-selectin is present in an extended 
conformation, with interdomain angle of 136°. Another significant difference is the position 
of the loop 81 – 89, which is now pointing upwards, closing in on the Ca2+-coordination site. 
In fact, Glu88 replaces Asn83 as a Ca2+-coordinating residue and forms additional interaction 
with the fucose residue. The interdomain interactions are weakened in this state, as the EGF-
like domain is rotated away from the lectin domain, and small rearrangements are observed 
in the loops across both domains. It has been speculated that such changes can lead to 
increased affinity for the sLex ligand. To test this hypothesis and compare the dynamic 
behaviour of the two structures, a 60 ns MD simulation was performed on this complex using 
the same methods as in the previous experiments. 
The energy of the system remained stable and the RMSD measured for the carbohydrate also 
remained stable throughout the simulation, with the mean value of 1.06 Å with respect to the 
lowest energy structure (Fig. 5. 3. 10. A). The RMSD for E-selectin underwent large 
fluctuations over the first 25 ns of the simulation. However, just before 30 ns, the RMSD 
values stabilised at the mean value of 1.87 Å and remained stable for the rest of the 
simulation (Fig. 5. 3. 10. A). Further analysis allowed to establish that the fluctuations 
observed in the first half of the simulation correlated with the movement of the EGF-like 
domain. Against expectations, the EGF-like domain did not move towards the lectin domain 
to achieve the bent conformational state, but rotated away from the lectin domain to face the 
opposite site of the protein, in what could be called a ‘hyper-extended’ state (Fig. 5. 3. 10. B). 
This rotation of 50° occurred along a different axis than the opening from the bent to 




tail to the opposite site of the protein than in the bent conformation. In this new 
conformational state, all residues previously involved in the interactions with the lectin 
domain, except for Glu135, have moved away from the protein’s N-terminus and a new set of 
interactions has developed between residues Ser2 – Tyr3 of the N-terminal β-sheet and 
residues Thr136 – Asn138 of the EGF-like domain.   
Fig. 5. 3. 10. MD simulation of the sLex-E-selectin complex from structure 4CSY. A. RMSD 
plot for E-selectin (blue) and sLex (green) over a 60 ns MD simulation. B. Ribbon representation 
of E-selectin at 0 ns (yellow) and 60 ns (blue) into the simulation. Bent conformation from 1G1T 
structure is shown for comparison (purple). The interdomain movement occurred just before 20 
ns and, after a few ns of equilibration the protein found a stable conformation. EGF-like domain 
rotated by 50° with respect to its position in the extended conformation to achieve the hyper-
extended state. Highlighted loop 83-89 is positioned closer to the binding site in this structure, 







Such interdomain movement has not been previously reported for selectins or observed in 
MD simulations on any other selectin structure used in this study. As the same methods have 
been applied to study all E-selectin structures, this result suggests that the starting 
conformation used here has features that promote higher flexibility in the interdomain 
region. It remains unclear whether this behaviour is affected by the position of the loop 81 – 
89. The loop did not switch its position throughout the simulation and maintained the 
interaction with the Ca2+ ion and the Fuc2OH group via residue Glu88 (1.76 Å).  
This additional stabilisation from loop 81-89 strengthens the interaction with sLex, making 
it energetically more favourable.  The calculated free binding energy of the interaction for the 
4CSY complex had a value of -22.8 ± 0.3 kcal mol-1, which is significantly lower than the values 
calculated for the complex from X-ray structure 1G1T. Although the initial set of interactions 
was highly similar to those reported in the X-ray structure 1G1T, binding of sLex was more 
stable in the case of 4CSY. The majority of the interactions remained stable for the full length 
of the simulation, providing the ligand with a larger number of stabilising interactions than 
in the case of the MD simulation on 1G1T complex. Again, Ca2+ ion was coordinated by FucO3 
(2.70 Å) and O4 (2.75 Å) and this interaction was further supported by H-bonds to Glu80 
(1.77 Å), Glu107 (1.76 Å), Asn82 (2.52 Å) and Asn105 (2.28 Å). The interaction with Tyr94 
proved to be much stronger in the case of 4CSY complex, with the mean value of 1.98 Å. 
Residue Arg97 maintained a stable interaction with GalO3 (2.16 Å) and the carboxyl group 
of sialic acid (2.71 Å). sLex interactions with Tyr48 and Glu92 were also found to be more 
stable than in the case of 1G1T complex. These findings show that the E-selectin 
conformation from the X-ray structure 4CSY is able to form more stable interactions with the 
sLex tetrasaccharide. 
Oligosaccharide position in the binding site did not undergo any major changes throughout 
the simulation. All dihedral angles remained very stable, indicating that the conformational 
switch in the protein did not affect the sLex conformation in the binding site. Comparison of 
average dihedral angles for the two X-ray structures studied here, along with the docked 












*All measurements were made using the following definition of dihedral angles: ϕ = O5 – C1 
– OX – C’X, ψ = C1 – OX – C’X – C’(X-1).  
 
 
5. 3. 1. 3. Conclusion 
 
In summary, the control study has shown that the computationally produced oligosaccharide 
can be docked to selectin X-ray structures using Autodock Vina and that the docking software 
correctly identified the binding site as the Ca2+-coordination site in the majority of cases. The 
software also correctly predicted some of the residues involved in the binding of sLex. In the 
studied complex, Ca2+ ion was coordinated by the fucose residue and the binding was 
supported by interactions with residues Asn83, Tyr94, Arg97, Asn105 and Glu107 which is 
in agreement with the experimental results. Therefore, it should be possible to use the 
described in silico methods to produce and dock the fCS oligosaccharides to P- and L-selectins 
to predict the location of the binding site and to identify the protein residues that are most 
likely involved in the fCS binding. Nevertheless, docking of sLex to two different E-selectin 
structures produced complexes characterised by many possible sugar orientations. Multiple 
structures had a potential to be stable and, without the support of experimental data, it would 
be difficult to distinguish between the binding candidates and decide which orientation 
would be most likely to occur in nature.   
In this study, MD simulations were used to validate the docking results and to look at the 
dynamics of the binding and the conformational changes within the protein and the ligand. 
The docked complex remained stable throughout the simulation, with no significant changes 
in either protein or oligosaccharide conformation.  Average dihedral angles of the docked 
Glycosidic linkage Dihedral angle Docked complex 1G1T 4CSY 
Galβ1-4GlcNAc 
Φ -99 -69 -82 
Ψ -70 131 135 
Fucα1-3GlcNAc 
Φ -66 -70 -72 
Ψ 94 -95 -93 
Neu5Acβ2-3Gal 
Φ 61 62 57 
Ψ -115 -120 -112 
Table 5. 3. 3. Comparison of average carbohydrate dihedral angles between the X-




sLex were compared to those from the X-ray structures. Large differences in the dihedral 
angles for glycosidic linkages Galβ1⟶4GlcNAc and Fucα1⟶3GlcNAc in the docked complex 
indicate that the proposed binding mode is energetically unfavourable when compared to 
the binding mode observed in the X-ray studies.  
MD simulations undertaken in this study were also used to look at the dynamic behaviour of 
sLex-selectin complexes from the existing X-ray structures. It was established that the 
extended conformation from the structure 4CSY forms more favourable interaction with sLex 
than the bent conformation of structure 1G1T. This is likely due to the difference in position 
of loop 81-89 which in 4CSY forms a stabilising H-bond to fucose via residue Glu88. Further 
analysis showed that the interdomain hinge is characterised by a high degree of flexibility in 
this complex and a new type of EGF-like domain movement was discovered, leading to a 
‘hyper-extended’ conformational state. In this twisting type of movement, the EGF-like 
domain rotated away by 50° from its position in the extended conformation, bringing the C-
terminal tail to the opposite side of the protein and allowing the residues Thr136 – Asn138 
to form contacts to the N-terminal region of the C-type lectin domain.  
The conformation of sLex was in good agreement between the two X-ray structures and did 
not undergo any major changes throughout the MD simulations. The interdomain movement 
did not correlate to any changes in the ligand conformation or in any of the sLex-E-selectin 
interactions. Therefore, this study does not confirm the hypothesis that the conformational 
transition at the interdomain hinge leads to changes in selectin affinity for sLex. 
 
 
5. 3. 2. Docking studies of fCS-selectin interactions 
 
The in silico experiments described in this section aimed to investigate the ability of Autodock 
and MD simulations to predict the binding between fCS oligosaccharides and selectins and to 
shed light on the possible mechanism of binding between fCS trisaccharides and P-selectin. 
fCS trisaccharide variants with 2,4-sulfated and 3,4-sulfated fucose were prepared 
computationally and docked to the available P-selectin structures. The docking results were 
further evaluated with the use of MD simulations, analogous to those undertaken for the sLex 





5. 3. 2. 1. Preparation of the fCS oligosaccharides 
 
fCS oligosaccharides were prepared in GLYCAM Carbohydrate Builder, as described for the 
sLex tetrasaccharide. 2,4S trisaccharide was built using the following formula: 
DGalpNAc[4S,6S]b1-4[LFucp[2,4S]a1-3]DGlcpAb1-OME. Minimisation produced a single file 
that was further minimised in Amber 14 under GLYCAM06 force field. Data from the MD 
simulation was analysed as before. The energy of the system remained very stable 
throughout the 40 ns simulation (sample energy plots are included in Appendix 4). Although 
RMSD values fluctuated slightly, they maintained the average value of 1.66 Å with respect to 
the lowest energy conformation (Fig. 5. 3. 11). Average dihedral angles were measured and 
were found consistent with the values recorded for the corresponding linkages in sLex and 
CS oligosaccharides (Table 5. 3. 4).  
Fig. 5. 3. 11. MD simulation of the fCS 2,4S trisaccharide. A. Lowest energy conformation of 
the fCS 2,4S trisaccharide over a 40 ns simulation. B. Plot of overall RMSD for the fCS 2,4S-
trisaccharide with respect to the lowest energy conformation. 
 
 
*All measurements were made using the following definition of dihedral angles: ϕ = O5 – C1 
– OX – C’X, ψ = C1 – OX – C’X – C’(X-1).  












φ -66.6 ± 0.5 -66.2 ± 0.5 -68.4 ± 0.4 -80 
ψ 129.1 ± 0.3 130.4 ± 0.6 130.9 ± 0.3 110 
Fucα1-3GlcA 
φ -69.3 ± 0.6 -71.9 ± 0.7 -69.0 ± 0.2 N/A 
ψ -94.4 ± 0.2 -95.6 ± 0.3 -96.0 ± 0.3 N/A 
Table 5. 3. 4. Average dihedral angles from the 40 ns MD simulation, compared to the 




Oligosaccharide conformations were clustered over the 40 ns period and four most 
frequently occurring conformations were extracted for the docking studies. UCSF Chimera 
Cluster tool identified 398 clusters. The top five clusters were populated by a similar number 
of structures – from 52 structures for the first cluster to 48 for the fifth cluster. The dihedral 
angles between 20 representative conformations from each cluster are compared in Fig. 5. 3. 
12. The representative conformations are highly similar to each other, with only slight 
differences in the values of dihedral angles. Therefore, it is evident that the UCSF Chimera 
clustering tool struggles to distinguish between the highly similar carbohydrate 
conformations as the differences in dihedral angles between the individual conformations 
are very small. Nevertheless, five representative conformations were chosen based on the 












Fig. 5. 3. 12. Distribution of dihedral angles φ and ψ within the simulated fCS 2,4S 
trisaccharide. A. Plot of ψ versus φ for the glycosidic linkages GalNAcβ1→4GlcA (squares) and 
Fucα1→3GlcA (triangles). Five clusters are represented in yellow, red, grey, blue and green for 
Clusters I to V respectively. 20 representatives were chosen at random from each cluster as data 
points for this plot. All measurements were made using the following definition of dihedral angles: 




5. 3. 2. 2. Docking of the fCS 2,4S trisaccharide to P-selectin 
 
The computationally prepared fCS 2,4S trisaccharide was docked to the P-selectin structure 
1G1Q. This structure has been widely studied in literature and was prepared using the same 




comparison could be made between the results of these docking tests and previous results 
on sLex-E-selectin interactions.  
Four conformations of trisaccharide were isolated from MD simulation as described above 
and docked to the P-selectin structure in AutoDock Vina, using the same parameters as for 
the docking of sLex tetrasaccharide to E-selectin. The distribution of the docking results was 
similar to that observed for sLex and E-selectin, with majority of the results (83 %) binding 
at the Ca2+-coordination site (Fig. 5. 3. 13). However, many different possible orientations of 
the fCS trisaccharide in the binding site were identified and not all of them bound to protein 
via Ca2+ ion – in some of the results, oligosaccharide formed interactions with amino acid 
residues on the other side of the binding surface (Fig. 5. 3. 13. B, D). As time and 
computational resources were limited, it was not possible to analyse all of the returned 
results in detail by MD and selection criteria had to be established to identify the most 
promising candidate complexes.  
Fig. 5. 3.13. Docking results for four different conformations of fCS 2,4S trisaccharide. 
Four representative conformations of fCS 2,4S trisaccharide were docked to P-selectin structure 
1G1Q. Nine structures returned by Autodock Vina are superimposed for each docking experiment 
in A – D (input conformation I – IV, respectively). The protein is shown in a surface representation, 




The first criterion to be considered was the interaction with Ca2+ ion. Due to the fact that fCS 
binding has been shown to inhibit selectin binding to sLex, it is likely that it blocks selectin 
interaction with native ligands by competitive binding at the Ca2+-coordination site42. 
Moreover, fCS trisaccharide structurally resembles the sLex tetrasaccharide, adopting similar 
3D conformation which could allow it to mimic sLex and to bind to selectins in analogous 
manner. For this reason, the first step in selection process was to identify the docked 
complexes where the ligand interacts with the protein by coordinating the calcium ion. That 
allowed to eliminate close to 50% of the docking results. 
The second selection criterion focused on the trisaccharide orientation within the binding 
site. Previous studies have shown that the unique biological activity of fCS relies on the 
presence of its fucose branches and the sulfate modifications30,42,50. Therefore, it is most 
likely that fucose will be directly involved in selectin binding and that sulfate groups will 
contribute to the binding by forming electrostatic interactions with the positively charged 
protein residues or by hydrogen bonding to polar amino acid side chains or protein 
backbone. Following on the hypothesis that the fCS trisaccharide unit binds to selectins in a 
manner similar to sLex determinant, it is likely that its interaction with the Ca2+-coordination 
site would also occur via fucose residue. The STD NMR studies described in the previous 
chapter have confirmed that fucose is positioned close to the protein surface in fCS-selectin 
complexes, with the methyl group showing high response in the STD difference spectra. 
Based on this information, docking results with fucose located close to the protein surface 
and directly involved in the interaction with the protein were ranked above other results. 
Moreover, preference was given to the results where the Ca2+ ion was coordinated by fucose. 
Use of the above selection criteria allowed to reduce the number of candidate binding 
structures from thirty-six to four. These four results were further evaluated by 15 ns MD 
simulations to assess the stability and dynamic behaviour of the produced complexes. Two 
of the structures dissociated during the simulation, leaving only two complexes that could be 
analysed in more detail. These complexes underwent further 15 ns simulation and their 








5. 3. 2. 3. MD analysis of fCS 2,4S trisaccharide-P-selectin complexes 
 
The first complex (complex I) was characterised by a large number of H-bonding interactions 
between the protein and the trisaccharide ligand. The initial set of interactions involved 
residues Tyr48 (2.00 Å), Asn82 (3.00 Å), Ser97 (2.98 Å), Ser99 (1.80 Å), Lys111 (1.77 Å) and 
Lys113 (1.88 Å) (Fig. 5. 3. 14). Calcium in this complex was coordinated by the Fuc 2SO3 
group and this interaction remained stable throughout the 30 ns MD simulation, with the 
average distance of 2.67 Å. H-bonding interaction between Fuc 2SO3 group and residue 
Asn82 also remained stable, with the average distance of 3.24 Å. A weak interaction between 
Fuc 4SO3 and Arg85 developed within the first nanosecond and was maintained until the end 
of the simulation (3.67 Å). However, all the remaining interactions were broken within the 
first 15 ns and by the end of the simulation the complex was close to dissociation. 
Fig. 5. 3. 14. Structural representation of complex I as predicted by AutoDock. Ribbon 
representation of P-selectin complexed to the fCS 2,4S trisaccharide. Complex I was one of the 
highly ranked results from the docking tests. However, the interactions in this complex weakened 
significantly during the 30 ns MD simulation. Protein is shown in blue, with the interacting 
residues highlighted in orange. Carbohydrate residues are shown in light grey. 
 
 
The overall RMSD remained stable for the first 25 ns of the simulation, with a mean value of 
1.97 Å with respect to the lowest energy conformation. In the last 5 ns, however, RMSD 
suddenly increased, maintaining the mean value of 2.97 Å for the rest of the simulation. When 




more dramatic for the trisaccharide than for the protein – increasing from the mean value of 
1.37 Å over the first 25 ns to 3.47 Å over the last 5 ns of the simulation (Fig. 5. 3. 15).  
Fig. 5. 3. 15. RMSD plots from the 30 ns MD simulation of complex I. RMSD plots with 
respect to the lowest energy conformation for the fCS 2,4S trisaccharide (green) and P-selectin 
(blue) over a 30 ns MD simulation. A large change in the RMSD values can be observed in the final 
5 ns of the simulation.  
 
 
This change in RMSD values was correlated to the dramatic change in trisaccharide 
orientation in the binding site, leading to dissociation of the GalNAc and GlcA residues from 
the protein surface. After further analysis, it was linked to the change in dihedral angle ψ for 
glycosidic linkage Fucα1⟶3GlcA (Fig. 5. 3. 16).  
Fig. 5. 3. 16. Changes in dihedral angle ψ for the glycosidic linkage Fucα1-3GlcA. Plot 
from a 30 ns MD simulation of complex I, showing changes in dihedral angle ψ for the glycosidic 
linkage Fucα1-3GlcA. These changes correlate with the changes in RMSD observed for the fCS 




Over the first 25 ns of the simulation, the value of ψ was very high (mean value of 69°) when 
compared to the value observed for the free fCS 2,4S trisaccharide (-94°). At 25 ns, a sudden 
change occurred as the value of ψ dropped to -94°, which is in agreement with the average 
value for the free trisaccharide. Such behaviour indicates that the native conformation of the 
fCS trisaccharide was significantly altered upon docking to P-selectin and that the return to 
its equilibrium conformation causes weakening of P-selectin-fCS interactions in this case. It 
was also noted that the average value of the dihedral angle ψ for the glycosidic linkage 
GalNAcβ1⟶4GlcA was largely different from the average angle measured for the free 
trisaccharide (-63° vs 129°) (see Appendix 6).  Taken together, these results indicate that 
complex I is not likely to be a good model for the fCS-P-selectin interactions. 
In the second fCS 2,4S trisaccharide-P-selectin complex tested by MD (complex II), Ca2+ ion 
was coordinated by the GalNAc 4SO3 group (mean distance of 2.67 Å) (Fig. 5. 3. 17). This 
interaction was further stabilised by H-bonds between GalNAc 4SO3 and Asn105 (2.19 Å), 
GalNAc O5 and Tyr94 (3.29 Å) and GalNAc CO and Lys111 (2.77 Å). In the complex returned 
by Autodock, fucose formed multiple H-bonds to Lys111, Lys113 and Ser46. However, only 
interaction between Fuc 2SO3 and Lys113 proved to be stable throughout the full duration of 
the simulation, with a mean distance of 3.07 Å. Glucuronic acid maintained interactions with 
Tyr48 (1.87 Å) and Ser97 (3.77 Å) via its carboxyl group.  
Fig. 5. 3. 17. Complex II between the fCS 2,4S trisaccharide and P-selectin. Ribbon 
representation of the second P-selectin-fCS trisaccharide complex, also returned by AutoDock 
Vina in the docking experiments. Protein is shown in blue, with the interacting residues 






Interestingly, a few of the protein residues involved in the fCS binding in this complex were 
directly involved in the interactions with fCS trisaccharide in complex I, despite the 
differences in the carbohydrate orientation. Such result suggests that, although AutoDock 
may struggle with correctly identifying the orientation of the trisaccharide in the binding site, 
it recognises a set of residues within the binding site that are most likely involved in the fCS 
trisaccharide binding. Indeed, residues Tyr48, Tyr94, Asn105 and Lys111 are the same 
residues that support sLex binding by E-selectin and Ser97 acts as a replacement for Arg97 
which also mediates the E-selectin-sLex interaction (see Section 5. 3. 1). 
Complex II remained stable throughout the 30 ns MD simulation, maintaining many of the 
interactions predicted by the docking software. The overall RMSD oscillated around the mean 
value of 1.86 Å with respect to the lowest energy structure. fCS had a lower average RMSD 
value (0.98 Å) than the protein (1.88 Å) and smaller changes in RMSD over time (Fig. 5. 3. 
18). As the RMSD fluctuations for both the protein and sugar were relatively small, no major 
conformational changes occurred in either molecule during the 30 ns simulation.  
Fig. 5. 3. 18. RMSD plots from MD simulation of Complex II. RMSD plot for the fCS 2,4S 
trisaccharide (green) and P-selectin (blue) over a 30 ns MD simulation. Unlike in the case of 




This finding was confirmed by the analysis of changes in dihedral angles over time. None of 
the angles underwent any major changes during the simulation, confirming that the fCS 
trisaccharide maintained a single stable conformation. However, their average values 
differed significantly from those recorded for the free trisaccharide during MD equilibration 




a value of 58°, compared to -94° for the unbound trisaccharide and ψ for the linkage 
GalNAcβ1⟶4GlcA had a value of -72°, compared to 129° for the unbound trisaccharide. This 
large variation in the values of dihedral angles indicates that the proposed mode of binding 
would involve substantial reorientation of the equilibrium conformation of the fCS 
trisaccharide and thus it may not be favourable in vivo.  
In agreement with the STD NMR experiments, GalNAc residue played an important role in 
the binding, forming multiple interactions to amino acid residues and with the acetyl group 
positioned close to the P-selectin surface. Fucose also remained close to the protein surface 
throughout the simulation. However, fucose methyl group was pointing away from the 
protein which contradicts the results obtained in the STD NMR experiments.  
Free binding energy was also calculated for both complexes. Complex II was found to have 
ΔGbind of a value of -0.2 ± 0.4 kcal mol-1, lower than the value of 10.4 ± 0.3 kcal mol-1 calculated 
for complex I. Both values are relatively high which may indicate weak binding for the two 
proposed complexes, with a thermodynamic preference towards complex II. Nevertheless, it 
is important to note again that the MM-PBSA free energy calculation is not an accurate 
measure of free binding energy for all systems and can only be taken as a rough estimate and 
not as a reliable measure of the stability of each complex.  
Taken together, the above results suggest that the obtained complexes must be treated with 
caution. It is possible that the amino acid residues implicated in the binding by Autodock Vina 
do contribute to fCS 2,4S trisaccharide binding by P-selectin in vivo. However, the orientation 
and conformation of the 2,4S trisaccharide are likely different from those proposed by the 
docking studies, based on the structural and energetic analysis of the MD data.  
For comparison, two of the trisaccharide conformers were docked to P-selectin structure 
from the PDB entry 1G1S. This structure was produced using the same methods as for the 
entry 1G1Q, however, in 1G1S P-selectin was crystallised when complexed with PSGL-1 (see 
Section 1. 3. 3.). The important difference between the two P-selectin structures is that in the 
1G1Q entry the protein is present in bent conformation, whilst in the 1G1S entry it exists in 
the extended conformation. As selectin conformation significantly affected the docking 
results in the study on sLex-E-selectin binding, it was thought that a similar effect could be 
observed in the docking of fCS oligosaccharides to P-selectin. 
PSGL-1 was removed from the PDB structure and the fCS trisaccharides were docked as 
previously described. This time, trisaccharide bound to P-selectin via the Ca2+-coordination 




results, five of the eighteen complexes were identified as suitable for further analysis. After 
a 15-ns MD simulation, two of the complexes dissociated, leaving only three binding options. 
One complex did not dissociate but, after 15 ns, fCS trisaccharide was no longer bound via 
Ca2+ ion. The remaining two complexes were simulated for another 15 ns, however, the 
binding weakened significantly throughout the simulation and, in both cases, fucose residue 
moved away from the protein and did not participate in the binding for most of the 
simulation.  
These results suggest that, although the initial docking results for P-selectin structure 1G1S 
are more consistent and structurally more promising than upon docking to 1G1Q, the 
returned complexes are not stable enough to withstand MD simulation longer than 15 ns and 
do not provide much insight into the fCS-P-selectin binding. Therefore, unlike in the case of 
sLex binding to E-selectin, the extended conformation of the protein did not improve the 
overall outcome of the docking experiments. It is possible that fCS trisaccharide binds to P-
selectin in a different manner to sLex and that the selection criteria may need to be changed 
to obtain a more stable complex. Moreover, alternative starting conformations of the 
trisaccharide or the protein may need to be explored to improve the docking results. 
However, due to the time restrictions, it was not possible to investigate such further options 
in this project. 
 
 
5. 3. 2. 4. Docking of the fCS 3,4S trisaccharide to P-selectin 
 
After the docking tests on 2,4S trisaccharide, a similar study was performed where 3,4S fCS 
trisaccharide was docked to P-selectin structure 1G1Q. Two representative conformations 
from the UCSF Chimera cluster analysis were used in the docking experiments. In 50 % of the 
results fCS bound to protein at the Ca2+-coordination site, which is a smaller proportion than 
in the case of 2,4S trisaccharide. In 50 % of the results fCS bound in alternative regions of the 
protein, either within the C-type lectin domain or at the interdomain hinge (Fig. 5 3. 19). 
These alternative binding regions were not considered in this study – only the complexes 





Fig. 5. 3.19. Docking results for two different conformations of fCS 3,4S trisaccharide. 
Two representative conformations of fCS 3,4S trisaccharide were docked to P-selectin structure 
1G1Q. Nine structures returned by Autodock Vina are superimposed for each docking experiment 
for conformation I (A) and II (B). The protein is shown in a surface representation, with positively 
charged residues highlighted in blue and negatively charged residues – in red. 
 
 
Only in two of the complexes fucose residue was directly involved in the binding and it is 
these two results that were further tested by MD simulations. Both complexes remained 
stable throughout the initial set of tests (25 ns) and interacted with the protein via a similar 
set of amino acid residues, with fucose playing a key role in the binding. As the interactions 
in these complexes after the 25 ns simulation were promising, it was decided that one of the 
complexes would be studied by a longer (100 ns) simulation. Due to the computational 
limitations, only the complex that was calculated to have a slightly lower value of ΔGbind (11.9 
± 0.3 vs. 13.3 ± 0.4 kcal mol-1) was further studied by MD. This complex will be referred to as 
complex III. 
Although the energy remained stable throughout the full duration of the simulation, overall 
RMSD for complex III showed a large drop from the mean value of 4.91 Å to 2.15 Å just after 
65 ns into the simulation. When the RMSD for P-selectin and the fCS was measured 
separately, it was established that the main contribution to this change comes from the 
conformational changes within the protein (Fig. 5. 3. 20). RMSD plot for the fCS shows a 





Fig. 5. 3. 20. RMSD plots from MD simulation of Complex III. RMSD plot for the fCS 3,4S 
trisaccharide (green) and P-selectin (blue) with respect to the lowest energy structure over a 100 
ns MD simulation. Conformational changes within the sugar and the protein occur at 30 ns and 
65 ns into the simulation, respectively. 
 
 
The sudden drop in the protein RMSD was correlated to the interdomain movement in the 
hinge region, similar to that observed for E-selectin in the earlier study on sLex-1G1T 
complex (Section 5. 3. 1. 3.). The interdomain angle changed dramatically, from 109° at 60 ns 
to 135° at 65 ns, corresponding to conformational transition from the bent to extended state. 
This observation indicates that it is possible for P-selectin to undergo conformational change 
between these two states when bound to the 3,4S fCS trisaccharide. It can also be seen that 
the interdomain movement in P-selectin did not cause any rearrangement in the 
carbohydrate structure. 
The sudden change in the RMSD for the trisaccharide at 30 ns indicates that the fCS also 
experienced a conformational change during the simulation. Indeed, when the carbohydrate 
dihedral angles were plotted over time, a large drop in dihedral angle ϕ for the linkage 
GalNAcβ1⟶4GlcA was observed at 30 ns (Fig. 5. 3. 21). The mean value for this angle over 
the first 30 ns was 19.4°. After the conformational change has occurred, the mean value 







Fig. 5. 3. 21. Changes in dihedral angle ϕ for the glycosidic linkage GalNAcβ1-4GlcA. 
Plot from a 100 ns MD simulation of complex III, showing changes in dihedral angle ϕ for the 
glycosidic linkage GalNAcβ1-4GlcA. These changes correlate with the changes in RMSD observed 
for the fCS trisaccharide in Fig. 5. 3. 20. 
 
 
Interestingly, after this change, the average dihedral angles measured for the fCS 3,4S 
trisaccharide in complex with P-selectin were close to those recorded for the unbound 3,4S 
trisaccharide. This is in contrast to the analysed fCS 2,4S trisaccharide-P-selectin complexes 
where the dihedral angles for the bound carbohydrate differed significantly from those 
measured for the free trisaccharide. This observation suggests that complex III may be a 
better model of the interactions occurring in nature, as it would not require such a large 
rearrangement of the equilibrium structure of the fCS trisaccharide. 
The interactions in complex III involved similar amino acid residues as in the case of fCS 2,4S 
trisaccharide-P-selectin complexes. Many of these interactions were maintained by the 
fucose residue which also coordinated the Ca2+ ion with its sulfate groups. In the complex 
returned by Autodock Vina this coordination occurred via Fuc 4SO3 group. However, within 
the first nanosecond of the MD simulation this group was replaced by the Fuc 3SO3 group 
which coordinated the Ca2+ ion for the rest of the simulation with the mean distance of         
2.68 Å. Other interactions identified by the docking software involved residues Tyr48, Asn82, 
Glu92, Tyr94, Ser97, Ser99, Asn105, Lys111 and Lys113 (Fig. 5. 3. 22. A). However, the 
majority of these interactions were broken 30 ns into the simulation, when the trisaccharide 
underwent the conformational change. From this point onwards, GalNAc and GlcA were 




protein residues. Only fucose remained firmly attached to the protein, anchoring the sugar 
to the Ca2+-coordination site. Fuc 3SO3 maintained its interaction with Asn82 (mean distance 
of 3.50 Å), Fuc 2OH formed a stable H-bonding interaction with residue Glu80 (1.78 Å), Fuc 
O4 – with Tyr94 (3.28 Å) and Asn105 (3.06 Å), and Fuc 4SO3 maintained electrostatic 
interactions with Lys111 (3.84 Å and 3.88 Å) (Fig. 5. 3. 22. B).   
Fig. 5. 3. 22. Initial (A) and final (B) set of interactions for Complex III. Ribbon 
representation of P-selectin 1G1Q structure bound to fCS 3,4S trisaccharide at the start of the MD 
simulation (A) and after 100 ns of the simulation (B). Protein is shown in blue, with the interacting 
residues highlighted in orange. Carbohydrate residues are shown in light grey. 
 
 
As can be seen from the comparison of the initial and final interactions, the binding weakened 




remained bound to the P-selectin for the full 100 ns which indicates that the interactions 
between fucose and P-selectin are strong in this complex. Additional MD simulation was 
performed, using different starting coordinates to further investigate the stability of this 
complex. Again, the complex remained stable for 100 ns and the fucose residue played a 
crucial role in the interaction. Interestingly, identical conformational change occurred in the 
carbohydrate at 80 ns of the second MD simulation, again leading to partial dissociation of 
the fCS from the protein surface. Therefore, although the initial set of interactions seems 
stable, withstanding 30 ns and 80 ns in two separate MD simulations, these interactions are 
not strong enough to balance out the thermodynamic drive for the equilibrium conformation 
of the fCS trisaccharide.  
The fact that the fucose residue played an important role in the P-selectin binding and that 
both Fuc CH3 group and Fuc H1 remained in close contact with the protein surface is in 
agreement with the results from STD NMR experiments (Section 4. 3. 4.). However, it is 
important to note that there were differences between the docked complex and the 
experimental results – GalNAc residue has dissociated from the protein after the first 30 ns 
and its CH3 group did not maintain contacts with the P-selectin surface. GlcA residue also 
moved away from the protein at 30 ns which means that fucose was the only carbohydrate 
residue involved in the binding for the majority of the simulation. This is unlikely to be the 
case in nature and the STD experiments clearly showed that both GalNAc and GlcA residues 
maintain contacts with P-selectin surface. Therefore, the complex presented here can only 
partially reflect the interactions occurring in vivo. It is possible that the true set of 
interactions is similar to the one observed in the beginning of the MD simulation. However, 
the conformation of the fCS trisaccharide would need to be different to the one proposed by 
Autodock in order to maintain these interactions for a longer time. 
 
 
5. 3. 2. 5. Docking of the fCS trisaccharide - conclusions 
 
In summary, in the above in silico studies on the fCS trisaccharide-P-selectin interactions, 
Autodock Vina was used to explore the potential binding sites and conformations for two 
types of fCS trisaccharides – with fucose either 2,4 or 3,4-sulfated. These trisaccharides were 





The docking studies showed that Autodock Vina predicts that the fCS trisaccharide binds to 
the Ca2+-coordination site in 83 % of cases for the 2,4S trisaccharide and in 50 % of cases for 
the 3,4S trisaccharide. However, only in a small proportion of all results, the binding is 
consistent with the STD NMR experimental results and the current knowledge on selectin-
ligand binding. In this study, only the docked complexes that fulfilled the selection criteria 
underwent further analysis. It is possible that in future studies, the alternative binding 
options may also need to be considered. 
The complete analysis by MD was performed on three complexes: two for 2,4S trisaccharide 
(complexes I and II) and one for 3,4S trisaccharide (complex III). Complexes I and II 
underwent a 30 ns MD simulation during which complex II proved to be more stable, 
maintaining the fCS-P-selectin interactions. However, the carbohydrate dihedral angles in 
this complex were largely different from those reported for the unbound 2,4S trisaccharide. 
Complex III proved to be very stable during the initial 25 ns simulation and was further 
studied by 100 ns MD simulation. During the longer MD simulation, the fCS trisaccharide 
underwent a conformational change as the value of dihedral angle ϕ for glycosidic linkage 
GalNAcβ1⟶4GlcA dropped to the equilibrium value for the unbound fCS. Following this 
conformational change, the GalNAc and GlcA residues dissociated from the protein and the 
interactions were only maintained by the Fuc residue. Although the interactions with fucose 
were very stable, the proposed conformation of fCS trisaccharide in this complex is not 
energetically favourable. 
Structural and energetic analysis of these three complexes led to a conclusion that Autodock 
Vina has a difficulty in predicting a stable carbohydrate conformation during the docking. 
Therefore, the proposed complexes provide only partial information on the true nature of 
fCS-selectin binding and the true trisaccharide conformation upon binding is likely to be 
different to that proposed in the above docking studies. However, the docking results were 
consistent in their prediction of the amino acid residues that participate in the fCS binding. 
The residues that were repetitively found to form H-bonding interactions with the fCS 
trisaccharide were: Tyr48, Glu80, Asn82, Asn83, Tyr94, Ser97, Asn105 and Lys111. 
Comparison to existing X-ray structures for selectin-sLex complexes show that some of these 
residues participate in selectin interaction with sLex. It can therefore be said with confidence 
that a subset of these residues is involved in the fCS trisaccharide-P-selectin interactions in 
vivo. Further experimental data would be needed to develop better computational models 





Overall, the in silico studies of the interactions between the fCS oligosaccharides and P-
selectin provided useful information on the nature of the binding and conformational 
behaviour of both the protein and the fCS ligands. However, it is clear that Autodock Vina 
struggles to predict the conformation of fCS trisaccharides in the binding site. It is not 
surprising, as this docking software is optimised for docking of small ligands, with minimal 
number of rotatable bonds. If the docking experiments were to be continued in future, it 
would be necessary to explore the use of a different docking software, more suited for 
performing calculations on carbohydrate ligands or to alter the docking parameters, for 
example by reducing the number of rotatable bonds. Finally, the MD studies would provide 
the most useful information if complementary experimental data was obtained to allow for 





























Chapter 6: Development of GFT NMR 







NMR is one of the greatest and most commonly used techniques for structural studies on 
small, as well as large molecules and is commonly used for elucidation of carbohydrate 
structure and conformation. Many literature reviews on carbohydrate studies by NMR have 
been published and it is not within the scope of this thesis to comment on all available 
techniques. Typically, a combination of 1D and 2D NMR experiments is used to assign the 
chemical shifts to individual atoms within each carbohydrate ring and to establish the 
connectivity between the rings175-178. For example, a combination of 2D 1H, 13C HSQC, 2D 
HSQC-TOCSY and HMBC experiments can be used to determine the connectivity between 
atoms177,179,180. A good starting point for such assignment is the anomeric region of the 
spectra which is well separated from other signals. This region allows to estimate the number 
of carbohydrate species in the sample and often allows to find correlations with other signals 
within each carbohydrate ring. Further connections can be found by ‘walking’ along the 
carbohydrate chain, following the correlations between individual protons and carbons both 
within one ring and between two connected rings (HMBC)177,180. Other methods, such as NOE 
experiments, can provide information about the inter-residual linkages and spatial 
conformation of the oligosaccharides175,181,182. 
Despite the large array of available mono- and multidimensional NMR experiments, 
determination of carbohydrate structure for oligosaccharides still poses many challenges. 
Carbohydrate subunits are structurally highly similar to one another. The differences 
between the individual oligosaccharide chains can be very small, based only on 
stereochemistry, different pattern of modifications along the carbohydrate rings or 
connectivity between the individual residues. For this reason, chemical shifts of 
oligosaccharides are often overlapped and structural elucidation by NMR can become 
difficult. Moreover, most oligosaccharide samples extracted from natural sources are 




oligosaccharides with overlapping signals, adding another level of complexity to the NMR 
spectra. In many cases, traditional 2D NMR methods are not sufficient to allow to assign the 
signals and determine the structure of oligosaccharide chains with confidence. 
In the 1H dimension, most carbohydrate signals are clustered between ~3.4 – 4.0 ppm. In 
order to correctly assign the networks of coupled spins using heteronuclear 2D experiments, 
it is necessary that the signals are well separated in the 13C dimension. This can be 
problematic in the complex carbohydrate samples, where many species of similar structure 
are present, such as the depolymerised fCS samples. In such samples, small variations in 1H 
and 13C chemical shifts cause clusters of cross peaks to appear on the 2D spectra with high 
overlap in both dimensions. In some cases, such overlap could be resolved by the use of a 3D 
HSQC-TOCSY experiment183. However, acquisition of such an experiment requires long 
experimental time and the resulting spectra are characterised by reduced resolution. 
Therefore, 3D experiments offer limited help and are often not practical. A more suitable 
solution might be to use a modified 2D experiment where the signals are separated from each 
other in the 13C dimension by a factor originating from the difference in 1H chemical shifts. 
Such approach is used in the G-matrix Fourier Transform (GFT) NMR spectroscopy – a 
technique which allows rapid sampling of multidimensional data184. In GFT NMR 
experiments, two or more frequencies are sampled simultaneously by co-incrementing 
corresponding delays in the radio-frequency pulse sequence – for example, in HSQC-TOCSY 
experiment mentioned above, 1H and 13C chemical shifts are sampled at the same time. Such 
experiment is referred to as a (3,2)D HSQC-TOCSY, as it allows to acquire high-resolution 3D 
spectral data in a 2D experiment, allowing to reduce the dimensionality and experimental 
time. Data which would normally form a 3rd dimension in a 3D NMR experiment is now 
encoded within the 2D spectrum, causing splitting of each peak into two peaks. The two 
resulting peaks are separated from each other by a factor of the corresponding chemical shift 
from the 3rd dimension (Ω3) (Fig. 6. 1. 1)184,185. 
Fig. 6. 1. 1. Schematic representation of the main principle of GFT experiments. 
GFT experiments allow to reduce the dimensionality of NMR experiments. Data which would 
otherwise be acquired as a separate dimension in GFT is encoded within the 2D NMR spectrum, 




(3,2)D HSQC-TOCSY was previously implemented in the metabolomics studies by 
Pudakalakatti et al.186. In this study, two (3,2)D HSQC-TOCSY spectra were produced – in one 
of them the frequencies in the indirectly detected dimension were offset by +Ω1H, whilst in 
the second spectrum – by - Ω1H (Fig. 6. 1. 2). Using this approach, it was possible to separate 
some of the signals, otherwise overlapped in 13C dimension. 
Fig. 6. 1. 2. An illustration of the overlap in 2D HSQC-TOCSY spectrum, resolved by a 
GFT (3,2)D HSQC-TOCSY experiment. A Schematic representation illustrating the principle of 
the (3,2)D HSQC-TOCSY experiment. The overlapping signals with 13C frequencies i ad j can be 
separated by linear combinations of corresponding 1H and 13C. B Spectral overlap of two spin 
systems (Lys and Met) in a conventional HSQC-TOCSY experiment on a sample of 21 metabolites 




In the study undertaken here, a (3,2)D 1H, 13C HSQC-TOCSY experiment was implemented in 
which a modulation of cross peaks in the indirectly detected dimension (F1) due to proton-
proton couplings was removed. Such modulation is inherent to a regular (3,2)D 1H, 13C HSQC-
TOCSY experiment and its removal produces high-resolution singlets in the F1 dimension, 
which makes it a suitable tool for analysis of complex samples with clusters of cross peaks. A 
simple manipulation of the original spectra allows to produce two spectra with signals at 
either the Ω13C+Ω1H or Ω13C-Ω1H frequency. This method was tested on a sample of fCS 




6.2. Material and methods 
 
 
6. 2. 1. fCS sample preparation 
 
The fCS polysaccharide was extracted from the body wall of a sea cucumber H. forskali at 
Glycomar Ltd. as previously described55. The sample was depolymerised using a modified 
protocol for β-eliminative depolymerisation of carbohydrate in anhydrous solutions187.  
 
6. 2. 2. NMR spectroscopy 
 
20 mg sample of the produced oligosaccharide mixture was dissolved in 550 µL of D2O 
and measured at 300 K. The (3, 2)D 1H, 13C HSQC and (3, 2)D 1H, 13C HSQC-TOCSY 
spectra of the fCS mixture were acquired on a 4-channel Avance III 800 MHz Bruker 
spectrometer equipped with a 5 mm TCI CryoProbe with automated matching and 
tuning. The following parameters were used: 2048 and 2048 complex points in t2 and 
t1, respectively, spectral widths of 8 and 130 ppm in F2 and F1, yielding t2 and t1 
acquisition times of 160 and 39.17 ms, respectively. Four scans were acquired for each 
t1 increment using a relaxation time of 1.4 s. The overall acquisition time was 7 hours 
and 47 min (for two interleaved spectra, using 4096 t1 points). A 40 ms mixing time 
for the TOCSY transfer used DIPSI-2 pulse sequence188. A forward linear prediction to 
4096 points was applied in F1. A zero filling to 4096 was applied in F2. A cosine square 
window function was used for apodization prior to Fourier transformation in both 
dimensions. Identical parameters were used to acquire regular 2D 1H, 13C HSQC and 
2D 1H, 13C HSQC-TOCSY spectra (Bruker pulse programs hsqcedetgpsisp2.3 and 







6. 2. 3. Pulse sequence parameters 
 
The following parameters are associated with pulse sequences shown in Fig. 6. 2. 1. 
Narrow and wide filled rectangles represent 90 and 180 pulses, respectively. Open 
rectangles with inclined arrows were 500 s 13C CHIRP pulses, while filled rectangles 
with and inclined arrows were 2 ms composite 13C CHIRP pulses. The delays used 
were, 1 = 0.5/1JCH – p14/2; g =1.2 ms (1 ms gradient and 200 s recovery), 2 = 
0.25/1JCH – g – p14/2; 3 = 0.25/1JCH + g – p14/2 + k*t1(0);  = g + p180 *2* t1(0); 4 = 
0.25/1JCH + p14/4; 5 = 0.25/1JCH – p14/2; 6 = g – 0.78*p90 – DE, where p14 = 500 s, 
p90 and p180 are 90 and 180 1H pulses, k is the scaling factor for 1H frequencies, t1(0) 
is the initial t1 increment, typically 3 s and DE is a pre scan delay (10 s). Unless 
specified otherwise, the pulses were applied from the x axis; 1 = x or y for cosine and 
sine modulated signals, respectively; 2 = 2x, 2(-x); 3 = x; 4 = x, -x; 5 = 2y, 2(-y);  = 
x, 2(-x), x. Phases 3 , 4 and  were increased in a TPPI manner by 180 
simultaneously with t1 incrementation; the real and imaginary points were acquired 
by changing the polarity of the G1 gradient and increasing by 180o the phase 5. 
Gradient G3 was 600 s long, while all other gradients were applied for 1 ms. The 
following relative strength was used: G1 = 80%, G2 = 20.1%, G3 = 11%, G4 = -5% and 
G5 = 7%. Bruker pulse sequences for the 1H, 13C (3,2)D BIRDr,X-HSQC and 1H, 13C (3,2)D 
BIRDr,X-HSQC-TOCSY experiments can be found in Appendices 7 and 8, respectively.    
Fig. 6. 2. 1. Pulse sequences of the two GFT NMR experiments. 
A 1H, 13C (3,2)D BIRDr,X-HSQC. B 1H, 13C (3,2)D BIRDr,X-HSQC-TOCSY. Parameters are described in 




6.3. Results and discussion 
 
 
6. 3. 1. Pulse sequence 
 
Experiments developed in this study were based on a Bruker implementation of 
sensitivity-enhanced 2D 1H-13C HSQC189,190 and 2D 1H-13C HSQC-TOCSY189-191 
experiments and will be referred to as (3,2)D BIRDr,X-HSQC and (3,2)D BIRDr,X-HSQC-
TOCSY. In each of the two experiments, 1H chemical shift is labelled during a variable 
t1 period. The evolution of the proton-proton and proton-carbon couplings is 
suppressed by a central BIRDr,X pulse192,193 (Fig. 6. 2. 2.). This pulse inverts only the 
magnetisation of protons attached to 12C, thus allowing to label the chemical shift Ω1H 
of protons attached to 13C.  
Depending on the phase of the first 90o 1H pulse, the 13C chemical shifts labelled during 
the t1 interval after the transfer of polarisation to carbons, are modulated either by 
cos(21Hkt1) or sin(21Hkt1) frequencies. 1H is the difference between the 1H 
chemical shift and the 1H carrier frequency and k is the scaling factor between the two 
simultaneously incremented indirectly detected periods. As a result, cross peaks in 
(3,2)D BIRDr,X-HSQC-TOCSY spectra appear as in-phase or antiphase doublets centred 
around 13C chemical shifts of the directly bonded  1H-13C pairs and separated by 2k1H 
in F1. This generates k1H dependent displacement of signals. The cosine and sine 
modulated spectra are acquired in an interleaved manner and processed to produce 
two simplified spectra by the addition or subtraction of the original spectra. The 
simplified spectra thus contain only one part of the F1 doublets, each as positive 
signals with increased intensity. They are referred to here as the 13C + 1H and the 
13C - 1H spectrum. The overall theoretical sensitivity of the (3,2)D BIRDr,X-HSQC-
TOCSY experiment is half of that of a regular 2D HSQC-TOCSY experiment. In practise, 
additional signal-to-noise reduction is observed, which can be attributed to the 1JCH 
mismatch and relaxation effects during the BIRDr,X pulse. Overall, signal-to-noise 
reduction of 30-45% was measured for the corresponding cross peaks in the (3,2)D 






6. 3. 2. (3,2)D BIRDr,X-HSQC 
 
A partial 2D BIRDr,X-HSQC spectrum for the studied fCS sample is presented in Fig. 6. 3. 1. As 
can be seen from this figure, 2D HSQC spectra of fCS oligosaccharide mixtures are very 
complex, with many groups of overlapping peaks. For this reason, 2D HSQC-TOCSY 
experiments are normally used to allow to find correlations between individual cross peaks. 
However, many of the signals have the same 13C chemical shift, which hinders the analysis of 
traditional 2D HSQC-TOCSY spectra in such samples.  
 
Fig. 6. 3. 1. Partial (non-anomeric region) 2D 1H, 13C BIRDr,X-HSQC spectrum. 
Traditional 2D HSQC spectrum of the fCS oligosaccharide mixture under study. As the sample 
contains multiple oligosaccharide chains of different lengths and composition, the spectrum 




Although not essential, the (3,2)D BIRDr,X-HSQC experiment helps to identify the position of 
the direct proton-carbon correlation cross peaks in the (3,2)D BIRDr,X-HSQC-TOCSY spectra 




BIRDr,X-HSQC spectrum, overlaid with the traditional 2D HSQC spectrum is presented in Fig. 
































Fig. 6. 3. 2. Overlay of 2D 1H, 13C HSQC spectrum and 1H, 13C (3,2)D BIRDr,X-HSQC 
spectrum. A Complete spectrum of the fCS sample – the 2D HSQC spectrum is shown in red 
and the (3,2)D BIRDr,X-HSQC spectrum is shown in blue. B Expansion of the anomeric region 
of the spectrum. The 2D HSQC spectrum is shown in purple and the two parts of the (3,2)D 




Cross peaks in the F1 dimension of the (3,2)D BIRDr,X-HSQC spectrum are displaced by ±Ω1H 
relative to the cross peaks in a regular HSQC spectrum (k = 1 was used). In this instance, the 
1H carrier frequency was set on the HOD signal, resulting in the cross peaks to the left 
(positive Ω1H) and right (negative Ω1H) of the water signal to swap the direction of the 
displacement. Expansions in the rectangles allow to see how the cross peaks which were 
overlapped in the traditional HSQC spectrum became resolved in the GFT version of this 
experiment (Fig, 6. 3. 2. B). Depending on the local topology of the cross peaks, increased 




6. 3. 2. (3,2)D BIRDr,X-HSQC-TOCSY 
 
In the (3,2)D BIRDr,X-HSQC-TOCSY spectrum cross peaks are displaced from their positions 
in a traditional 2D HSQC-TOCSY experiment in the same manner as in the (3,2)D BIRDr,X-
HSQC spectrum: by either +Ω1H or -Ω1H. A complete (3,2)D BIRDr,X-HSQC-TOCSY spectrum, 

















Fig. 6. 3. 3. Overlay of 2D 1H, 13C HSQC-TOCSY spectrum and 1H, 13C (3,2)D BIRDr,X-HSQC-
TOCSY spectrum. The 2D HSQC-TOCSY spectrum is shown in red and the (3,2)D BIRDr,X-





In order to demonstrate how the GFT experiments can help to resolve some of the 
problematic regions of the carbohydrate spectra, analysis of a fragment of the (3,2)D BIRDr,X-
HSQC-TOCSY spectrum of the fCS oligosaccharide mixture is presented in Fig. 6. 3. 4. Even in 
this small fragment of the spectrum, a large number of peaks can be seen which may initially 
make the analysis difficult. In this figure, three different spectra are overlaid: traditional 2D 
HSQC and 2D HSQC-TOCSY and a (3,2)D BIRDr,X-HSQC-TOCSY. Although there is a large group 
of peaks on the right hand side of the spectrum, corresponding to the direct and TOCSY cross 
peaks for H5/H6 of GalNAc, this group of peaks will be ignored for the purpose of this 
discussion. Peaks of special interest here are the four groups of cross peaks shown in pink 
that resonate at ~66.5 ppm in F1, located between the two pink arrows. These peaks are 
direct correlation cross peaks from a 2D HSQC spectrum. In a regular 2D HSQC-TOCSY 
spectrum, TOCSY correlation peaks from those signals will all appear at ~66.5 ppm, which 
makes it impossible to distinguish which of the signals are correlated with each other. 
However, because of their different position along the F2 dimension, these signals will be 
displaced to different positions along the F1 axis in the (3,2)D HSQC and (3,2)D HSQC-TOCSY 
experiments (indicated by black arrows). This allows to separate the TOCSY correlations to 
different lines and, therefore, to assign the spectrum more easily. 
 
Fig. 6. 3. 4. Overlay of the regular 2D 1H, 13C HSQC spectrum (pink), 2D 1H, 13C HSQC-
TOCSY spectrum (purple) and 1H, 13C (3,2)D BIRDr,X-HSQC-TOCSY spectra (red and 
blue). The thick pink arrows indicate four groups of cross peaks that overlap in the 13C 
dimension, while the vertical and horizontal black arrows show the displacement and the 






In this example, the TOCSY cross peaks are stronger than the direct correlation peaks, as the 
magnetisation was efficiently transferred from the 13C- to 12C-attached protons during a 40 
ms TOCSY mixing time. The HSQC cross peaks at the δ1H of 4.90 and 4.36 ppm do not show 
any TOCSY correlations in the displayed region of the spectra and will be discussed later. On 
the other hand, signals resonating at 4.16 and 3.97 ppm show several HSQC-TOCSY 
correlations (purple circles), such as the cross peaks overlapping in the proton dimension of 
a regular HSQC-TOCSY spectrum between 4.44 and 4.66 ppm. This overlap is removed in the 
(3,2)D BIRDr,X-HSQC-TOCSY spectra (cross peaks circled by full and dashed red and blue 
lines). Analysis of the spectra showed that the original HSQC cross peaks belong to protons 
H3 and H2 of fucose 2,4-sulfated (4.16 ppm) and 3,4-sulfated (3.97 ppm), respectively. These 
protons show TOCSY transfers to protons H2 from 2,4S fucose (4.56 – 4.44 ppm, dashed 
circle) and H3 from 3,4S fucose (4.66 – 4.49 ppm, full line circle), respectively. Their 
separation in the (3,2)D BIRDr,X-HSQC-TOCSY spectra is a consequence of the unique 1H 
chemical shifts of H3 (4.16 ppm) and H2 (3.97 ppm) protons.  
Transfer of magnetisation from the H3 and H2 protons is seen to continue to protons H4 and 
H1 of their individual monosaccharide rings, an observation that allowed their assignment. 
These (H4, H1)/C2 and (H4, H1)/C3 cross peaks are also circled in Fig. 6. 3. 4 and appear in 
pairs between 4.7 and 5.7 ppm. The observed doubling of signals with distinct 1H chemical 
shifts within each circle is a consequence of the depolymerisation. Cleavage of the glycosidic 
bond generated fucose linked to a terminal modified GlcA monosaccharide with a C4-C5 
double bond (GlcA), while the original inner GlcA units are still present to some extent. A 
comparison with the chemical shifts of the native fCS allowed to establish that the H1 and H4 
chemical shifts of the terminal fucose linked to GlcA are always up to 0.2 ppm smaller. Their 
cross peaks are labelled with a  symbol in Fig. 6. 3. 4.  
The other two groups of cross peaks at ~66.5 ppm in F1 and at 4.87 and 4.36 ppm in F2, were 
assigned to H5/C5 of fucose, based on their TOCSY transfer to H6 protons that produced 
H6/C5 cross peaks in the empty region of the HSQC-TOCSY spectra (1.30 – 1.45/~66.5 ppm). 
The fact that both of these groups of signals belong to H5 of fucose was, however, only 
established through the analysis of (3,2)D BIRDr,X-HSQC-TOCSY spectra. Figure 6. 3. 5 
illustrates how the ambiguity of a regular HSQC-TOCSY experiment, where it is not clear 







Fig. 6. 3. 5. Overlay of the regular 2D 1H, 13C HSQC-TOCSY (purple) spectrum and 1H, 13C 
(3,2)D BIRDr,X-HSQC-TOCSY spectra (blue and red), focusing on H5/C5 (A) and H6/C5 
(B) cross peaks. The black arrows indicate displacement along the vertical axis and 
horizontal lines connect the H5 and H6 cross peaks. Blue cross peaks labelled by an asterisk 
indicate additional CH3 signals. 
 
 
In the native fCS polysaccharide fucose ring is stacked above the neighbouring GalNAc 
residue, enabling a formation of an unusual hydrogen bond from its H5 proton to the ring 
oxygen of GalNAc, as described previously55,194. During depolymerisation, β-elimination 
breaks the GalNAc(1→4)GlcA glycosidic bond, making fucose a terminal unit in the newly 
formed oligosaccharides. This results in significant lowering of the H5 chemical shift (by ca. 
0.51 ppm) and is indicative of successful depolymerisation. As seen above, the H1 and H4 of 
fucose are also affected in a similar manner, although to a lesser degree. 
The (3,2)D BIRDr,X-HSQC-TOCSY experiment also enabled assignment of H6 protons of both 
forms of fucose. As the coupling constant between protons H4 and H5 of fucose is close to 
zero, no transfer is possible from H5 to H4 protons and the correlations to H6 protons are 
strong. As seen in Fig. 6. 3. 5, protons H6 appear at around 1.41 and 1.33 ppm, for native and 
terminal fucose respectively, following the chemical shift trends seen for the other protons 
of fucose in different environments. Correlations in the opposite direction, from H6 to H5, 
are also resolved in a (3,2)D BIRDr,X-HSQC-TOCSY spectrum presented in Fig. 6. 3. 6. In the 
regular HSQC-TOCSY spectrum, these peaks were overlapped and it was not possible to 







Fig. 6. 3. 6. The methyl region of 2D 1H, 13C HSQC-TOCSY spectrum (purple) and 1H, 13C 
(3,2)D BIRDr,X-HSQC-TOCSY spectra (blue and red). A Overview of the methyl region for 
the depolymerised fCS mixture, as well as the correlated H5 protons. B Expanded view of the 
groups of peaks highlighted in A. Displacement of the H5 peaks in (3,2)D BIRDr,X-HSQC-







Upon the examination of the (3,2)D BIRDr,X-HSQC-TOCSY it became clear that it is useful to 
inspect both the Ω13C + Ω1H and Ω13C - Ω1H spectra. Peak separation in each spectrum follows 
a different pattern, depending on the pattern of correlations between 1H and 13C signals in 
the original 2D HSQC-TOCSY spectrum. If 13C chemical shifts are identical, separation of 
signals is identical in both spectra (Fig. 6. 3. 7. A). However, in cases when the proton and 
carbon chemical shifts in the overlapped areas both increase, better cross peak separation is 
achieved in the Ω13C - Ω1H spectrum (Fig. 6. 3. 7. B). On the other hand, in cases when 13C 
chemical shift decreases and 1H chemical shift increases (inverse correlation), better cross 
peak separation is achieved in the Ω13C + Ω1H spectrum (Fig. 6. 3. 7. C). Inspecting both spectra 
is also useful when the displaced peaks become overlapped with other peaks in one 
spectrum, as a clearer view can be provided by the second spectrum. 
 
Fig. 6. 3. 7. A schematic representation of different patterns of peak displacement in 
the two 1H, 13C (3,2)D BIRDr,X-HSQC-TOCSY spectra. A The pattern of peak separation in 
two spectra (red and blue for Ω13C - Ω1H and Ω13C + Ω1H, respectively) is identical when 13C 
chemical shifts in the original HSQC spectrum (pink) are the same for all peaks. B Better 
separation is obtained in the Ω13C - Ω1H spectrum (red) when 1H and 13C chemical shifts 
increase at the same time. C Better separation is obtained in the Ω13C + Ω1H spectrum (blue) 




These points are further illustrated in Fig. 6. 3. 8, where an overlay of four partial spectra is 
presented. Focusing on the overlapping 2,4S-H2 and 3,4S H3 2D HSQC cross peaks at ~4.52 
ppm (pink circle) and the 2,4S-H3 HSQC-TOCSY cross peaks at ~4.17 ppm (red and blue 




spectrum than in the Ω13C + Ω1H spectrum (blue). This is a consequence of the topology of the 
2,4S-H2 HSQC cross peaks indicated by the dotted arrows. 
 
Fig. 6. 3. 8. Overlay of the regular 2D 1H, 13C HSQC (pink), 2D 1H, 13C HSQC-TOCSY 
(purple) spectrum and 1H, 13C (3,2)D BIRDr,X-HSQC-TOCSY spectra (blue and red), 
focusing on H5/C5 (A) and H6/C5 (B) cross peaks. The black arrows indicate 
displacement along the vertical axis and horizontal lines connect the TOCSY cross peaks. The 
dotted arrows indicate a different degree of cross peak separations in the 2D HSQC and 







The presented methodology introduces a new application of a powerful 2D 1H, 13C 
HSQC-TOCSY experiment to carbohydrate samples with signal overlap in the 13C 
dimension. The proposed (3, 2)D BIRDr,X-HSQC-TOCSY experiment preserves high 
digital resolution in the indirectly detected (F1) dimension while accepting some 
sensitivity loss. The method was illustrated on the assignment of fucose resonances in 
a mixture of oligosaccharides containing FucX(1→3)GlcA and FucX(1→3)GlcA 
disaccharide fragments. The achieved resolution also made possible a more detailed 
assignment of individual resonances belonging to 2,4 or 3,4 sulfated fucose in different 
fCS oligosaccharides and accounted for the effects of reducing rings, which are a 




Although illustrated here on the TOCSY transfer, the same principles can also be 
applied to a NOESY experiment. In conclusion, the (3, 2)D BIRDr,X-HSQC-
TOCSY/NOESY are a powerful addition to the limited arsenal of NMR techniques 






































The main purpose of this thesis was to study the interactions between the fCS 
oligosaccharides from the sea cucumber species H. forskali and L- and P-selectins. This 
research aimed to provide new information on the nature of the fCS-selectin binding and to 
reveal structural data that could be used in the development of new drugs targeting selectins 
in treatment of conditions such as inflammation, cancer metastasis and HIV. The fCS-selectin 
interactions were studied using two different methods – the Saturation Transfer Difference 
(STD) NMR and the in silico modelling of the fCS-selectin complexes. 
STD experiments performed with the use of the commercially available L- and P-selectin 
constructs confirmed that the fCS oligosaccharides bind to the extracellular domains of these 
two proteins. Comparison of the STD response upon fCS binding to those two constructs 
indicates that the mode of binding is likely similar for both proteins. It was also possible to 
identify the regions within the fCS that are located in close proximity to the selectin surface 
upon binding. The largest response was observed for the methyl groups of galactosamine and 
fucose residues and from the fucose anomeric proton. Additional 2D STD-TOCSY experiment 
allowed to confirm the identity of other signals, such as protons H2, H3 and H5 of fucose and 
H1 and H2 of glucuronic acid. It was also possible to establish that fCS oligosaccharides of 
different sulfation pattern bind to selectins with different affinities.  
An STD experiment on the fCS binding to the L-selectin construct consisting of only the C-
type lectin domain was also performed. This experiment allowed to establish that the mode 
of binding is similar for a single-domain construct as for the larger constructs of L-selectin. 
No significant changes in the STD spectrum were observed in absence of the EGF-like and the 
SCR domains. This is an interesting observation as it is currently believed that the EGF-like 
domain plays a role in selectin-ligand binding and it has been shown that this domain 
influences the ability of cells to attach to the vascular endothelium. Unfortunately, the STD 
experiments do not provide enough structural information to elucidate the exact mechanism 
of the binding and make a detailed comparison for both constructs. It appears however, that 
the presence of the EGF-like domain is not required for the fCS-L-selectin binding to occur. 
Further STD experiments could be performed in future, using the same selectin constructs 
and testing their binding to native L-selectin ligand such as sLex. Use of other techniques, 




could also be explored in future to further investigate and compare the binding between the 
two L-selectin constructs and fCS oligosaccharides. 
Further insight into the fCS-selectin interactions was obtained from a series of computational 
studies on the binding between the fCS trisaccharides to P-selectin. Docking of the fCS 
oligosaccharides to P-selectin PDB structure 1G1Q allowed to establish that the binding site 
for fCS 2,4S and 3,4S trisaccharide is most likely the Ca2+-coordination site and that the P-
selectin residues predicted to participate in the binding are Tyr48, Glu80, Asn82, Asn83, 
Tyr94, Ser97, Asn105 and Lys111. These results indicate that both fCS trisaccharides inhibit 
P-selectin function by binding to the Ca2+-coordination site and preventing its interaction 
with the natural selectin ligand sialyl Lewis X (sLex). The computational studies also allowed 
to explore the dynamic behaviour of P-selectin upon binding to these two different 
trisaccharides. It was found that the P-selectin is able to undergo a conformational switch 
from the bent to extended state upon binding to fCS 3,4S trisaccharide at the Ca2+-
coordination site and that this movement does not cause any changes in the conformation of 
the ligand.  
In addition to the new information about the fCS-P-selectin binding, new insight into the 
binding between the sLex and the E-selectin was also obtained. The MD studies confirmed 
that sLex binds with higher energetic preference to the extended conformation of E-selectin 
(PDB structure 4CSY) than to the bent conformation (PDB structure 1G1T), and that the 
interactions were more stable upon binding to the 4CSY structure. A possible reason for this 
behaviour could be the position of the loop 83 – 90, which in the 4CSY structure points 
towards the carbohydrate and interacts with the fucose residue. The position of this loop has 
been previously correlated to the affinity of selectins for their ligands in both E- and P-
selectins. However, none of the computational studies undertaken in this work have detected 
a switch in position of this loop in either the bent or extended conformation of these two 
proteins. 
It was also found that in the 4CSY structure, the E-selectin exhibits a higher degree of 
flexibility in the interdomain region and adopts a new conformational ‘hyper-extended’ state. 
This conformation is achieved by a twisting movement of the EGF-like domain which turns 
by 50° degrees from its position in the extended conformation. After switching to this 
position, residues Thr136 – Asn138 of the EGF-like domain were able to develop interactions 
with the N-terminal region of the protein. As it was not the main focus of this study, the 
reason for this movement was not studied in more detail here. However, as the 4CSY 




interesting point of future research to determine the structural features within this protein 
that allow for such movement. Similarly as in the case of the fCS-P-selectin binding, the 
changes in protein conformation did not lead to any observable changes in the conformation 
of the carbohydrate ligand. 
Although the computational studies described here allowed to obtain new information about 
the fCS-selectin binding, they suffered from some imperfections. The docking software 
struggled to predict stable conformation of the oligosaccharides upon binding to selectins. 
Autodock Vina is a software more suitable for docking of smaller ligands to proteins with a 
clearly defined binding pocket. Future studies could test the use of different types of the 
docking software such as Dock, ICM, FlexX or Glide. Freezing the oligosaccharide in a single 
conformation during the docking and making it flexible only for the MD component of the 
simulation could also help in finding more stable docked complexes. For larger 
oligosaccharides, it could be possible to dock small segments of the carbohydrate in 
increments - such approach has previously been used to dock large ligands in Autodock195.  
In order to obtain more detailed structural information on the fCS-selectin binding, it would 
be desirable to have an isotopically labelled sample of the L- or P-selectin extracellular 
domains that could be used in the protein-observed NMR experiments. In such experiments, 
the ligand is titrated into the protein sample and changes in the chemical shifts of the protein 
signals are monitored, which allows to identify the amino acid residues that interact with the 
ligand. Therefore, another aim of this work was to develop protocols for expression of 
13C,15N-labelled L- and P-selectin constructs consisting of either the C-type lectin domain only 
or of both the C-type lectin and the EGF-like domains. Extensive work was undertaken in 
which many protocols for expression of these constructs in either the P. pastoris or E. coli 
were tested. Unfortunately, none of these tests were successful and, therefore, it was not 
possible to establish a suitable protocol for expression of the isotopically labelled selectin 
constructs. However, the experimental work described here can provide guidance for future 
attempts of expression of selectin constructs. It is possible that these proteins could be 
expressed if a different construct design was implemented. For example, expression levels of 
the soluble protein in E. coli could be increased by using a different fusion partner or by co-
expression of molecular chaperones that assist in protein folding processes. In some cases, 
use of a weaker promoter can help to increase the yield of soluble protein in E. coli cytoplasm. 
Alternatively, intracellular expression in P. pastoris could be tested, which would not require 
the addition of the N-terminal signalling sequence, believed to interfere with the correct 




used. For example, strain SMD1168 is deficient in proteases and, therefore, could help to 
prevent protein degradation during expression.  
Despite the lack of success with expression of selectin constructs in the bacterial and yeast 
cells, work undertaken in this project allowed to express a single-domain L-selectin construct 
in HEK293 cells, in collaboration with the Oxford Protein Production Facility. This construct 
was successfully used in the STD NMR experiments and could be used in the future studies 
on the L-selectin-ligand binding. For example, mutant versions of this construct could be 
produced to test the role of individual amino acid residues in the binding of selectin C-type 
lectin domain to the fCS oligosaccharides, verifying the findings of the computational studies. 
As proteins expressed in mammalian cells have previously been labelled with 13C and 15N 
isotopes, it could be possible to develop protocols for production of isotopically labelled L-
selectin construct in HEK293 cells in the future. 
Overall, this project provided a new insight into the interaction between the L- and P-
selectins and the fCS oligosaccharides. The information obtained in this work could help in 
development of future experiments on expression of selectin constructs, the studies of 
selectin-ligand interactions and potentially in the design of future drugs. 
Further work undertaken as part of this project allowed to develop a new NMR method for 
the study of carbohydrate mixtures, incorporating the concepts of G-matrix Fourier 
Transform (GFT) NMR into 2D HSQC and 2D HSQC-TOCSY experiments. The method allows 
to separate peaks in the regions of high spectral overlap in the 13C dimension, based on the 
difference in the 1H chemical shifts. This method was applied to the study of an fCS sample, 
containing a mixture of oligosaccharides produced via β-eliminative depolymerisation. It 
allowed to assign individual resonances of 2,4- and 3,4-sulfated fucose in different fCS 
oligosaccharides and account for the effects of reducing rings. The proposed (3, 2)D BIRDr,X-
HSQC-TOCSY experiment preserves high digital resolution and could be used in analysis of 
mixtures containing carbohydrates or small molecules. Other variants of this method, for 
example incorporating NOESY experiment, could be developed in future to further assist with 
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Calculated molecular weight (MW) and isoelectric point (pI) values for 
selectin constructs expressed in P. pastoris and E. coli  
 
Host Construct MW (kDa) pI 
Pichia 
pastoris 
LS1 14.5 8.6 
LS2 18.6 7.0 
PS1 14.5 9.1 
PS2 18.7 8.0 
Escherichia 
coli 
LS1 28.1 6.0 
LS2 32 5.9 
 
All values presented here were calculated using the ExPASy ProtParam On-line Tool from SIB 




















Temperature and energy plots for MD simulation on computationally 
produced sLex tetrasaccharide 
Temperature (A) and energy (B) plots for sLex tetrasaccharide over a 40 ns MD simulation. Total 
energy (ETOT) is shown in blue, kinetic energy (KE) – in red, and potential energy (PE) – in yellow. 
It should be noted that these values correspond to the whole solvated system and are not accurate 







Sample energy plots for MD simulations on fCS oligosaccharides 
Energy plots for fCS 2,4S trisaccharide (A) and nonasaccharide (B) over a 40 ns MD simulation. 
Total energy (ETOT) is shown in blue, kinetic energy (KE) – in red, and potential energy (PE) – in 
yellow. It should be noted that these values correspond to the whole solvated system and are not 







Structure and MD analysis of fCS 3,4S trisaccharide 
 
A. Lowest energy structure of the fCS 3,4S trisaccharide over a 40 ns MD simulation. B. Plot of 




































φ -70 -67 -66 -88 -106 -45 
ψ 130 129 130 -63 -72 129 
Fucα1-
3GlcA 
φ -79 -69 -72 -73 -88 -68 
























Pulse sequence of 2D 1H, 13C (3,2)D BIRDr,X-HSQC experiment 
 
;(3, 2)D BIRD(r,X)-HSQC 
;based on Bruker hsqcetgpsisp2.2 
;avance-version (12/01/11) 
;Interleaved HSQC with additional cosine or sine modulation of 13C chemical shift 
;by omega(1H) 
;2D H-1/X correlation via double inept transfer 
;   using sensitivity improvement 
;phase sensitive using Echo/Antiecho-TPPI gradient selection 
;with decoupling during acquisition 
;using trim pulses in inept transfer 
;using shaped pulses for all 180degree pulses on f2 - channel 
;with gradients in back-inept 
; 
; N. Brodaczewska, Z. Košťálová, D. Uhrín 
 
;A.G. Palmer III, J. Cavanagh, P.E. Wright & M. Rance, J. Magn. 
;   Reson. 93, 151-170 (1991) 
;L.E. Kay, P. Keifer & T. Saarinen, J. Am. Chem. Soc. 114, 
;   10663-5 (1992) 
;J. Schleucher, M. Schwendinger, M. Sattler, P. Schmidt, O. Schedletzky, 
;   S.J. Glaser, O.W. Sorensen & C. Griesinger, J. Biomol. NMR 4, 












































  d11 pl12:f2 
2 d11 do:f2  
 
# ifdef PRESAT 
  4u BLKGRAD 
  d12 pl9:f1 
  d1 cw:f1 ph29 
  d12 do:f1 
  d12 pl1:f1 
  50u UNBLKGRAD 
# else 
  4u BLKGRAD 
  d1 




if "l0 %2 == 0" 
     { 
   (p1 ph2) ; sin 
     } 
  else 
     { 
   (p1 ph1) ; cos 
     } 
 
  d25 
  p16:gp5 
  d16 
 
  (p1 ph1)      ;BIRD(r,X) 
  DELTA5  
  4u 
  (center (p2 ph2) (p14:sp3 ph1):f2 ) 
  4u 
  DELTA5 





  p16:gp5*-1 
  d16 
  d25  
 
  TAU1 pl0:f2 
  4u 
  (center (p2 ph1) (p14:sp3 ph6):f2 ) 
  4u 
  TAU2 pl2:f2  
  p28 ph1 
  4u 
  (p1 ph2) (p3 ph3):f2 ; transfer to 13C 
  d0  
  (p2 ph7) 
  d0 
  p16:gp1*EA 
  d16 pl0:f2 
  (p24:sp7 ph8:r):f2 
  4u 
  DELTA pl2:f2 
  (center (p1 ph1) (p3 ph4):f2 ) 
  4u 
  p19:gp3 
  d16 
  DELTA3 pl0:f2 
  (center (p2 ph1) (p24:sp7 ph9:r):f2 ) 
  4u 
  DELTA3 pl2:f2 
  p19:gp3 
  d16 
  (center (p1 ph2) (p3 ph5):f2 ) 
  4u 
  p16:gp4 
  d16 
  DELTA4 pl0:f2 
  (center (p2 ph1) (p14:sp3 ph1):f2 ) 
  4u 
  DELTA4 
  p16:gp4 
  d16 
  (p1 ph1) 
  DELTA1 
  (p2 ph1) 
  4u 
  p16:gp2 
  d16 pl12:f2 
; 4u BLKGRAD 
  go=2 ph31 cpd2:f2 
  d11 do:f2 mc #0 to 2  
     F1I(iu0, 2) 
     F1EA(calgrad(EA) & calph(ph5, +180), caldel(d0, +in0) & caldel(d25, +in25) & 
calph(ph3, +180) & calph(ph6, +180) & calph(ph31, +180)) 










ph4=0 0 2 2 
ph5=1 1 3 3 
ph6=0 
ph7=0 0 2 2 
ph8=0 0 2 2 
ph9=0 
ph29=0 
ph31=0 2 2 0 
 
;pl0 : 0W 
;pl1 : f1 channel - power level for pulse (default) 
;pl2 : f2 channel - power level for pulse (default) 
;pl3 : f3 channel - power level for pulse (default) 
;pl12: f2 channel - power level for CPD/BB decoupling 
;sp3: f2 channel - shaped pulse (180degree inversion) 
;spnam3: Crp60,0.5,20.1 
;sp7: f2 channel - shaped pulse (180degree refocussing) 
;spnam7: Crp60comp.4 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p3 : f2 channel -  90 degree high power pulse 
;p14: f2 channel - 180 degree shaped pulse for inversion 
;     = 500usec for Crp60,0.5,20.1 
;p16: homospoil/gradient pulse                         [1 msec] 
;p19: gradient pulse 2                                 [500 usec] 
;p22: f3 channel - 180 degree high power pulse 
;p24: f2 channel - 180 degree shaped pulse for refocussing 
;     = 2msec for Crp60comp.4 
;p28: f1 channel - trim pulse 
;d0 : incremented delay (2D)                           [3 usec] 
;d25 : incremented omega(1H) evolution delay  [3 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d4 : 1/(4J)XH 
;d11: delay for disk I/O                               [30 msec] 
;d16: delay for homospoil/gradient recovery 
;d24: 1/(8J)XH for all multiplicities 
;     1/(4J)XH for XH 
;cnst2: = J(XH) 
;cnst17: = -0.5 for Crp60comp.4 
;inf1: 1/SW(X) = 2 * DW(X) 
;in0: 1/(2 * SW(X)) = DW(X) 
;in25 = cnst1*in0 
;nd0: 2 
;ns: 1 * n 
;ds: >= 16 
;td1: twice the usual number of experiments 
;FnMODE: echo-antiecho 
;cpd2: decoupling according to sequence defined by cpdprg2 






;use gradient ratio:  gp 1 : gp 2 : gp 3 : gp 4 
;                       80 : 20.1 :   11 :   -5    for C-13 
;                       80 :  8.1 :   11 :   -5    for N-15 
 
;for z-only gradients: 
;gpz1: 80% 













;cnst17: Factor to compensate for coupling evolution during a pulse 
;       (usually +1). A positive factor indicates that coupling 
;       evolution continues during the pulse, whereas a negative 









Pulse sequence of 2D 1H, 13C (3,2)D BIRDr,X-HSQC - TOCSY experiment 
 
;(3, 2)D BIRD(r,X)-HSQC-TOCSY 
;Based on Bruker hsqcdietgpsisp.2 
;avance-version (12/01/11) 
;Interleaved HSQC-TOCSY with additional cosine or sine modulation of 13C chemical shift 
;by omega(1H) 
;2D H-1/X correlation via double inept transfer 
;   using sensitivity improvement and DIPSI2 
;   for homonuclear Hartman-Hahn mixing 
;phase sensitive using Echo/Antiecho-TPPI gradient selection 
;with decoupling during acquisition - using f2 
;using trim pulses in inept transfer 
;using shaped pulses for all 180degree pulses on f2 – channel 
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  DELTA3 pl0:f2 
  (center (p2 ph1) (p24:sp7 ph1):f2 ) 
  4u 
  DELTA3 pl2:f2 
  (center (p1 ph2) (p3 ph5):f2 ) 
  4u 
  DELTA2 pl0:f2 
  (center (p2 ph1) (p14:sp3 ph1):f2 ) 
  4u 
  DELTA2 pl10:f1 
 
      ;begin DIPSI2 
4 p6*3.556 ph22 
  p6*4.556 ph24 
  p6*3.222 ph22 
  p6*3.167 ph24 
  p6*0.333 ph22 
  p6*2.722 ph24 
  p6*4.167 ph22 
  p6*2.944 ph24 
  p6*4.111 ph22 
   
  p6*3.556 ph24 
  p6*4.556 ph22 
  p6*3.222 ph24 
  p6*3.167 ph22 
  p6*0.333 ph24 
  p6*2.722 ph22 
  p6*4.167 ph24 
  p6*2.944 ph22 





  p6*3.556 ph24 
  p6*4.556 ph22 
  p6*3.222 ph24 
  p6*3.167 ph22 
  p6*0.333 ph24 
  p6*2.722 ph22 
  p6*4.167 ph24 
  p6*2.944 ph22 
  p6*4.111 ph24 
 
  p6*3.556 ph22 
  p6*4.556 ph24 
  p6*3.222 ph22 
  p6*3.167 ph24 
  p6*0.333 ph22 
  p6*2.722 ph24 
  p6*4.167 ph22 
  p6*2.944 ph24 
  p6*4.111 ph22 
  lo to 4 times l1 
      ;end DIPSI2 
 
  4u pl1:f1 
  (p1 ph1) 
 
  DELTA1 
  (p2 ph1) 
  4u 
  p16:gp2 
  d16 pl12:f2 
; 4u BLKGRAD 
 
  go=2 ph31 cpd2:f2 
  d11 do:f2 mc #0 to 2  
     F1I(iu0, 2) 
     F1EA(calgrad(EA) & calph(ph5, +180), caldel(d0, +in0) & caldel(d25, +in25) & 
calph(ph3, +180) & calph(ph6, +180) & calph(ph31, +180)) 
exit 





ph4=0 0 2 2 
ph5=1 1 3 3 
ph6=0 




ph31=0 2 2 0 
   
 




;pl1 : f1 channel - power level for pulse (default) 
;pl2 : f2 channel - power level for pulse (default) 
;pl10: f1 channel - power level for TOCSY-spinlock 
;pl12: f2 channel - power level for CPD/BB decoupling 
;sp3: f2 channel - shaped pulse (180degree inversion) 
;spnam3: Crp60,0.5,20.1 
;sp7: f2 channel - shaped pulse (180degree refocussing) 
;spnam7: Crp60comp.4 
;p1 : f1 channel -  90 degree high power pulse 
;p2 : f1 channel - 180 degree high power pulse 
;p3 : f2 channel -  90 degree high power pulse 
;p6 : f1 channel -  90 degree low power pulse 
;p14: f2 channel - 180 degree shaped pulse for inversion 
;     = 500usec for Crp60,0.5,20.1 
;p16: homospoil/gradient pulse                         [1 msec] 
;p24: f2 channel - 180 degree shaped pulse for refocussing 
;     = 2msec for Crp60comp.4 
;p28: f1 channel - trim pulse                          [1 msec] 
;d0 : incremented delay (2D)                           [3 usec] 
;d25 : incremented omega(1H) evolution delay  [3 usec] 
;d1 : relaxation delay; 1-5 * T1 
;d4 : 1/(4J(XH)) 
;d9 : TOCSY mixing time 
;d11: delay for disk I/O                               [30 msec] 
;d16: delay for homospoil/gradient recovery 
;d24: 1/(8J)XH for all multiplicities 
;     1/(4J)XH for XH 
;cnst1: scaling factor for omega(1H) relative to omega(13C) 
;cnst2: = J(XH) 
;cnst17: = -0.5 for Crp60comp.4 
;l1: loop for DIPSI cycle: ((p6*115.112) * l1) = mixing time 
;inf1: 1/SW(X) = 2 * DW(X) 
;in0: 1/(2 * SW(X)) = DW(X) 
;in25 = cnst1*in0 
;nd0: 2 
;ns: 4 * n 
;ds: >= 16 
;td1: twice the usual number of experiments 
;FnMODE: echo-antiecho 
;cpd2: decoupling according to sequence defined by cpdprg2 
;pcpd2: f2 channel - 90 degree pulse for decoupling sequence 
 
;use gradient ratio: gp 1 : gp 2 
;     80 : 20.1       for C-13 
;     80 :  8.1       for N-15 
 
;for z-only gradients: 
;gpz1: 80% 
;gpz2: 20.1% for C-13, 8.1% for N-15 
;gpz5: 7% 
 








;cnst17: Factor to compensate for coupling evolution during a pulse 
;       (usually +1). A positive factor indicates that coupling  
;       evolution continues during the pulse, whereas a negative  


























Pulse sequence of 2D 1H, 13C (3,2)D BIRDr,X-HSQC (A) and 2D 1H, 13C 
(3,2)D BIRDr,X-HSQC-TOCSY (B) experiments 
 
